txt 20150306 hdrsgml 20150306 20150306084605 accession number 000119312515079935 conformed submission type d public document count filed date 20150306 date change 20150306 subject company company data company conformed name salix pharmaceutical ltd central index key 0001009356 standard industrial classification pharmaceutical preparation 2834 irs number 943267443 state incorporation fiscal year end 1231 filing value form type d sec act 1934 act sec file number 00553269 film number 15679762 business address street 8510 colonnade center drive city raleigh state zip 27615 business phone 919 8621000 mail address street 8510 colonnade center drive city raleigh state zip 27615 former company former conformed name salix holding ltd date name change 19970807 filed by company data company conformed name salix pharmaceutical ltd central index key 0001009356 standard industrial classification pharmaceutical preparation 2834 irs number 943267443 state incorporation fiscal year end 1231 filing value form type d business address street 8510 colonnade center drive city raleigh state zip 27615 business phone 919 8621000 mail address street 8510 colonnade center drive city raleigh state zip 27615 former company former conformed name salix holding ltd date name change 19970807 d ddscdhtm d d table content united state security exchange commission washington dc 20549 schedule d solicitationrecommendation statement section d security exchange act 1934 salix pharmaceutical ltd name subject company salix pharmaceutical ltd name person filing statement common stock par value 0001 per share title class security 795435106 cusip number class security william bertrand jr acting chief operating officer executive vice president general counsel salix pharmaceutical ltd 8510 colonnade center drive raleigh north carolina 27615 919 8621000 copy to christopher cox gregory patti jr cadwalader wickersham taft llp one world financial center new york 10281 212 5046000 name address telephone number person authorized receive notice communication behalf person filing statement check box filing relates solely preliminary communication made commencement tender offer table content table content page item subject company information item identity background filing person item past contact transaction negotiation agreement item solicitation recommendation item personsassets retained employed compensated used item interest security subject company item purpose transaction plan proposal item additional information item exhibit i table content item subject company information name address name subject company solicitationrecommendation statement schedule d together exhibit annex attached hereto schedule d relates salix pharmaceutical ltd delaware corporation the company we us companys principal executive office located 8510 colonnade center drive raleigh north carolina 27615 companys telephone number address 919 8621000 security title class equity security schedule d relates companys common stock par value 0001 per share the shares february 27 2015 i 64248604 share issued outstanding excluding share company restricted stock a defined below ii outstanding option company options purchase 105199 share iii 3724554 share subject issuance available grant companys stock option plan iv 11367710 share issuable upon conversion companys outstanding convertible note issued pursuant a indenture company u bank national association dated march 16 2012 b indenture company u bank national association dated june 2010 in case without giving effect makewhole adjustment giving effect companys election settle principal amount conversion cash v outstanding warrant purchase 10484343 share without giving effect makewhole adjustment vi 1361497 outstanding unvested restricted share company restricted stock item identity background filing person name address filing person subject company name business address business telephone number company set forth item subject company information name address companys website wwwsalixcom information companys website considered part schedule d incorporated herein reference tender offer merger schedule d relates tender offer sun merger sub inc purchaser delaware corporation whollyowned subsidiary valeant pharmaceutical international vpi delaware corporation whollyowned subsidiary valeant pharmaceutical international inc valeant corporation organized law british columbia purchase issued outstanding share purchase price 15800 per share the offer price net holder cash without interest le applicable withholding tax upon term subject condition set forth offer purchase dated march 2015 the offer purchase related letter transmittal the letter transmittal which together amendment supplement thereto collectively constitute offer offer described tender offer statement schedule filed vpi purchaser united state security exchange commission the sec march 2015 a may amended supplemented time time schedule to offer purchase letter transmittal filed exhibit a a schedule d respectively incorporated herein reference offer made pursuant agreement plan merger dated february 20 2015 among company vpi purchaser and solely certain section specified merger agreement valeant a may amended modified time time merger agreement merger agreement provides among thing following consummation offer subject satisfaction waiver applicable condition set forth merger agreement purchaser merged company the merger company surviving whollyowned subsidiary vpi the surviving corporation table content effective time merger the effective time share acquired offer other i share owned valeant vpi purchaser company respective whollyowned subsidiary ii share held stockholder properly demand appraisal share pursuant section 262 general corporation law state delaware the dgcl cancelled converted right receive amount cash equal offer price the merger consideration without interest subject applicable withholding tax merger agreement provides merger effected pursuant section h dgcl permit completion merger upon acquisition purchaser offer least percentage stock company would required adopt merger agreement meeting stockholder merger effected pursuant section h dgcl vote stockholder company required consummate merger immediately prior effective time unexpired unexercised company option stock plan company including amended restated company 2014 stock incentive plan company 2005 stock plan company 1996 stock plan plan agreement arrangement the company stock plans whether exercisable vested cancelled and exchange therefor former holder cancelled company option entitled receive consideration cancellation company option settlement therefor payment cash subject applicable withholding tax amount equal product i total number share previously subject company option ii excess any merger consideration exercise price per share previously subject company option such amount referred option payments immediately prior effective time share company restricted stock automatically become fully vested cancelled effective time exchange therefor former holder cancelled company restricted stock entitled receive consideration cancellation company restricted stock settlement therefor payment cash subject applicable withholding tax equal per share merger consideration offer initially scheduled expire 1200 midnight eastern time april 2015 one minute 1159 pm eastern time march 31 2015 the expiration date unless purchaser extends offer pursuant accordance term merger agreement event expiration date mean latest time date offer extended expire upon term subject condition offer including offer extended amended term condition extension amendment purchaser accept payment share validly tendered properly withdrawn pursuant offer soon practicable expiration date but later 900 am eastern time first business day expiration date soon practicable later three business day expiration date purchaser pay share foregoing summary offer qualified entirety detailed description explanation contained offer purchase letter transmittal offer purchase state address principal executive office purchaser vpi 400 somerset corporate boulevard bridgewater new jersey 08807 telephone number principal office 908 9271400 upon filing schedule d sec company make schedule d publicly available website wwwsalixcom 2 table content item past contact transaction negotiation agreement except set forth schedule d otherwise incorporated herein reference knowledge company date schedule d material agreement arrangement understanding actual potential conflict interest company affiliate one hand i companys executive officer director affiliate ii valeant vpi purchaser respective executive officer director affiliate hand relationship vpi purchaser certain affiliate merger agreement summary material term merger agreement set forth section offer purchase description condition offer contained section offer purchase incorporated herein reference summary purport complete qualified entirety reference merger agreement filed exhibit e schedule d hereby incorporated herein reference merger agreement provided solely inform stockholder company term representation warranty covenant contained merger agreement made solely benefit party merger agreement addition representation warranty covenant i intended statement fact rather way allocating risk party merger agreement ii qualified reference confidential disclosure made party connection merger agreement iii may apply standard materiality way different may viewed material stockholder of investor in company valeant accordingly merger agreement included filing provide investor information regarding term merger agreement provide investor factual information regarding company business stockholder rely representation warranty covenant description thereof characterization actual state fact condition company vpi purchaser valeant respective subsidiary affiliate moreover information concerning subject matter representation warranty may change date merger agreement subsequent information may may fully reflected public disclosure company acknowledges that notwithstanding inclusion foregoing cautionary statement responsible considering whether additional specific disclosure material information regarding material contractual provision required make statement schedule d misleading confidentiality agreement valeant company entered confidentiality agreement effective january 20 2015 the confidentiality agreement term confidentiality agreement valeant agreed that subject certain exception nonpublic information made available company valeant representative would kept confidential except provided confidentiality agreement related amendment dated february 2015 used valeant representative solely purpose evaluating negotiating possible mutually agreed business combination valeant company confidentiality agreement includes standstill provision prohibits valeant representative taking certain action respect company period eighteen month date agreement subject certain customary exception termination provision foregoing summary description confidentiality agreement purport complete qualified entirety reference confidentiality agreement filed exhibit e schedule d hereby incorporated herein reference 3 table content arrangement current executive officer director company certain companys executive officer director may deemed interest transaction contemplated merger agreement including offer merger different from addition to interest companys stockholder generally companys board director the board aware interest considered them among matter evaluating negotiating merger agreement reaching decision approve merger agreement transaction contemplated thereby described detail below interest include cancellation unexpired unexercised company option held executive officer director effective time exchange payment cash subject applicable withholding tax equal product i total number share subject company option immediately prior effective time ii excess any merger consideration exercise price per share company option full vesting acceleration share company restricted stock held executive officer director effective time cancellation company restricted stock exchange payment cash subject applicable withholding equal merger consideration receipt severance payment benefit executive officers individual employment agreement upon qualifying termination employment occur following effective time certain commitment regarding compensation benefit provided vpi surviving corporation employee including executive officer remain employed vpi subsidiary thereof following effective time entitlement indemnification benefit favor executive officer director company information respect arrangement company named executive officer see information included item additional information potential mergerrelated compensation which hereby incorporated item reference effect offer merger agreement company share option restricted stock company share company executive officer director tender share purchase pursuant offer receive cash consideration per share term condition stockholder company tender share executive officer director tender share offer upon consummation merger share represent right receive merger consideration term condition stockholder company company option merger agreement provides that immediately prior effective time company option whether exercisable vested cancelled and exchange therefor former holder cancelled company option entitled receive consideration cancellation company option payment cash equal product i total number share subject company option immediately prior effective time ii excess any merger consideration exercise price per share company option subject withholding tax company restricted stock merger agreement also provides that immediately prior effective time share company restricted stock automatically become fully vested cancelled effective time 4 table content exchange therefor former holder cancelled company restricted stock entitled receive consideration cancellation company restricted stock payment cash equal per share merger consideration subject withholding tax summary equity award payment following table set forth companys executive officer director february 27 2015 i number share beneficially owned person which clarity excludes share issuable upon exercise company option vesting company restricted stock ii aggregate cash consideration would payable share iii aggregate number share subject company option company restricted stock iv value cash amount payable respect company option company restricted stock pretax basis effective time calculated a case company option multiplying number share subject company option excess merger consideration respective per share exercise price applicable company option b case company restricted stock multiplying merger consideration number share subject company restricted stock award number ofsharesbeneficiallyowned cashconsiderationfor sharesbeneficiallyowned numberof sharessubject tovestedoptions aggregatecashconsiderationfor option number ofunvestedstockawards cashconsiderationfor stockawards nonemployee director john chappell 316394 49990252 0 6370 1006460 william keane 33390 5275620 15000 2105550 6370 1006460 mark sirgo 31057 4907006 0 6370 1006460 executive officer thomas dalonzo 92845 14669510 15000 2105550 21032 3323056 william bertrand 2969 469102 0 28289 4469662 timothy creech 9165 1448070 0 21372 3376776 william forbes 62880 9935040 0 51714 8170812 rick scruggs 30956 4891048 0 48006 7584948 current director executive officer group person 579656 91585648 30000 4211100 189523 29944634 employment agreement company previously entered employment agreement executive officer mr dalonzo messrs bertrands creechs scruggss dr forbes employment agreement provides executive officer certain severance payment benefit event termination employment without reasonable cause resignation good reason a term defined below occurs within twelve month change control company would include consummation offer such termination qualifying termination event qualifying termination subject executive officers execution effective release claim favor company executive officer paid lump sum cash amount equal sum thirtysix month thirty month mr creech base salary date termination product three time two half time mr creech maximum annual target bonus cash severance addition executive officer reimbursed cost health insurance coverage lesser thirtysix month thirty month mr creech executive officer commences employment subsequent employer or gainful selfemployment health coverage reimbursement executive officer also provided outplacement benefit six month following termination outplacement assistance reimbursed relocate back original place residence executive relocated request company within eighteen month prior change control relocation reimbursement 5 table content based compensation level february 27 2015 estimated total value severance payment benefit executive officer would entitled termination employment without reasonable cause good reason case within twelve month following effective time follows mr bertrand 2860241 mr creech 1440160 dr forbes 2954192 mr scruggs 2187408 total estimated amount consist following executive officer cashseverance health coveragereimbursement 1 outplacementassistance 2 relocationreimbursement mr bertrand 2722500 69192 5000 63549 2860241 mr creech 1377500 57660 5000 0 1440160 dr forbes 2880000 69192 5000 0 2954192 mr scruggs 2113216 69192 5000 0 2187408 9093216 265236 20000 63549 9442001 1 executive officer health coverage reimbursement amount assumes monthly cost 1922 thirtysix month thirty month mr creech 2 assumes provision outplacement service six month executive officer employment agreement subject nonsolicitation employee covenant period one year following termination employment employment agreement reasonable cause generally defined a i act gross negligence fraud dishonesty willful violation law material violation significant written policy company cause material harm company ii conviction a felony b serious crime involving moral turpitude iii willful gross failure substantially perform duty reasonably assigned executive intentional refusal without compelling reason executive discharge job responsibility andor respond companys legitimate jobrelated request insofar duty responsibility andor request contravene law consistent executives position iv failure cooperate investigation conducted andor undertaken company governmental agency reasonable legitimate objective v act intentional conflict interest executive related company result likely result material economic andor material damage company good reason generally mean occurrence following event condition i material adverse change in assignment executive duty responsibility inconsistent with executives status title position responsibility including reporting responsibility company ii reduction executives salary andor benefit except extent reduction comparable percentage reduction salary andor benefit employee company failure pay executive compensation benefit executive entitled within five day date due iii company successor relocates executives workplace fifty mile executives current workplace iv material breach company provision employment agreement compensation action signing merger agreement completion merger term merger agreement company may take certain compensation action prior completion merger affect executive officer interim period company may implement increase compensation benefit director officer employee consultant company grant new equity award person treatment 2014 annual bonus company will ordinary course business make annual bonus payment employee including executive officer respect 2014 fiscal year provided aggregate amount payment exceed specified amount agreed vpi based companys projected accrual bonus payment 6 table content employee matter following closing merger agreement provides period beginning effective time ending first anniversary effective time the continuation period vpi provide cause surviving corporation provide company employee remains employed vpi subsidiary thereof company employee following closing date compensation benefit le favorable aggregate either compensation benefit generally made available company employee immediately prior effective time similarly situated employee vpi determined vpi sole discretion except expressly provided merger agreement nothing merger agreement intended limit right vpi surviving corporation i terminate employment company employee time ii change modify incentive compensation employee benefit plan arrangement time manner iii change modify term condition employment employee addition respect compensation benefit plan sponsored vpi affiliate each vpi benefit plan company employee participate effective effective time vpi will cause surviving corporation to use reasonable best effort i waive preexisting condition exclusion waiting period respect participation coverage requirement applicable company employee vpi benefit plan welfare plan extent inapplicable to satisfied under benefit compensation plan sponsored company prior effective time each company benefit plan ii cause eligible expense incurred salix employee company benefit plan portion plan year ending closing date taken account purpose satisfying applicable deductible outofpocket requirement corresponding vpi benefit plan welfare plan extent employee would received credit copayment deductible corresponding company benefit plan applicable employee participated immediately prior effective time iii recognize service company employee company subsidiary prior effective time purpose eligibility vesting but benefit accrual vpi benefit plan company employee eligible participate effective time extent service credited company benefit plan except extent service credit result duplication benefit company employee including executive officer company terminates employment period beginning effective time ending first anniversary thereof entitled severance pay benefit le favorable aggregate severance pay benefit company employee would entitled pursuant severance plan arrangement effect prior execution merger agreement termination employment occurred immediately prior effective time including executive officer mr dalonzo severance payment benefit described employment agreements respect company employee employment agreement previously disclosed vpi connection execution merger agreement vpi honor cause honored term employment agreement expiration modification termination agreement conformity applicable law provision contained merger agreement respect employee included sole benefit respective party merger agreement create thirdparty beneficiary right person including company employee former employee participant company benefit plan beneficiary dependent thereof provision merger agreement may i construed x establish amend modify company benefit plan benefit plan program agreement arrangement including vpi benefit plan y require vpi surviving corporation continue amend company benefit plan vpi benefit plan particular benefit plan consummation transaction contemplated merger agreement z prevent limit vpi terminating modifying vpi benefit plan company benefit plan employee benefit plan vpi may establish maintain ii require vpi continue maintain employment company employee following closing date 7 table content indemnification directors officers insurance merger agreement provides right indemnification exculpation liability act omission occurring prior effective time and right advancement expense existing time merger agreement favor person is prior effective time becomes time prior date merger agreement director officer employee agent including fiduciary respect employee benefit plan company subsidiary respective predecessor i survive merger ii continue full force effect accordance term respect claim person arising act omission iii amended repealed otherwise modified manner would adversely affect right thereunder person vpi ensure surviving corporation complies honor obligation described paragraph event threatened actual action suit claim proceeding investigation arbitration each indemnified proceeding whether civil criminal administrative reason i fact individual member board officer company date merger agreement becomes prior effective time an indemnified party director officer employee agent including fiduciary respect employee benefit plan company subsidiary respective predecessor serving request company director officer employee agent another person ii merger agreement transaction contemplated merger agreement whether case asserted arising effective time surviving corporation indemnify hold harmless fullest extent permitted applicable law indemnified party loss claim damage liability cost expense including reasonable attorneys fee expense advance final disposition indemnified proceeding indemnified party fullest extent permitted applicable law upon receipt undertaking required applicable law judgment fine amount paid settlement connection threatened actual indemnified proceeding period beginning upon acceptance payment of payment purchaser for share pursuant offer ending six year effective time surviving corporation will vpi cause surviving corporation to maintain benefit indemnified party insurance indemnification policy provides coverage event occurring prior effective time the do insurance contains term including respect coverage amount condition including respect deductible exclusion are individually aggregate le favorable indemnified party companys directors officers liability insurance policy effect date merger agreement or insurance coverage unavailable best available coverage however surviving corporation required pay premium do insurance excess 300 last annual premium paid prior date merger agreement the maximum amount amount annual premium necessary maintain procure insurance coverage exceeds maximum amount vpi surviving corporation procure maintain sixyear period advantageous policy available annual premium equal maximum amount obligation indemnification section merger agreement may terminated modified manner adversely affect indemnified party without written consent affected indemnified party it expressly agreed indemnified party third party beneficiary section merger agreement section matter pursuant merger agreement company agreed take action reasonably necessary cause transaction contemplated merger agreement disposition equity security company including derivative security connection transaction contemplated merger agreement individual subject reporting requirement section a security exchange act 1934 amended the exchange act exempt rule b exchange act 8 table content item solicitation recommendation recommendation board meeting held february 20 2015 board i determined transaction contemplated merger agreement including offer merger fair best interest company stockholder ii approved declared advisable merger agreement transaction contemplated merger agreement including offer merger iii determined recommend companys stockholder accept offer tender share purchaser offer accordingly board recommends companys stockholder accept offer tender share offer background reason recommendation background offer merger part ongoing evaluation companys business member companys senior management board respectively periodically review ass companys operation financial performance industry condition regulatory development may impact companys longterm strategic goal plan potential opportunity business combination acquisition financial strategic alternative november 2013 company announced entered definitive merger agreement acquire santarus inc santarus approximately 26 billion cash board believed santarus acquisition i solidified companys lead gastrointestinal market ii provided opportunity revenue diversification iii resulted attractive financial profile combined company iv provided significant revenue expense synergy opportunity closing price share november 2013 immediately prior announcement santarus acquisition 7131 also november 2013 chief executive officer party contacted companys chief executive officer carolyn logan requested meeting m logan november 11 2013 board held telephonic meeting authorized m logan accept meeting party as chief executive officer addition board authorized management engage cadwalader wickersham taft llp cadwalader legal counsel nationally recognized investment banking firm financial advisor the prior financial advisor connection discussion party december 2013 board held person meeting representative cadwalader prior financial advisor participating representative cadwalader prior financial advisor provided overview party representative cadwalader discussed boards fiduciary duty context potential offer party acquire company representative prior financial advisor discussed director recent merger acquisition activity life science industry public market perspective company including analysis stockholder base december 19 2013 m logan met chief executive officer party meeting party chief executive officer expressed party as interest company requested party permitted conduct high level due diligence review company party chief executive officer 9 table content provide specific information regarding potential offer company might make transaction party might interested pursuing company december 20 2013 board held telephonic meeting representative cadwalader prior financial advisor participating considering party chief executive officers request board unanimously determined best interest company stockholder permit party proceed due diligence exercise time due to among thing pending santarus acquisition largest companys history significant time resource would required successfully integrate santarus company following completion acquisition december 24 2013 m logan advised party chief executive officer boards determination party chief executive officer replied would contact m logan february january 2014 company completed santarus acquisition february 2014 board held person meeting representative cadwalader prior financial advisor participated light party chief executive officers statement would contact m logan february representative prior financial advisor discussed certain financial analysis company representative cadwalader discussed board fiduciary duty context potential offer acquire company march 2014 company received proposal third party domiciled outside united state the nonus party company acquire certain asset party merger transaction company would redomicile outside united state march 2014 party chief executive officer requested party given opportunity conduct high level due diligence review company party chief executive officer provide specific information regarding potential offer party might make regarding company transaction party might interested pursuing company march 13 2014 board held telephonic meeting representative cadwalader prior financial advisor participated director discussed companys advisor party as request conduct due diligence company director noted party made transaction proposal provided insight whether proposal would follow due diligence review company director also agreed factor considered connection party as prior request conduct due diligence continued apply based foregoing board unanimously determined provide party access due diligence material time board also discussed potential transaction nonus party including advantage disadvantage domiciled nonus jurisdiction march 20 2014 board held person meeting representative cadwalader prior financial advisor participated board discussed companys advisor inversion transaction generally advantage disadvantage transaction well potential transaction nonus party april 2014 nonus party advised company withdrawing interest potential transaction company due tax structuring issue nonus partys proposal also april 2014 company initiated discussion cosmo pharmaceutical spa cosmo respect potential strategic transaction involving two company discussion company cosmo regarding structure term potential transaction continued beginning july 2014 board discussed transaction including companys legal financial advisor meeting held april 17 june june 13 june 24 july july 2014 10 table content july 2014 company entered agreement plan merger reorganization the cosmo agreement cosmo cosmo technology limited irish incorporated subsidiary cosmo cosmo tech sangiovese llc newly formed subsidiary cosmo tech term cosmo agreement company would become whollyowned subsidiary irish domiciled cosmo tech would change name salix pharmaceutical plc salix plc companys stockholder would become stockholder salix plc result transaction combined company would cosmos u patent rifamycin mmx methylene blue mmx uceris which company licensed cosmo one companys key product specified right negotiation respect product cosmo affiliate sought develop commercialize u addition combined company would hold cosmos patent rifamycin mmx several country closing cosmo transaction subject several condition including approval companys stockholder june 27 2014 chief executive officer party contacted m logan request meet m logan scheduled meeting party chief executive officer held july 29 2014 discussed board july 2014 meeting party chief executive officer made oral offer acquire company cash price 180 per share subject party as satisfactory completion due diligence review company july 30 2014 board held telephonic meeting representative cadwalader participating m logan reported meeting party chief executive officer board also determined engage centerview partner llc centerview serve companys financial advisor connection with among thing offer party prior financial advisor retained connection matter time engaged party certain matter august 13 2014 board held person meeting representative centerview cadwalader participating representative cadwalader discussed board directors fiduciary duty context considering evaluating party proposal representative centerview discussed certain financial analysis respect company based information provided company following discussion including directors companys advisors expectation party would willing increase offer board unanimously determined m logan advise party as chief executive officer 180 per share offer insufficient form basis discussion party including commencement due diligence party board would review improved offer consistent fiduciary duty m logan advised party as chief executive officer august 14 2014 august 19 2014 wall street journal reported party approached company respect potential acquisition company day closing price share 16080 increase approximately 155 previous days closing price 13917 august 20 2014 party chief executive officer called m logan communicate increase party as proposal 180 200 per share cash party chief executive officer advised party as intention position complete due diligence announce transaction within three week later day m logan updated board revised offer board agreed meet person august 22 2014 evaluate revised proposal august 22 2014 board held person meeting representative centerview cadwalader participated representative centerview discussed board certain financial analysis respect company party offer based information provided company director discussed whether company engage party company also contact potential acquirors noted despite medium report regarding party as approach company potential sale company company contacted potential bidder other accountant investment banker purporting represent potential interested party also noted 11 table content board determined party offer presented compelling full price time would take conduct presigning market check presented substantial risk party withdrawing offer detailed discussion board unanimously authorized i m logan contact party chief executive officer counteroffer 210 per share ii management agree subject negotiation board approval definitive merger agreement allcash transaction 205 per share including agreeing period exclusive negotiation price iii management permit party conduct due diligence company august 25 2014 m logan conveyed boards counteroffer 210 per share advised party willing proceed price company would willing enter exclusive negotiation party august 26 2014 party chief executive officer advised m logan party board director initially viewed party as 200 per share offer best final offer exchange three week period exclusivity would increase offer 205 per share cash party chief executive officer noted offer party as best final offer later day board held telephonic meeting representative centerview cadwalader participating board approved engagement party respect potential sale company including providing due diligence access party granting party three week exclusivity exchange price increase 200 205 per share august 27 2014 party as counsel provided company initial draft merger agreement august 28 2014 company party entered confidentiality standstill exclusivity agreement which standstill provision terminated upon company entering merger agreement company provided party access electronic data room course next seven day party conducted due diligence review company concurrently negotiation definitive merger agreement september 2014 party raised question regarding data provided company respect inchannel inventory advised company party needed conduct additional due diligence september 15 2014 party advised company become concerned level wholesaler inventory companys key product distribution channel discussion regarding potential transaction ceased party reviewed matter september 22 2014 new york time reported party discussion acquire company september 22 2014 treasury department internal revenue service issued notice 201452 the notice reduced tax benefit available inversion made difficult u company invert notice require congressional action applied immediately inversion completed september 21 2014 result notice created uncertainty regarding potential benefit company expected achieve cosmo agreement september 23 2014 party chief executive officer advised m logan party decreasing proposed purchase price acquire company 175 per share result review wholesaler inventory level companys key product also september 23 2014 chief executive officer party contacted m logan express party bs interest commencing discussion party acquire company september 24 2014 board met telephonically representative centerview cadwalader participating board discussed party as revised proposal party bs invitation discus potential 12 table content acquisition company party following detailed discussion board unanimously determined advise party willing discus transaction substantially lower offer price goal compelling party increase offer board also determined with mr chappell dissenting authorize management respond party bs invitation discus potential acquisition company order obtain additional information including party bs proposed purchase price anticipated timeline entering transaction mr chappell expressed view company instead refocus companys standalone plan discussion party potentially going discontinued following companys response party party make revised proposal initiate contact company later contacted company fully described below september 24 2014 several medium outlet reported party bs interest potential acquisition company intraday trading share achieved alltime high trading price 17298 per share september 29 2014 board met telephonically representative cadwalader participating board discussed pending cosmo transaction result story press regarding potential sale company issuance notice treasury department internal revenue service representative cosmo contacted representative company inquired whether company intended terminate cosmo transaction board discussed rapidly changing political environment respect inversion transaction risk future congressional action could substantially reduce eliminate benefit transaction company risk companys stockholder would approve transaction following discussion board unanimously determined authorize direct management enter agreement cosmo terminate cosmo transaction september 30 2014 party delivered letter company setting forth preliminary proposal subject completion satisfactory due diligence review company acquire company price range 178 185 per share 60 70 consideration paid cash remainder party stock october 2014 board met telephonically representative centerview cadwalader participating discussed whether authorize management engage discussion party respect proposal contact party ascertain whether remained interested potential acquisition company detailed discussion i board determined with mr chappell dissenting authorize management allow party perform due diligence negotiate party respect proposal ii board unanimously agreed authorize company management contact party ascertain whether party remained interested potential transaction october 2014 company entered termination agreement cosmo cosmo tech certain affiliate wherein party mutually agreed terminate effective immediately cosmo agreement consideration termination cosmo agreement company paid cosmo tech 25 million party agreed mutually release certain related person respect matter relating cosmo agreement transaction contemplated thereby october 2014 company entered confidentiality standstill agreement party which standstill provision terminated upon company entering merger agreement provided party access electronic data room october 2014 companys management conducted management presentation party october 2014 chief executive officer party advised m logan party would proceeding transaction citing concern transaction antitrust perspective october 13 2014 chief executive officer party advised m logan party would proceeding transaction time may reapproach company companys announcement third quarter earnings 13 table content period following party as expression potential concern regarding level wholesaler inventory companys key product distribution channel management direction board engaged detailed review fact circumstance respect inventory level companys key product including whether fact circumstance raised significant accounting concern impacted companys reported financials october 14 2014 board directed audit committee board the audit committee conduct review with outside counsel retained audit committee respect inventoryrelated disclosure related matter november 2014 connection release companys financial operating result quarter ended september 30 2014 company announced wholesaler inventory level certain key product excess amount indicated companys chief financial officer previous investor conference call company also announced negotiating principal wholesaler enter distribution service agreement product portfolio expected agreement finalized would enable company achieve objective predictably deliberately reducing wholesaler inventory level xifaxan 550 apriso uceris approximately month end 2016 depending future demand product company also announced audit committee retained outside counsel conducting review issue related managements prior characterization wholesaler inventory level company stated notified security exchange commission audit committee conducting review company also announced november 2014 chief financial officer resigned timothy creech companys senior vice president finance administrative service appointed acting chief financial officer company retained nationally recognized executive search firm assist company identifying individual serve companys chief financial officer permanent capacity help formulate execute companys financial strategy successfully navigate companys continued growth open trading november 2014 share opened price 9017 per share approximately 35 reduction closing price 13855 november 2014 immediately prior companys announcement regarding wholesaler inventory level audit committee review share closed price 9147 per share november 2014 shortly following companys announcement chief executive officer party contacted m logan inquire whether company would interested reengaging party discus potential acquisition company party proposed meeting senior management company party held november 20 2014 november 13 2014 board authorized management attend meeting party m logan advised party chief executive officer accordingly november 17 2014 party party announced entered definitive agreement pursuant party would acquire party following companys announcement november 2014 company board took significant step address remediate issue raised companys wholesale inventory level ensure company positioned continue execute longterm strategy independent company addition companys management notified investment banking relationship party interest exploring potential acquisition company representative centerview also informed party interest potential acquisition company november 18 2014 board held telephonic meeting representative cadwalader participated board discussed whether company conduct market check respect potential sale company director discussed detail risk facing company standalone basis risk discussed director meeting future meeting board potential sale company considered included without limitation i risk relating pending audit 14 table content committee review matter subject review including risk adverse action sec companys major wholesale distributor may cease purchasing companys product ii possibility food drug administration fda approval xifaxan 550 treatment irritable bowel syndrome diarrhea ibsd core driver potential growth companys longterm plan could delayed would obtained all iii possibility even fda approval xifaxan 550 treatment ibsd obtained result challenge facing company may unable launch product level success originally anticipated iv risk generic competition including respect significant contribution companys earnings single product xifaxan 550 v liquidity risk relating fact companys 3450 million convertible senior note due may 15 2015 the 2015 notes coming due near term company may adequate liquidity able pay 2015 note continue operate business ordinary course november 22 2014 board held telephonic meeting representative centerview cadwalader participated representative centerview discussed preliminary valuation analysis company based information provided company well illustrative list potential buyer company following detailed discussion board determined mr chappell dissenting authorize management companys financial advisor contact potential buyer near term determine whether interest acquiring company mr chappell expressed view company instead focus companys standalone plan making determination board discussed decision made sell company rather board seeking information regarding potential interest third party acquiring company company continued implement standalone plan board also authorized management contact jp morgan security llc jp morgan retain jp morgan companys financial advisor addition centerview connection potential sale company board believed two financial advisor would broaden depth contact potential bidder increase opportunity maximize stockholder value event potential sale company november 22 2014 meeting m logan also updated board discussion companys primary wholesaler regarding entering distribution service agreement well timing reducing wholesaler inventory level companys key product november 24 2014 company announced engaged nationally recognized search firm conduct comprehensive search assist company identifying experienced highly qualified individual serve independent member board company noted search process would seek identify proven business leader complementary relevant expertise increase depth skillset perspective board december 2014 board held telephonic meeting representative centerview cadwalader participated board discussed issue surrounding upcoming maturity 2015 note potential solution well companys upcoming liquidity need board also discussed completing previously announced reduction wholesaler inventory level companys key product rapidly previously planned representative centerview also reported recent conversation two party party party expressed interest potential acquisition company december 2014 board held telephonic meeting attended representative centerview jp morgan cadwalader representative centerview jp morgan discussed director list potential interested party connection potential sale company list divided three tier based financial advisors judgment prospective bidders financial capability complete transaction likelihood interest based strategic fit history successfully executing transaction following deliberation board authorized companys financial advisor contact five party party party party party one additional party whom except party included first tier list 15 table content discussed board party included based boards belief result relationship company party may high interest potential transaction board determined one party included first tier would contacted result competitive concern party party party party expressed interest evaluating potential transaction company fifth party advised interested pursuing potential transaction december 11 2014 company entered confidentiality standstill agreement party party december 16 2014 company entered confidentiality standstill agreement party which standstill provision terminated upon company entering merger agreement companys management conducted management presentation party party party week december 15 2014 december 2014 board held person meeting representative centerview cadwalader participated board engaged detailed discussion regarding financial plan developed company management respect companys financial strategic direction standalone basis board believed appropriate company develop financial plan take account intention reduce wholesaler inventory level key product impact thereof business operation financial plan included financial forecast remainder 2014 2015 2016 expectation company would accelerate reduction wholesaler inventory level companys key product previously discussed board reviewing financial plan board considered factor could cause actual result better projected financial plan including i fda approval xifaxan 550 treatment ibsd ii discount price paid companys principal wholesaler companys product le projected iii prescription demand companys product excess projected addition board discussed management detail factor could cause actual result worse projected including i companys primary wholesaler refusing purchase companys product result matter subject audit committee review wholesaler unwilling purchase product discount higher projected ii companys primary wholesaler requiring payment term companys product allow longer timeframe make payment company relative timeframe assumed financial plan iii prescription demand companys product le projected board discussed one negative factor could impact companys liquidity operation impact companys ability successfully launch xifaxan 550 treatment ibsd fda approval product obtained well companys ability pay 2015 note due noted 2015 note would coming due around time company preparing launch xifaxan 550 treatment ibsd meaning two event requiring significant company liquidity would occurring substantially concurrently board also discussed covenant contained companys credit agreement placed constraint ability refinance 2015 note end meeting m logan representative centerview also updated board discussion date potential buyer also december 2014 company centerview entered amendment centerviews engagement letter pursuant which addition service already provided centerview centerview would requested company provide company general financial advice planning assistance connection companys business operation december 16 2014 company announced working cooperatively principal pharmaceutical wholesaler accelerate reduction wholesaler inventory level xifaxan 550 apriso uceris companys target approximately three month end 2015 one year earlier previously announced accordingly company withdrew previouslyissued guidance fourth quarter 2014 full year 2014 based companys accelerated inventory reduction plan expectation 16 table content finalizing distribution service agreement principal wholesaler first quarter 2015 company also provided preliminary financial guidance full year 2015 2016 concurrently announcement accelerated inventory reduction plan company announced december 15 2014 fda provided written notice company extended prescription drug user fee act pdufa action date xifaxan 550 treatment ibsd february 28 2015 may 27 2015 company noted remained confident fda approval xifaxan 550 treatment ibsd would obtained assurance fda approval would obtained timely manner all december 19 2014 chief executive officer party provided orally m logan initial indication interest acquire company price per share 150 consideration would form unspecified mix cash party stock proposal subject party completing satisfactory due diligence review company later day board met representative companys advisor participating determined company enter confidentiality agreement party management conduct management presentation party december 24 2014 company party entered confidentiality standstill agreement which standstill provision terminated upon company entering merger agreement december 30 2014 company provided party access electronic data room january 2015 close trading company announced m logan would retire president chief executive officer director company effective january 30 2015 that upon retirement thomas dalonzo chairman board would named acting chief executive officer william bertrand jr companys senior vice president general counsel would named acting chief operating officer company also stated intended retain nationally recognized executive search firm assist company identifying highly qualified experienced pharmaceutical executive lead company goingforward basis several analyst speculated m logans retirement signaled company sale january 2015 closing price share 11284 january 2015 share closed 11599 per share companys share price continued increase next several day closing 12019 january 16 2015 approximately 65 increase closing price immediately prior announcement m logans retirement january 2015 company conducted management presentation party also january 2015 representative centerview spoke chief executive officer party communicated orally indication interest acquire company price per share 135 140 comprised mix approximately 25 cash 75 party share subject completion satisfactory due diligence review company january 12 2015 member companys management team met representative party following meeting chairman party provided mr dalonzo written nonbinding indication interest party acquire company price per share 135 145 consideration would form unspecified mix cash party share indication interest subject party fs completion satisfactory due diligence review company companys timely filing annual report form k fiscal year ended december 31 2014 unqualified audit opinion companys independent registered public accounting firm respect companys financial statement internal control financial reporting january 13 2015 certain member company management met representative party discus party es interest potential transaction offer company communicated party meeting 17 table content january 15 2015 representative party advised company management party board director would meeting february 11 2015 discus potential acquisition company party would provide revised offer company time january 17 2015 board met telephonically representative centerview jp morgan cadwalader participating discussed status various parties interest company director discussed based initial indication interest received party party whether provide access data room party companys financial advisor reported director speculation marketplace regarding interest potential acquisition company valeant party board authorized management companys financial advisor engage valeant party ascertain interest potential acquisition company also january 17 2015 board meeting director discussed potential transaction involving 2015 note alleviate pressure companys liquidity position resulting 2015 note becoming due near term received update search new independent director january 19 2015 representative party advised company party longer pursuing potential acquisition company light size company relative size party january 19 2015 january 20 2015 company granted party party respectively access companys electronic data room january 20 2015 reuters reported company working centerview explore option including potential sale larger drug maker closing price share january 20 2015 12583 approximately 47 increase previous closing price 12019 approximately 115 increase closing price immediately prior announcement m logans retirement resulting analyst speculation regarding potential sale company later day january 20 2015 representative jp morgan contacted michael pearson chairman board director chief executive officer valeant ascertain valeants interest potential acquisition company mr pearson indicated valeant would interested conducting due diligence order evaluate potential transaction two company mr pearson subsequently spoke later evening mr dalonzo discussed valeants interest exploring possible transaction two company mr pearson indicated valeant pursue transaction expected pursue one allcash basis would interested moving quickly company entered confidentiality standstill agreement valeant effective january 20 2015 granted valeant access companys electronic data room january 21 2015 january 20 2015 financial advisor party contacted representative centerview january 22 2015 chief executive officer party contacted mr dalonzo indicate party gs interest potential acquisition company january 26 2015 party provided company written expression interest indicated party would willing pay customary transaction premium companys unaffected trading price contain specific value value range company january 28 2015 representative valeant attended management presentation given company management also january 28 2015 company announced audit committee discussion management companys independent registered public accounting firm ernst young llp ey concluded companys previously issued audited consolidated financial statement year ended december 31 2013 previously issued unaudited consolidated financial statement fiscal quarter ended march 31 june 30 september 30 2014 disclosure related communication period required correction certain error longer relied upon company advised 18 table content i managements report internal control financial reporting year ended december 31 2013 longer relied upon ii eys opinion consolidated financial statement year ended december 31 2013 well eys opinion effectiveness companys internal control financial reporting december 31 2013 longer relied upon iii light audit committees review company audit committee reevaluating companys internal control financial reporting disclosure control procedure iv company management consultation audit committee determined material weakness existed companys internal control financial reporting disclosure control procedure ineffective december 31 2013 december 31 2014 company also announced immediately prior filing annual report form k fiscal year ended december 31 2014 company would restate financial result contained companys annual report form k fiscal year ended december 31 2013 previously unaudited financial statement financial information contained companys quarterly report form q fiscal quarter ended march 31 june 30 september 30 2014 disclosure related communication period january 31 2015 board met telephonically representative centerview jp morgan cadwalader participating discussed status companys discussion valeant party party party party later day january 31 2015 company entered confidentiality standstill agreement party which standstill provision terminated upon company entering merger agreement february 2015 company granted party access companys electronic data room february 2015 representative party attended management presentation given company management course month february daily basis companys management team advisor responded supplemental due diligence request valeant party party party party conducted conference call party respective advisor respect various due diligence matter including pending audit committee review restatement previous financial statement february 2015 board held person meeting also attended representative centerview jp morgan cadwalader meeting board discussed preliminary draft financial projection company prepared company management determined board would review projection provide feedback management representative cadwalader discussed director antitrust profile potential transaction various interested party next companys financial advisor discussed board various public market perspective company review trading multiple certain company deemed comparable company judgment companys financial advisor review financial term certain recent transaction deemed comparable potential sale company judgment companys financial advisor february 2015 party submitted company nonbinding written proposal acquire company 150 per share payable 45 per share cash 105 per share party share subject completion due diligence mr dalonzo advised party cs chief executive officer board would consider party cs proposal belief board would accept proposal price also february 2015 mr pearson discussed representative jp morgan valeant may deliver oral nonbinding indication interest 150 per share meeting february 2015 among mr dalonzo mr pearson robert ingram valeants lead independent director mr pearson conveyed oral nonbinding indication interest acquire company 19 table content 150 per share cash mr dalonzo advised messrs pearson ingram would present proposal board belief board would accept proposal price mr pearson advised mr dalonzo reviewing potential acquisition transaction present quickly would refocus valeants effort opportunity february 11 2015 representative cadwalader sent representative sullivan cromwell llp sullivan cromwell valeants counsel draft merger agreement merger agreement structured allcash tender offer subsidiary valeant acquire share followed merger subsidiary company company surviving wholly owned subsidiary valeant pursuant section h dgcl also february 11 2015 cadwalader sent representative party jp morgan draft merger agreement merger agreement structured onestep merger consideration consisting combination cash party share later day chief executive officer party called mr dalonzo advised party board director met party yet prepared specify price company party ds chief executive officer relayed certain additional due diligence request raised possibility portion transaction consideration would need contingent company receiving fda approval xifaxan 550 treatment ibsd party indicate would prepared specify price company despite mr dalonzos request february 12 2015 bloomberg reported valeant secured financing potential acquisition company closing price share february 12 2015 14918 approximately 39 increase previous days closing price 14334 later february 12 2015 party advised would longer pursue potential transaction due party fs lack interest proceeding competitive multiparty process february 12 2015 mr pearson requested mr dalonzo representative jp morgan company provide counterproposal valeants cash 150 per share proposal february 17 2015 date board meeting discus proposal would withdraw interest company pursue potential transaction available valeant february 13 2015 representative sullivan cromwell distributed representative cadwalader revised draft merger agreement among thing revised draft merger agreement included proposed termination fee 40 enterprise value company transaction approximately 544 million based valeants 150 per share offer approximately 572 million based ultimate transaction price payable company merger agreement terminated certain circumstance sullivan cromwell draft accepted tender offer structure proposed company initial draft order reduce time period signing closing also accepted companys draft provision respect antitrust matter would require valeant agree divestiture necessary order obtain antitrust approval february 14 2015 board met telephonically representative centerview jp morgan cadwalader present meeting board unanimously approved revised financial projection prepared company management based feedback received board february 2015 board meeting projection provided valeant potential acquiror company boardapproved projection described item additional information certain management projections 20 table content week february 16 2015 representative centerview jp morgan contacted representative party party party several time advise needed to case party party submit proposed price acquire company and case party increase proposed purchase price and case needed prepared move quickly successful reaching agreement company february 17 2015 board met person representative centerview jp morgan cadwalader participating director companys advisor discussed potential response valeants 150 per share proposal representative cadwalader reviewed boards fiduciary duty context possible sale company director next discussed companys advisor process potential bidder date including that five party initially invited conduct due diligence company one declined interest two party party since withdrawn interest two additional party valeant party joined process late january three remaining party in addition valeant party party yet submitted proposal valuation since commencing due diligence either provided timeframe so despite repeated request company financial advisor party submitted proposal 150 per share substantial stock component indication little room increase proposed purchase price party party would require approval shareholder complete acquisition company would increase time period signing closing create additional execution risk relative transaction valeant require shareholder approval transaction party party presented additional antitrust risk relative transaction valeant including potential extended regulatory review and case party required divestiture result reuters bloomberg article substantial market speculation regarding potential sale company party would likely already approached company interested pursuing transaction none done so mr pearson requested company provide counterproposal valeants offer day valeant would cease pursuit potential transaction representative centerview jp morgan presented certain preliminary financial analysis respect company based managements financial projection approved board february 14 2015 director discussed analysis presented companys financial advisor process bidder date challenge facing company standalone basis including respect i risk relating audit committee review matter subject review including wholesaler purchasing risk impact liquidity ii risk relating companys ability retain qualified permanent chief executive officer chief financial officer iii risk relating approval launch xifaxan 550 treatment ibsd iv risk relating generic competition case fully described reason recommendation following discussion board mr chappell dissenting authorized mr dalonzo make counterproposal mr pearson price 160 per share authorized mr dalonzo accept price subject negotiation definitive agreement approved board le 155 per share mr chappell dissented because opinion board sufficiently analyzed prospect company standalone basis relative potential sale 21 table content following meeting mr dalonzo called mr pearson advised company would willing negotiate merger agreement price per share cash 160 per share mr pearson advised mr dalonzo expected fully committed financing friday february 20 2015 valeants financing structure vetted valeants rating agency hour later mr pearson called mr dalonzo indicate valeant would prepared offer 155 per share long transaction could executed end weekend mr dalonzo called mr pearson two party agreed proceed nonexclusive basis negotiating merger agreement subject approval board director respective company based transaction pursuant valeant would acquire company 158 per share cash later day representative cadwalader distributed revised draft merger agreement representative sullivan cromwell revised merger agreement provided termination fee 30 equity value company transaction approximately 3564 million february 18 2015 member company management well one companys independent director attended presentation party management regarding business prospect party light substantial stock component party proposal meeting party chief executive officer indicated party currently prepared increase offer price later february 18 2015 representative cadwalader sullivan cromwell held conference call discus term merger agreement february 19 2015 representative sullivan cromwell distributed revised draft merger agreement cadwalader revised draft included termination fee 35 equity value company transaction approximately 4159 million plus 50 million expense reimbursement valeant later afternoon parties respective legal advisor held conference call discus revised draft merger agreement early morning february 20 2015 representative cadwalader distributed revised draft merger agreement representative sullivan cromwell revised draft included termination fee 3564 million representing approximately 30 equity value company transaction plus 50 million expense reimbursement valeant represented amount included final merger agreement later morning representative cadwalader sullivan cromwell held conference call substantially finalized merger agreement addition discussion surrounding termination fee principal point negotiation term merger agreement included scope companys representation warranty related disclosure obligation companys obligation signing closing including restriction relating nonsolicitation recommendation board respect offer merger restriction respect employee matter including payment 2014 annual bonus new hire promotion exclusion certain item including pending audit committee review matter subject review bringdown representation warranty relating absence material adverse effect company right company behalf stockholder pursue damage including extent proven damage based loss economic benefit transaction contemplated merger agreement companys stockholder afternoon february 20 2015 board director valeant met approve acquisition company later afternoon board held telephonic meeting consider proposed transaction valeant representative centerview jp morgan cadwalader also participated meeting meeting representative cadwalader reviewed proposed transaction structure timing summarized key term merger agreement next representative centerview jp morgan presented financial analysis rendered respective oral opinion board subsequently confirmed writing effect 22 table content that february 20 2015 subject factor assumption matter considered limitation qualification described respective written opinion consideration 158 per share cash paid holder share other specified respective opinion pursuant merger agreement fair financial point view holder fully described caption opinion companys financial advisors below companys financial advisor left meeting board discussed whether approve entry merger agreement valeant following discussion board mr chappell dissenting without explanation i determined transaction contemplated merger agreement including offer merger fair best interest company stockholder ii approved declared advisable merger agreement transaction contemplated thereby including offer merger iii determined recommend companys stockholder accept offer tender share purchaser offer later night company vpi purchaser and solely certain specified purpose set forth merger agreement valeant executed delivered merger agreement february 22 2015 company valeant issued joint press release announcing execution merger agreement march 2015 purchaser commenced offer march 2015 valeant authorized company waive company sent notice waiving standstill obligation party party confidentiality agreement reason recommendation evaluating merger agreement offer merger transaction contemplated merger agreement board consulted senior management company well representative centerview jp morgan cadwalader course making determination merger agreement offer merger transaction contemplated merger agreement fair best interest company stockholder recommend companys stockholder accept offer tender share offer board considered numerous factor including following nonexhaustive list material factor benefit offer merger board believed supported determination recommendation business financial condition company risk facing company board considered current historical financial condition result operation company well prospect for risk both near term long term facing company standalone entity among thing board considered wholesale distributor purchasing liquidity risk board considered result audit committee review potential event arising audit committee review matter subject review companys major wholesale distributor may cease purchasing companys product would impair companys liquidity position adversely impact companys ability pay 2015 note due ability company successfully launch xifaxan 550 treatment ibsd approved ability company otherwise operate ordinary course management risk upon resignation companys former chief financial officer retirement m logan company retained executive search firm identify permanent chief financial officer chief executive officer respectively board considered company may unable identify qualified permanent chief executive officer permanent chief financial officer lead management companys future operation development pipeline product risk relating xifaxan 550 treatment ibsd board considered possibility fda approval xifaxan 550 treatment ibsd could delayed beyond currently scheduled pdufa action date well possibility fda approval would 23 table content obtained all board also considered light companys management search limitation liquidity position fda approval received company may able launch product level success previously anticipated generic competition board considered risk generic competition pharmaceutical industry heightened case company result significant contribution companys earnings single product xifaxan 550 result process conducted board considered result process conducted company respect potential acquirors including following fact five party initially invited conduct due diligence company one declined interest two party party since withdrawn interest two additional party valeant party joined process late january three remaining party in addition valeant party party yet submitted proposal valuation since commencing due diligence either provided timeframe so despite repeated request company financial advisor party submitted proposal 150 per share substantial stock component advised company prepared increase offer time party party would require approval shareholder complete acquisition company would increase time period signing closing create additional execution risk relative transaction valeant require shareholder approval transaction party party presented additional antitrust risk relative transaction valeant including potential extended regulatory review and case party required divestiture result reuters new york time bloomberg article substantial market speculation regarding potential sale company party would likely already approached company interested pursuing transaction none done so mr pearson requested party prepared execute transaction end weekend merger agreement announced valeant would terminate discussion company move opportunity see background offer above offer price board considered fact offer price represents 315 premium trading price share closed january 16 2015 last trading day reuters reported company working centerview explore option including potential sale fact offer price represents 348 premium average trading price share onemonth period ending january 16 2015 fact offer price represents 447 premium average trading price share date company released third quarter earnings announced audit committee review january 16 2015 boards belief obtained valeants best final offer that date merger agreement offer price represented highest pershare consideration reasonably obtainable 24 table content centerviews jp morgans fairness opinion related analysis board considered oral opinion centerview jp morgan delivered board february 20 2015 subsequently confirmed writing effect that february 20 2015 subject factor assumption matter considered limitation qualification described respective written opinion consideration 158 per share cash paid holder share other specified respective opinion pursuant merger agreement fair financial point view holder centerviews jp morgans written opinion fully described caption opinion companys financial advisors certainty consideration board considered allcash nature consideration paid offer merger allows holder share realize immediate value cash investment company avoiding companys business risk also providing holder share certainty value liquidity share speed completion board considered offer followed secondstep merger cash consideration offered company stockholder offer would allow holder share obtain benefit transaction quickly would likely onestep merger transaction board also considered timeline transaction interested party based type consideration regulatory profile transaction board considered given various risk facing company fully described above potential speed afforded transaction structure benefit companys stockholder likelihood completion certainty payment board considered belief offer merger likely consummated based on among factor absence financing condition consummation offer merger fact vpi received fully committed financing transaction contemplated merger agreement reputation financial condition valeant valeants general ability complete acquisition transaction fact condition offer merger specific limited scope fact vpi purchaser would permitted refuse close offer merger terminate merger agreement result i pending audit committee review matter subject review well adverse development in arising of relating to resulting from matter case reasonably foreseeable date merger agreement ii decision action inaction fda respect xifaxan 550 treatment ibsd fact vote valeants shareholder required complete transaction companys ability request delaware court chancery specifically enforce merger agreement including consummation offer merger companys ability merger agreement pursue damage event breach vpi purchaser including extent proven damage based loss economic benefit transaction contemplated merger agreement companys stockholder term merger agreement board considered belief final term merger agreement resulted arms length negotiation conducted company assistance independent financial legal advisor board also considered specific term merger agreement including provision permitting board respond unsolicited takeover proposal change recommendation terminate merger agreement certain circumstance size termination fee board believed would likely deter competing bid 25 table content appraisal right board considered availability statutory appraisal right delaware law connection merger stockholder company tender share offer and otherwise comply statutory requirement delaware law believe exercising right would yield greater per share amount merger consideration course deliberation board also considered variety material risk countervailing factor related entering merger agreement previously identified discussed management company board including participation companys future board considered offer merger consummated stockholder company receive offer price cash longer opportunity participate future earnings growth company combined company benefit potential future appreciation value share including value could achieved company engages future strategic transaction successfully commercializes product candidate including xifaxan 550 treatment ibsd nonsolicitation covenant board considered merger agreement imposes restriction companys solicitation competing acquisition proposal third party however based upon process conducted company fully described background offer board believed strong basis determining offer merger best transaction likely available company termination fee expense reimbursement board considered fact that term merger agreement company must pay vpi termination fee 3564 million plus additional 50 million expense reimbursement merger agreement terminated certain circumstance including company order accept competing proposal board deemed superior proposal board also considered amount termination fee comparable termination fee transaction similar size reasonable would likely deter competing bid would likely required paid unless company entered favorable transaction board recognized provision merger agreement relating fee insisted upon vpi condition entering merger agreement interim operating covenant board considered that term merger agreement company would required conduct business ordinary course business consistent past practice and subject specified exception company would able undertake various action related conduct business without prior written consent vpi among thing although company would permitted sell product ordinary course company would permitted enter distribution service agreement principal wholesaler without prior written consent vpi regulatory approval board considered regulatory approval hartscottrodino antitrust improvement act 1976 amended united state would required consummate offer merger well likelihood receiving approval evaluating risk involved connection regulatory approval board considered fact vpi purchaser agreed take step necessary avoid eliminate every impediment antitrust competition law order consummate offer merger soon practicable including making required divestiture risk offer merger may completed board also considered risk cost company offer merger consummated including diversion management employee attention potential employee attrition potential effect vendor distributor customer partner others business company potential effect trading price share 26 table content potential conflict interest board considered potential conflict interest created fact companys executive officer director financial interest transaction contemplated merger agreement including offer merger may different addition stockholder fully described item past contact transaction negotiation agreement arrangement current executive officer director company tax treatment board considered receipt offer price consideration payable merger generally taxable stockholder company board believed mitigated fact entire consideration payable offer merger would cash providing adequate cash payment tax due foregoing discussion factor considered board intended summary intended exhaustive rather includes principal factor considered board considering factor board concluded positive factor relating merger agreement transaction contemplated thereby including offer merger substantially outweighed potential negative factor board collectively reached conclusion approve merger agreement related transaction including offer merger light various factor described factor member board believed appropriate view wide variety factor considered board connection evaluation merger agreement transaction contemplated thereby including offer merger complexity matter board consider practical attempt quantify rank otherwise assign relative weight specific factor considered reaching decision undertake make specific determination whether factor particular aspect factor supported support ultimate determination rather board made recommendation based totality information received investigation conducted considering factor discussed above individual director may given different weight different factor intent tender knowledge company making reasonable inquiry extent permitted applicable security law rule regulation including section b exchange act executive officer director company mr chappell currently intends tender share held record beneficially owned person share issuable upon exercise company option share individual dispositive authority opinion companys financial advisor opinion centerview partner llc company retained centerview financial advisor board connection with among thing review various strategic alternative including thirdparty proposal business combination transaction proposed offer merger transaction contemplated merger agreement collectively referred summary centerviews opinion transaction connection engagement board requested centerview evaluate fairness financial point view holder share other i share cancelled pursuant section b merger agreement ii dissenting share a defined merger agreement the share referred clause i ii together share held affiliate valeant collectively referred summary centerviews opinion summary jp morgans opinion included herein excluded shares per share consideration 15800 cash proposed paid holder pursuant merger agreement referred summary centerviews opinion summary jp morgans opinion included herein consideration 27 table content february 20 2015 centerview rendered board oral opinion subsequently confirmed written opinion dated date effect that date based upon subject assumption made procedure followed matter considered limitation review undertaken centerview connection opinion consideration paid holder share other excluded share pursuant merger agreement fair financial point view holder limitation imposed board upon centerview respect investigation made procedure followed rendering opinion full text centerviews written opinion dated february 20 2015 describes assumption made procedure followed matter considered qualification limitation upon review undertaken attached annex incorporated herein reference summary written opinion centerview set forth qualified entirety full text centerviews written opinion attached annex centerviews financial advisory service opinion provided information assistance board in capacity director capacity connection purpose consideration transaction centerviews opinion addressed fairness financial point view date thereof holder share other excluded share consideration paid holder pursuant merger agreement centerviews opinion address term aspect merger agreement transaction constitute recommendation stockholder company whether holder tender share connection offer otherwise act respect transaction matter full text centerviews written opinion read carefully entirety description assumption made procedure followed matter considered qualification limitation upon review undertaken centerview preparing opinion connection rendering opinion described performing related financial analysis centerview reviewed among thing draft merger agreement dated february 20 2015 referred summary centerviews opinion draft merger agreement annual report form k company year ended december 31 2013 december 31 2012 december 31 2011 certain interim report stockholder quarterly report form q company certain publicly available research analyst report company certain communication company stockholder certain internal information relating business operation earnings cash flow asset liability prospect company including certain financial forecast analysis projection relating company prepared management company furnished centerview company purpose centerviews analysis referred summary centerviews opinion forecasts collectively referred summary centerviews opinion internal data discussion forecast see item additional information management projections centerview also conducted discussion member senior management representative company regarding assessment internal data strategic rationale transaction addition centerview reviewed publicly available financial stock market data including valuation multiple company compared data similar data certain company security publicly traded line business centerview deemed relevant centerview also compared certain proposed financial term transaction financial term extent publicly available 28 table content certain transaction centerview deemed relevant conducted financial study analysis took account information centerview deemed appropriate centerview assumed without independent verification responsibility therefor accuracy completeness financial legal regulatory tax accounting information supplied to discussed with reviewed centerview purpose opinion and companys consent centerview relied upon information complete accurate regard centerview assumed companys direction internal data including without limitation forecast reasonably prepared base reflecting best currently available estimate judgment management company matter covered thereby centerview relied companys direction internal data purpose centerviews analysis opinion centerview expressed view opinion internal data assumption based addition companys direction centerview make independent evaluation appraisal asset liability contingent derivative offbalancesheet otherwise company centerview furnished evaluation appraisal asked conduct conduct physical inspection property asset company centerview assumed companys direction final executed merger agreement would differ respect material centerviews analysis opinion draft merger agreement reviewed centerview centerview also assumed companys direction transaction consummated term set forth merger agreement accordance applicable law relevant document requirement without delay waiver modification amendment term condition agreement effect would material centerviews analysis centerviews opinion that course obtaining necessary governmental regulatory approval consent release waiver transaction delay limitation restriction condition change imposed effect would material centerviews analysis centerviews opinion centerview evaluate express opinion solvency fair value company ability company pay obligation come due impact transaction matter state federal law relating bankruptcy insolvency similar matter centerview legal regulatory tax accounting advisor centerview expressed opinion legal regulatory tax accounting matter centerviews opinion expressed view address companys underlying business decision proceed effect transaction relative merit transaction compared alternative business strategy transaction might available company company might engage centerviews opinion limited addressed fairness financial point view date centerviews written opinion holder share other excluded share consideration paid holder pursuant merger agreement purpose opinion centerview asked to centerview not express view on opinion address term aspect merger agreement transaction including without limitation structure form transaction agreement arrangement contemplated merger agreement entered connection otherwise contemplated transaction including without limitation fairness transaction term aspect transaction to consideration received connection therewith by impact transaction on holder class security creditor constituency company party addition centerview expressed view opinion fairness financial otherwise amount nature aspect compensation paid payable officer director employee company party class person connection transaction whether relative consideration paid holder share other excluded share pursuant merger agreement otherwise centerviews opinion necessarily based financial economic monetary currency market condition circumstance effect on information made available centerview of date centerviews written opinion centerview obligation responsibility update revise reaffirm opinion based circumstance development event occurring date centerview written opinion centerviews opinion constitute recommendation stockholder company whether holder tender share connection offer otherwise act respect transaction matter centerviews financial advisory service 29 table content written opinion provided information assistance board in capacity director capacity connection purpose consideration transaction issuance centerviews opinion approved centerview partner llc fairness opinion committee following summary material financial analysis prepared reviewed board connection centerviews opinion dated february 20 2015 summary set forth purport complete description financial analysis performed factor considered by underlying opinion of centerview order financial analysis described represent relative importance weight given financial analysis centerview centerview may deemed various assumption le probable assumption reference range resulting particular portion analysis summarized taken centerviews view actual value company summary financial analysis set forth include information presented tabular format order fully understand financial analysis table must read together text summary table alone constitute complete description financial analysis performed centerview considering data table without considering financial analysis factor full narrative description analysis factor including methodology assumption underlying analysis factor could create misleading incomplete view process underlying centerviews financial analysis opinion performing analysis centerview made numerous assumption respect industry performance general business economic condition matter many beyond control company party transaction none company valeant vpi purchaser centerview person assumes responsibility future result materially different discussed estimate contained analysis necessarily indicative actual value predictive future result value may significantly le favorable set forth below addition analysis relating value company purport appraisal reflect price company may actually sold accordingly assumption estimate used in result derived from financial analysis inherently subject substantial uncertainty except otherwise noted following quantitative information extent based market data based market data existed february 19 2015 the last full trading day prior delivery centerview opinion board necessarily indicative current market condition implied per share equity value range described based companys fully diluted outstanding share calculated treasury stock method taking account outstanding inthemoney option warrant convertible security basis based information provided company selected comparable public company analysis centerview reviewed compared certain financial information company corresponding financial information following publicly traded company centerview deemed comparable based experience professional judgment company actavis plc valeant pharmaceutical international inc endo international plc mallinckrodt plc jazz pharmaceutical plc united therapeutic corporation although none selected company directly comparable company company listed chosen centerview among reason publicly traded life science company certain operational business andor financial characteristic that purpose centerviews 30 table content analysis may considered similar company however none selected comparable company exactly company centerview believed inappropriate to therefore not rely solely quantitative result selected comparable company analysis accordingly centerview also made qualitative judgment based experience judgment financial advisor concerning difference business financial operating characteristic prospect company selected comparable company could affect public trading value order provide context consider result quantitative analysis centerview calculated compared financial multiple selected comparable company based publicly available information obtained sec filing factset data source containing historical estimated financial data wall street research closing stock price february 19 2015 the last full trading day prior delivery centerview opinion board respect selected comparable company centerview calculated analyzed companys market price per share multiple consensus estimated wall street research analyst estimated earnings per share eps ratio commonly referred price earnings ratio pe calendar year 2015 2016 result analysis summarized follows high mean median low share pricee eps x x x x share pricee eps x x x x based foregoing analysis consideration centerview deemed relevant professional judgment centerview applied valuation range x x companys estimated calendar year 2015 fully taxed earnings per share 556 which reflects managements forecast company company sell product based prescription demand 2015 without regard inventory reduction plan described item additional information certain management projections resulted implied per share equity value range share approximately 8625 9450 centerview also applied valuation range x x companys estimated calendar year 2016 fully taxed cash earnings per share 833 set forth forecast resulted implied per share equity value range approximately 11250 12500 centerview compared range per share consideration 15800 paid holder share other excluded share pursuant merger agreement 31 table content selected precedent transaction analysis centerview reviewed analyzed certain information relating selected transaction centerview based experience judgment financial advisor deemed relevant consider relation company transaction transaction were date announced acquiror target 1112015 shire plc np pharmaceutical inc 1282014 merck co inc cubist pharmaceutical inc 11162014 actavis plc allergan inc 9162014 endo international plc auxilium pharmaceutical inc 692014 merck co inc idenix pharmaceutical inc 5162014 abbott laboratory cfr pharmaceutical sa 472014 mallinckrodt plc questcor pharmaceutical inc 2182014 actavis plc forest laboratory inc 182014 forest laboratory inc aptalis pharma inc 11112013 shire plc viropharma inc 1172013 salix pharmaceutical ltd santarus inc 8252013 amgen inc onyx pharmaceutical inc 932012 valeant pharmaceutical international inc medici pharmaceutical corp 7292013 perrigo company plc elan corporation plc 5272013 valeant pharmaceutical international inc bausch lomb holding incorporated 5192013 actavis inc warner chilcott plc 7162012 glaxosmithkline plc human genome science inc 11212011 gilead science inc pharmasset inc 5192011 takeda pharmaceutical company limited nycomed a 522011 teva pharmaceutical industry ltd cephalon inc 2162011 sanofiaventis genzyme corp 10122010 pfizer inc king pharmaceutical inc company transaction used analysis identical directly comparable company transaction company included selected transaction selected among reason certain characteristic that purpose analysis may considered similar certain characteristic company reason circumstance surrounding selected precedent transaction analyzed diverse inherent difference business operation financial condition prospect company company included selected precedent transaction analysis accordingly centerview believed purely quantitative selected precedent transaction analysis would particularly meaningful context considering transaction analysis involves complex consideration qualitative judgment concerning difference financial operating characteristic factor could affect public trading acquisition value selected target company company financial data precedent transaction based publicly available information time announcement relevant transaction centerview obtained sec filing relevant press release factset institutional brokers estimate system ibes wall street research using publicly available information centerview calculated selected transaction implied total enterprise value calculated equity value determined using treasury stock method taking account outstanding inthemoney option warrant convertible security plus book value debt le cash cash equivalent based purchase price paid transaction multiple target companys nexttwelve month ntm estimated earnings interest tax depreciation amortization ebitda time transaction announcement 32 table content result analysis summarized follows max mean median min enterprise valuentm ebtida x x x x based foregoing analysis consideration centerview deemed relevant professional judgment expertise centerview applied illustrative range enterprise value ntm ebitda multiple x x corresponding ntm ebitda company 791 million calendar year 2015 which reflects managements forecast company company sell product based prescription demand 2015 without regard inventory reduction plan described item additional information certain management projections calculate implied per share equity value range approximately 10000 15700 centerview compared range per share consideration 15800 paid holder share other excluded share pursuant merger agreement sumoftheparts discounted cash flow analysis centerview also performed sumoftheparts discounted cash flow analysis company discounted cash flow analysis traditional valuation methodology used derive valuation asset calculating present value estimated future cash flow asset present value refers current value future cash flow amount obtained discounting future cash flow amount discount rate take account macroeconomic assumption estimate risk opportunity cost capital expected return appropriate factor centerview calculated sumoftheparts discounted cash flow company based internal data including forecast centerview performed discounted cash flow analysis company productbyproduct basis based projected sale set forth forecast well productbyproduct data gross margin allocation expense estimated management company based data centerview calculated fully taxed unlevered free cash flow product 2015 2029 based management estimate product related expense including allocated identified selling general administrative expense product including stock based compensation expense excluding unidentified expense overhead research development expense excluding expenditure unidentified research development expense allocated change net working capital capital expenditure product case prepared management company centerview discounted free cash flow amount present value commercial near commercial product centerview used range discount rate 75 85 determined based centerviews analysis companys weighted average cost capital line weighted average cost capital high growth commercial pharmaceutical company pipeline product centerview used range discount rate 120 140 determined based centerviews analysis weighted average cost capital prerevenue pharmaceutical company case using midyear convention discounted december 31 2014 centerview calculated terminal value product end projection period ending 2029 product would achieved post loss exclusivity steady state demand terminal period centerview used range perpetuity growth rate 2 2 product le three year post loss exclusivity beginning terminal period centerview used range perpetuity growth rate 10 15 product centerview used applicable discount rate described above product centerview divided result foregoing calculation companys fully diluted outstanding share calculated described above centerview also performed discounted cash flow analysis respect companys unallocated unidentified selling general administrative expense excluding 50 unidentified selling general administrative expense associated unallocated future product investment depreciation amortization milestone payment tax attribute cash flow item using range discount rate 75 85 33 table content determined based centerviews analysis companys weighted average cost capital line weighted average cost capital high growth commercial pharmaceutical company range perpetuity growth rate 2 centerview divided result foregoing calculation companys fully diluted outstanding share calculated described above purpose analysis centerview assumed unidentified research development expense 50 unidentified selling general administrative expense associated unallocated future product investment would earn cost capital and therefore impact foregoing per share calculation arrive per share range centerview added per share result foregoing calculation subtracted companys estimated net debt per share calculated dividing companys estimated net debt december 31 2014 companys fully diluted outstanding share calculated described above resulted implied per share equity value range approximately 13500 15775 result analysis summarized follows implied per share range low high major current product xifaxan 550 6508 7027 xifaxan 550 ibs 4663 5192 xifaxan 200 107 115 apriso 575 650 uceris 708 813 relistor 579 646 ruconest 266 294 total 13407 14337 pipeline product rifaximin eir 367 451 rifaximin ssd 943 1229 oral relistor 1195 1425 total 2505 3105 product 1907 2524 corporate 1042 1366 total enterprise value per share 16776 19000 net debt per share 3284 3226 total per share 13492 15774 centerview compared implied per share equity value range approximately 13500 15775 per share consideration 15800 paid holder share other excluded share pursuant merger agreement consideration centerview noted board certain additional factor solely informational purpose including among thing following historical closing trading price share month period ended august 18 2014 the day prior medium report potential acquisition company reflected low high stock trading price company period 6573 14002 per share historical closing trading price share period november 2014 the day publication companys earnings third quarter ended september 30 2014 34 table content january 16 2015 the day prior medium report beginning appear stating company exploring potential sale reflected low high stock trading price company period 9147 12019 per share stock price target share publicly available wall street research analyst report february 11 2015 the day prior medium report stating company exploring potential sale valeant indicated low high stock price target company 10000 16000 per share respectively illustrative present value future share price company based oneyear forward multiple x x derived centerview based analysis described selected comparable public company analysis applied fully taxed 2016 2018 eps set forth forecast discounted illustrative 15 20 expected rate equity return reflected low high share price company 10750 16075 discount rate differ companys calculated cost equity 94 reflect centerviews view current equity return needed public market given current risk around companys business related issue general preparation financial opinion complex analytical process involving various determination appropriate relevant method financial analysis application method particular circumstance and therefore financial opinion readily susceptible summary description arriving opinion centerview draw isolation conclusion regard factor analysis considered rather centerview made determination fairness basis experience professional judgment considering result analysis centerviews financial analysis opinion one many factor taken consideration board evaluation transaction consequently analysis described viewed determinative view board management company respect consideration whether board would willing determine different consideration fair consideration transaction determined armslength negotiation company valeant approved board centerview provided advice company negotiation centerview not however recommend specific amount consideration company board specific amount consideration constituted appropriate consideration transaction centerview security firm engaged directly affiliate related person number investment banking financial advisory merchant banking activity except connection centerviews current engagement company centerview provided investment banking service company vpi valeant purchaser centerview may provide investment banking service respect company valeant vpi respective affiliate future centerview may receive compensation certain i centerviews centerviews director officer member employee family member person ii centerviews affiliate related investment fund iii investment fund person foregoing may financial interest may coinvest may time acquire hold sell trade debt equity security financial instrument including derivative bank loan obligation of investment in company valeant vpi respective affiliate party may involved transaction board selected centerview financial advisor connection transaction based centerviews reputation experience respect pharmaceutical industry generally centerview nationally recognized investment banking firm substantial experience transaction similar transaction connection centerviews service financial advisor board company agreed pay centerview aggregate fee approximately 444 million million paid prior december 31 2014 form advisory fee remaining 394 million payable 35 table content contingent upon consummation transaction similar transaction addition company agreed reimburse certain centerviews expense arising of indemnify centerview certain liability may arise of centerviews engagement opinion jp morgan security llc pursuant engagement letter dated december 2014 effective december 2014 company retained jp morgan cofinancial advisor connection possible transaction company person including a merger consolidation joint venture business combination pursuant business company combined purchaser b acquisition purchaser directly indirectly majority capital stock company way tender exchange offer negotiated purchase mean andor c acquisition purchaser directly indirectly majority asset property andor business company way direct indirect purchase lease license exchange joint venture mean meeting board february 20 2015 jp morgan rendered oral opinion board that date based upon subject factor assumption limitation set forth opinion consideration paid holder share other excluded share offer merger fair financial point view holder jp morgan confirmed february 20 2015 oral opinion delivering written opinion board dated february 20 2015 that date based upon subject factor assumption limitation set forth opinion consideration paid holder share other excluded share offer merger fair financial point view holder limitation imposed board upon jp morgan respect investigation made procedure followed rendering opinion full text written opinion jp morgan dated february 20 2015 set forth assumption made matter considered limit review undertaken attached annex schedule d incorporated herein reference companys stockholder urged read opinion entirety jp morgans written opinion addressed board directed consideration received holder share other excluded share offer merger constitute recommendation stockholder company whether stockholder tender share offer matter summary opinion jp morgan set forth schedule d qualified entirety reference full text opinion arriving opinion jp morgan among thing reviewed draft dated february 19 2015 merger agreement reviewed certain publicly available business financial information concerning company industry operates compared proposed financial term offer merger publicly available financial term certain transaction involving company jp morgan deemed relevant consideration paid company compared financial operating performance company publicly available information concerning certain company jp morgan deemed relevant reviewed current historical market price share certain publicly traded security company reviewed certain internal financial analysis forecast prepared management company relating business company including management projection performed financial study analysis considered information jp morgan deemed appropriate purpose opinion 36 table content jp morgan also held discussion certain member management company respect certain aspect offer merger past current business operation company financial condition future prospect operation company certain matter jp morgan believed necessary appropriate inquiry jp morgan relied upon assumed without assuming responsibility liability independent verification accuracy completeness information publicly available furnished discussed jp morgan company otherwise reviewed jp morgan jp morgan conduct provided valuation appraisal asset liability jp morgan evaluate solvency company vpi valeant state federal law relating bankruptcy insolvency similar matter relying financial analysis forecast provided it jp morgan assumed reasonably prepared based assumption reflecting best currently available estimate judgment management expected future result operation financial condition company analysis forecast relate jp morgan expressed view analysis forecast assumption based jp morgan also assumed offer merger transaction contemplated merger agreement tax consequence described discussion with material furnished jp morgan by representative company consummated described merger agreement definitive merger agreement would differ material respect draft thereof furnished jp morgan jp morgan also assumed representation warranty made company vpi purchaser merger agreement related agreement true correct respect material analysis jp morgan legal regulatory tax expert relied assessment made advisor company respect issue jp morgan assumed material governmental regulatory consent approval necessary consummation offer merger obtained without adverse effect company contemplated benefit offer merger projection furnished jp morgan company prepared management company company publicly disclose internal management projection type provided jp morgan connection jp morgans analysis offer merger projection prepared view toward public disclosure projection based numerous variable assumption inherently uncertain may beyond control management including without limitation factor related general economic competitive condition prevailing interest rate accordingly actual result could vary significantly set forth projection information regarding use projection please refer section entitled item additional information certain management projections jp morgans opinion necessarily based economic market condition effect on information made available jp morgan of date opinion subsequent development may affect jp morgans opinion dated february 20 2015 jp morgan obligation update revise reaffirm opinion jp morgans opinion limited fairness financial point view consideration paid holder share other excluded share offer merger jp morgan expressed opinion fairness offer merger to consideration of holder class security creditor constituency company underlying decision company engage offer merger furthermore jp morgan expressed opinion respect amount nature compensation officer director employee party offer merger class person relative consideration paid holder share other excluded share offer merger respect fairness compensation addition jp morgan expressed opinion price share trade future time accordance customary investment banking practice jp morgan employed generally accepted valuation method reaching opinion following summary material financial analysis utilized jp morgan connection providing opinion 37 table content public trading multiple using publicly available information jp morgan compared selected financial data company similar data selected publicly traded company engaged business jp morgan judged analogous company purpose analysis company selected jp morgan were actavis plc valeant endo international plc mallinckrodt plc jazz pharmaceutical plc united therapeutic corporation none selected company reviewed identical company certain company may characteristic materially different company company selected chosen publicly traded company operation business that purpose jp morgans analysis may considered similar company analysis necessarily involve complex consideration judgment concerning difference financial operational characteristic company involved factor could affect company compared company using publicly available information jp morgan calculated selected company ratio closing stock price february 19 2015 estimated earnings per share month period ended december 31 2016 e pe based consensus equity research analyst estimate based result analysis jp morgan selected multiple reference range company x x e pe multiple applied managements estimate companys calendar year 2016 fully taxed cash earnings per share 833 set forth line item fullytaxed eps company forecast yielding range implied equity value share rounded nearest 025 10825 12500 per share range implied equity value share compared proposed cash consideration 15800 per share share other excluded share offer merger selected transaction analysis using publicly available information jp morgan examined selected transaction involving acquired business that purpose jp morgans analysis considered relevant specifically jp morgan reviewed following transaction date announced acquiror target december 2014 merck co inc cubist pharmaceutical inc november 17 2014 actavis plc allergan inc july 18 2014 abbvie inc shire plc april 2014 mallinckrodt plc questcor pharmaceutical inc february 18 2014 actavis plc forest laboratory inc november 2013 company santarus inc may 27 2013 valeant bausch lomb holding inc february 16 2011 sanofi sa genzyme corp october 12 2010 pfizer inc king pharmaceutical inc september 2008 shionogi pharma inc sciele pharma inc august 22 2008 king pharmaceutical inc alpharma inc 38 table content none selected transaction reviewed identical offer merger certain transaction may characteristic materially different offer merger transaction selected chosen participant size factor purpose jp morgans analysis may considered similar offer merger analysis necessarily involve complex consideration judgment concerning difference financial operational characteristic transaction involved factor could affect transaction compared offer merger using publicly available information jp morgan calculated selected transaction ratio aggregate value transaction target companys ebitda defined earnings interest tax depreciation amortization stockbased compensation expense twelvemonth period following announcement transaction ntm ebitda based consensus equity research analyst estimate ratio referred evntm ebitda based result analysis jp morgan selected multiple reference range x x evntm ebitda multiple applied managements estimate companys calendar year 2015 demandbased ebitda 791 million set forth line item ebitda company forecast yielding range implied equity value share rounded nearest 025 10000 15700 per share after subtracting managements estimate net debt december 31 2014 dividing number outstanding share company fullydiluted basis indicated companys management range implied equity value share compared proposed cash consideration 15800 per share share other excluded share offer merger discounted cash flow analysis jp morgan conducted discounted cash flow analysis purpose determining fully diluted equity value per share share discounted cash flow analysis method evaluating asset using estimate future unlevered free cash flow generated asset taking consideration time value money respect cash flow calculating present value unlevered free cash flows refers calculation future cash flow generated asset without including calculation debt servicing cost specifically unlevered free cash flow represents unlevered net operating profit interest tax adjusted depreciation amortization capital expenditure change net working capital certain onetime cash flow item applicable present value refers current value future cash flow generated asset obtained discounting cash flow back present using discount rate take account macroeconomic assumption estimate risk opportunity cost capital appropriate factor terminal value refers present value future cash flow generated asset period beyond projection period conducting discounted cash flow analysis jp morgan calculated certain line item included company forecast a defined item additional information certain management projections projected unlevered free cash flow generated company fiscal year 2015 2029 set forth below calculation reviewed agreed upon company management e e e e e e e e e e e e e e e unlevered free cash flow 468 744 856 1109 1234 1384 1444 1740 1878 1872 1633 1380 1131 974 jp morgan also calculated range terminal value company end year period ending 2029 applying perpetual revenue growth rate range based managements guidance range discount rate 85 95 chosen jp morgan based upon analysis weighted average cost capital company unlevered free cash flow range 39 table content terminal value calculated described discounted present value using range discount rate arrive range implied equity value sum present value unlevered free cash flow range terminal value adjusted adding present value managements estimate companys tax benefit net operating loss research development tax credit subtracting managements estimate companys net debt december 31 2014 based foregoing discounted cash flow analysis indicated range implied equity value share standalone basis rounded nearest 025 12700 16675 per share based number outstanding share company fullydiluted basis indicated companys management range implied equity value share compared proposed cash consideration 15800 per share share other excluded share offer merger information trading range jp morgan reviewed trading range companys closing stock price november 2014 the day immediately following company publicly released financial result third quarter 2014 fiscal year january 16 2015 the day prior news report regarding companys engagement financial advisor possible transaction specifically reference range 9147 12019 per share period analyst price target jp morgan reviewed recent price target companys common stock certain equity research analyst available february 19 2015 noted price target ranged 10000 16000 per share jp morgan noted trading range analyst price target noted valuation methodology component fairness analysis presented informational purpose only general foregoing summary certain material financial analysis purport complete description analysis data presented jp morgan preparation fairness opinion complex process necessarily susceptible partial analysis summary description jp morgan belief foregoing summary analysis must considered whole selecting portion foregoing summary analysis without considering analysis whole could create incomplete misleading view process underlying analysis opinion result range valuation resulting particular analysis combination analysis described utilized create point reference analytical purpose taken view jp morgan respect actual value company arriving opinion jp morgan reviewed various financial operational metric company including forecast respect company made available jp morgan behalf company arriving opinion jp morgan attribute particular weight analysis factor considered form opinion whether individual analysis factor positive negative considered isolation supported failed support opinion rather jp morgan considered totality factor analysis performed determining opinion analysis based upon forecast future result inherently uncertain subject numerous factor event beyond control party advisor accordingly forecast analysis used made jp morgan necessarily indicative actual future result may significantly le favorable suggested analysis moreover jp morgans analysis purport appraisal otherwise reflective price business actually could bought sold 40 table content part investment banking business jp morgan affiliate continually engaged valuation business security connection merger acquisition investment passive control purpose negotiated underwritings competitive bidding secondary distribution listed unlisted security private placement valuation estate corporate purpose jp morgan selected advise board respect offer merger basis experience familiarity company service rendered connection offer merger company agreed pay jp morgan fee approximately 444 million million payable upon announcement offer merger delivery jp morgan opinion remainder contingent upon consummation offer merger addition company agreed reimburse jp morgan expense incurred connection service including fee disbursement counsel indemnify jp morgan certain liability including liability arising federal security law two year preceding date opinion neither jp morgan affiliate material financial advisory material commercial investment banking relationship company two year preceding date opinion jp morgan affiliate commercial investment banking relationship valeant jp morgan affiliate received customary compensation service period included acting valeants joint bookrunner bond offering june 2013 joint lead arranger bookrunner amendment revolving credit facility july 2013 joint bookrunner bond offering november 2013 joint lead arranger bookrunner amendment term loan december 2013 addition jp morgans commercial banking affiliate lender outstanding credit facility valeant receives customary compensation financial benefit ordinary course business jp morgan affiliate may actively trade debt equity security company valeant account account customer and accordingly may time hold long short position security item personsassets retained employed compensated used information pertaining retention centerview retention jp morgan item solicitation recommendation opinion companys financial advisors incorporated herein reference teneo holding assisted company public relation advisor offer merger customary term condition company agreed pay teneo holding customary compensation service except set forth above neither company person acting behalf currently intends employ retain compensate person make solicitation recommendation stockholder company behalf respect offer 41 table content item interest security subject company transaction respect share effected day prior date schedule d company or companys knowledge making reasonable inquiry executive officer director affiliate subsidiary than name date oftransaction nature transaction number ofshares disposition orgrant price asapplicable thomas dalonzo 2022015 grant restricted share 14662 12277 william bertrand jr 1312015 grant restricted share 2851 12277 william bertrand jr 1012015 forfeiture share company order pay tax withholding upon vesting restricted stock 350 11494 timothy creech 1022015 forfeiture share company order pay tax withholding upon vesting restricted stock 3248 11494 william forbes 1022015 forfeiture share company order pay tax withholding upon vesting restricted stock 10997 11494 rick scruggs 1022015 forfeiture share company order pay tax withholding upon vesting restricted stock 8408 11494 item purpose transaction plan proposal except otherwise set forth schedule d including exhibit schedule d incorporated schedule d reference company currently undertaking engaged negotiation response offer relate to would result in i tender offer for acquisition of share company subsidiary person ii extraordinary transaction merger reorganization liquidation involving company subsidiary iii purchase sale transfer material amount asset company subsidiary iv material change present dividend rate policy indebtedness capitalization company except described otherwise set forth schedule d including exhibit schedule d incorporated schedule d reference transaction resolution board agreement principle signed contract response offer relate to would result in one event referred preceding paragraph item additional information regulatory approval offer conditioned satisfaction or waiver condition applicable waiting period hartscottrodino antitrust improvement act 1976 amended rule regulation promulgated thereunder the hsr act expired terminated preclosing approval clearance reasonably required thereunder shall obtained the hsr condition order satisfy hsr condition party must make filing federal trade commission the ftc purchasers acquisition share delayed due failure satisfy hsr condition offer extended certain circumstance see section term offer offer purchase 42 table content hsr act certain acquisition transaction may consummated required information documentary material furnished review ftc antitrust division u department justice the antitrust division certain waiting period requirement satisfied requirement apply purchasers acquisition share offer merger purchase share pursuant offer subject requirement see section condition offer offer purchase hsr act purchase share offer may completed expiration fifteen calendar day waiting period begin acquiring person filed premerger notification report form hsr act ftc antitrust division unless waiting period earlier terminated reviewing agency end fifteen calendar day waiting period set fall federal holiday weekend day waiting period automatically extended 1159 pm eastern time next business day addition pursuant agency practice reviewing agency completed investigation fifteen calendar day waiting period acquiring person may withdraw hsr filing refile within two business day without paying additional filing fee procedure restarts fifteen calendar day waiting period reviewing agency may review transaction february 27 2015 march 2015 purchaser company respectively filed premerger notification report form hsr act ftc antitrust division connection purchase share offer merger required waiting period respect offer merger expire 1159 pm eastern time march 16 2015 unless earlier terminated reviewing agency acquiring person withdraws refiles hsr filing if prior expiration hsr waiting period either ftc antitrust division issue request additional information documentary material second request waiting period respect offer merger would extended additional period ten calendar day following date acquiring persons substantial compliance second request time period reviewing agency grant early termination waiting period expiration ten calendar day waiting period absent vpis companys agreement extend review time reviewing agency prevent closing court order time purchasers acquisition share pursuant offer antitrust division ftc could take action antitrust law either deems necessary desirable public interest including seeking enjoin purchase share pursuant offer seeking divestiture share acquired purchaser divestiture substantial asset company subsidiary vpi subsidiary state attorney general may also bring legal action state federal antitrust law applicable private party may also bring legal action antitrust law certain circumstance assurance challenge offer antitrust ground made or challenge made result thereof notice appraisal right holder share appraisal right connection offer however purchaser purchase share offer merger consummated holder share immediately prior effective time entitled appraisal right connection merger section 262 dgcl following discussion complete statement law pertaining appraisal right dgcl qualified entirety full text section 262 dgcl attached schedule d annex hereby incorporated herein reference reference section 262 dgcl summary stockholder holder shares record holder share immediately prior effective time appraisal right may asserted person beneficial interest share held record name another person broker dealer bank fiduciary nominee must act promptly cause record holder follow step summarized properly timely manner perfect appraisal right stockholder contemplating exercise appraisal right review carefully provision section 262 dgcl particularly 43 table content procedural step required perfect right failure follow step required section 262 dgcl perfecting appraisal right may result loss right dgcl merger completed holder share immediately prior effective time i tender share offer ii make timely proper demand appraisal share follow procedure set forth section 262 dgcl iii thereafter withdraw demand appraisal share otherwise lose appraisal right case accordance dgcl entitled share appraised delaware court chancery receive payment fair value share the fair value exclusive element value arising accomplishment expectation merger determined court together interest any paid upon amount determined fair value fair value could greater than le offer price merger consideration which equal offer price section 262 dgcl merger approved section h either constituent corporation effective date merger surviving corporation within ten day thereafter shall notify holder class series stock constituent corporation entitled appraisal right approval merger appraisal right available share class series stock constituent corporation shall include notice copy section 262 schedule d constitutes formal notice appraisal right section 262 dgcl holder share wish exercise appraisal right wish preserve his right so review following discussion annex carefully failure timely properly comply procedure specified result loss appraisal right dgcl stockholder wishing exercise appraisal right urged consult legal counsel attempting exercise right stockholder elect exercise appraisal right section 262 dgcl stockholder must following prior consummation offer which currently expected expire 1200 midnight eastern time april 2015 one minute 1159 pm eastern time march 31 2015 deliver company address indicated written demand appraisal share held demand must reasonably inform company identity stockholder stockholder intends thereby demand appraisal his share tender share offer continuously hold record share date written demand appraisal made effective time written demand record holder written demand appraisal addressed general counsel corporate secretary salix pharmaceutical ltd 8510 colonnade center drive raleigh north carolina 27615 written demand appraisal must executed record holder share fully correctly holders name appears certificate share owned holder share owned record fiduciary capacity trustee guardian custodian execution demand must made capacity share owned record one person joint tenancy tenancy common demand must executed joint owner authorized agent including one two joint owner may execute demand appraisal holder record however agent must identify record owner expressly disclose fact that executing demand agent acting agent record owner beneficial owner share held street name wish exercise appraisal right take action may necessary ensure timely proper demand appraisal made record holder share share held brokerage firm dealer bank fiduciary nominee turn hold share central security depository nominee cede co demand appraisal 44 table content share must made behalf depository nominee must identify depository nominee record holder beneficial owner wish exercise appraisal right hold share nominee holder responsible ensuring demand appraisal timely made record holder beneficial holder share instruct nominee holder demand appraisal made record holder share may central security depository nominee share deposited record holder broker bank fiduciary depository nominee hold share nominee several beneficial owner may exercise appraisal right respect share held one beneficial owner exercising right respect share held beneficial owner case written demand must set forth number share covered demand number share expressly stated demand presumed cover share held name record owner filing petition appraisal within onehundred twenty day effective time thereafter surviving corporation holder share complied section 262 dgcl entitled appraisal right section 262 may commence appraisal proceeding filing petition delaware court chancery demanding determination fair value share held holder tender offer demanded appraisal petition filed within onehundred twenty day period appraisal right lost holder share previously demanded appraisal share company obligation present intention file petition holder assume company file petition initiate negotiation respect fair value share accordingly holder share desire share appraised initiate necessary action perfect appraisal right respect share within period prescribed section 262 dgcl within onehundred twenty day effective time holder share complied requirement exercise appraisal right set forth section 262 entitled upon written request receive surviving corporation statement setting forth aggregate number share tendered offer respect demand appraisal received aggregate number holder share statement must mailed within ten day written request therefor received surviving corporation within ten day expiration period delivery demand appraisal whichever later notwithstanding foregoing requirement demand appraisal must made behalf record owner share person beneficial owner share held either voting trust nominee behalf person demand properly made effectively withdrawn may persons name file petition appraisal request surviving corporation statement described paragraph petition appraisal timely filed stockholders right appraisal cease upon filing petition appraisal holder share service copy thereof must made upon surviving corporation obligated within twenty day service file delaware register chancery duly verified list the verified list containing name address stockholder demanded payment share agreement value share reached upon filing petition delaware court chancery may order notice time place fixed hearing petition mailed surviving corporation stockholder shown verified list notice also published least one week day hearing newspaper general circulation published city wilmington delaware another publication determined delaware court chancery cost notice borne surviving corporation notice stockholder required delaware court chancery court chancery empowered conduct hearing petition determine stockholder complied 45 table content section 262 dgcl become entitled appraisal right thereunder court chancery may require stockholder demanded payment share submit stock certificate delaware register chancery notation thereon pendency appraisal proceeding and stockholder fails comply direction court chancery may dismiss proceeding stockholder determination fair value delaware court chancery determines stockholder entitled appraisal appraisal proceeding conducted accordance rule court chancery including rule specifically governing appraisal proceeding proceeding court chancery determine fair value share exclusive element value arising accomplishment expectation merger together interest any paid upon amount determined fair value unless court chancery discretion determines otherwise good cause shown interest effective time date payment judgment compounded quarterly accrue five percent federal reserve discount rate including surcharge established time time period effective time date payment judgment determining fair value delaware court chancery take account relevant factor weinberger uop inc supreme court delaware discussed factor could considered determining fair value appraisal proceeding stating proof value technique method generally considered acceptable financial community otherwise admissible court considered fair price obviously requires consideration relevant factor involving value company delaware supreme court stated that making determination fair value court chancery must consider market value asset value dividend earnings prospect nature enterprise fact could ascertained date merger throw light future prospect merged corporation section 262 dgcl provides fair value exclusive element value arising accomplishment expectation merger cede co technicolor inc delaware supreme court stated exclusion narrow exclusion encompass known element value rather applies speculative element value arising accomplishment expectation weinberger supreme court delaware also stated elements future value including nature enterprise known susceptible proof date merger product speculation may considered stockholder considering appraisal aware fair value share determined could than le offer price merger consideration which equal offer price investment banking opinion fairness financial point view consideration payable sale transaction offer merger opinion to otherwise address fair value section 262 dgcl although company belief offer price fair representation made outcome appraisal fair value determined delaware court chancery stockholder recognize appraisal could result determination value higher lower than a offer price merger consideration which equal offer price neither vpi company anticipates offering offer price stockholder exercising appraisal right reserve right assert appraisal proceeding purpose section 262 dgcl fair value share le offer price merger consideration which equal offer price upon application surviving corporation holder share entitled participate appraisal proceeding delaware court chancery may discretion proceed trial upon appraisal prior final determination stockholder entitled appraisal holder share whose name appears verified list submitted stockholders certificate stock delaware register chancery required may participate fully proceeding finally determined 46 table content stockholder entitled appraisal right court chancery direct payment fair value share together interest any surviving corporation stockholder entitled thereto payment made stockholder upon surrender surviving corporation stockholders certificate court chancerys decree may enforced decree court may enforced cost appraisal proceeding which include attorneys fee fee expense expert may determined delaware court chancery taxed upon party court chancery deems equitable upon application stockholder court chancery may order portion expense incurred stockholder connection appraisal proceeding including without limitation reasonable attorneys fee fee expense expert utilized appraisal proceeding charged pro rata value share entitled appraisal absence determination assessment party bear expense stockholder duly demanded perfected appraisal right compliance section 262 dgcl not effective time entitled vote share purpose entitled payment dividend distribution thereon except dividend distribution payable holder record share date prior effective time stockholder demand appraisal share section 262 dgcl fails perfect successfully withdraws loses stockholders right appraisal stockholders share deemed converted effective time right receive merger consideration stockholder fail perfect effectively lose stockholders right appraisal petition appraisal filed within onehundred twenty day effective time addition indicated explained detail below stockholder may withdraw his demand appraisal accordance section 262 dgcl accept merger consideration time within sixty day effective time stockholder commenced appraisal proceeding joined appraisal proceeding named party right withdraw stockholders demand appraisal accept term offered merger period stockholder may withdraw stockholders demand appraisal consent company petition appraisal filed delaware court chancery within onehundred twenty day effective time stockholders right appraisal shall cease holder share entitled receive merger consideration inasmuch company obligation file petition present intention so holder share desire petition filed advised file timely basis stockholder may withdraw stockholders demand appraisal delivering company written withdrawal demand appraisal acceptance merger consideration except i attempt withdraw made sixty day effective time require written approval company ii appraisal proceeding delaware court chancery shall dismissed stockholder without approval delaware court chancery approval may conditioned upon term delaware court chancery deems just however notwithstanding foregoing stockholder commenced appraisal proceeding joined appraisal proceeding named party may withdraw stockholders demand appraisal accept term offered upon merger within sixty day effective time wish exercise appraisal right must tender share offer must strictly comply procedure set forth section 262 dgcl including delivering demand appraisal share company provided herein consummation offer which currently expected expire 1200 midnight eastern time april 2015 one minute 1159 pm eastern time march 31 2015 fail take required step connection exercise appraisal right result termination waiver appraisal right failure follow step required section 262 dgcl perfecting appraisal right may result loss right 47 table content foregoing summary right companys stockholder seek appraisal right delaware law purport complete statement procedure followed companys stockholder desiring exercise appraisal right available thereunder qualified entirety reference section 262 dgcl proper exercise appraisal right requires strict adherence applicable provision dgcl copy section 262 dgcl included annex schedule d antitakeover statute delaware corporation company subject section 203 dgcl general section 203 dgcl prevents delaware corporation engaging business combination defined include merger certain action interested stockholder including person owns right acquire fifteen percent corporations outstanding voting stock period three year following date person became interested stockholder unless among thing business combination approved board director corporation person became interested stockholder none valeant vpi purchaser is time past three year been interested stockholder company defined section 203 dgcl addition board taken action required taken order exempt offer merger merger agreement transaction contemplated thereby restriction business combination set forth section 203 dgcl number state adopted law purport varying degree apply attempt acquire corporation incorporated in substantial asset stockholder principal executive office principal place business whose business operation otherwise substantial economic effect in state company directly subsidiary conduct business number state throughout united state may enacted law except described herein company know whether law will term apply offer merger company complied law extent certain provision law purport apply offer merger company belief reasonable base contesting application law vote required approve merger board approved merger agreement offer merger transaction contemplated merger agreement accordance dgcl merger agreement contemplates merger effected pursuant section h dgcl permit completion merger upon acquisition purchaser one share fifty percent number share issued outstanding merger effected pursuant section h dgcl vote stockholder company required consummate merger certain litigation following announcement execution merger agreement four purported stockholder class action filed challenging proposed transaction action filed delaware court chancery feinstein valeant pharmaceutical international inc al ca no 10721 filed february 25 2015 garcia salix pharmaceutical ltd al ca no 10728 filed february 27 2015 gonsalves salix pharmaceutical ltd al ca no 10737 filed march 2015 lindgren salix pharmaceutical ltd al ca no 10748 filed march 2015 feinstein complaint name board valeant vpi purchaser defendant garcia gonsalves lindgren complaint name board valeant vpi purchaser company defendant complaint allege generally member board breached fiduciary duty stockholder defendant aided abetted breach seeking sell company inadequate consideration agreeing allegedly preclusive deal protection four complaint seek among thing injunctive relief including enjoining proposed transaction rescission rescissory damage event proposed transaction consummated unspecified attorneys fee cost intend vigorously defend claim 48 table content mergerrelated compensation section set forth information required item t regulation sk regarding compensation named executive officer and mr bertrand based otherwise relates offer merger compensation referred golden parachute compensation applicable sec disclosure rule section use term describe mergerrelated compensation payable named executive officer and mr bertrand term merger agreement provide vesting outstanding company option company restricted stock connection transaction effective time effective time outstanding company option previously exercised company restricted stock converted right receive merger consideration cash described item past contact transaction negotiation agreement arrangement current executive officer director company effect offer merger agreement equity awards certain named executive officer and mr bertrand also entitled certain payment benefit pursuant agreement described item past contact transaction negotiation agreement arrangement current executive officer director company employment agreements amount set forth table assume following effective time occurred february 27 2015 last practicable date prior filing schedule d companys named executive officer and mr bertrand terminated without cause resigned good reason immediately following effective time february 27 2015 per share cash consideration payable merger agreement 158 amount reported estimate based multiple assumption may may actually occur including assumption described schedule d reflect certain compensation action occurring completion merger result actual amount any received individual listed may differ materially amount set forth below name cash severancepayments 1 equity 2 perquisitesbenefits 3 total thomas dalonzo 0 3323056 0 3323056 william bertrand jr 2722500 4469662 137741 7329903 timothy creech 1377500 3376776 62660 4816936 william forbes 2880000 8170812 74192 11125004 rick scruggs 2113216 7584948 74192 9856836 carolyn logan 4 0 26908822 123313 27032135 adam derbyshire 5 0 8527736 131560 8659296 1 amount represent doubletrigger cash severance amount payable following qualifying termination employment within twelve month following consummation offer case assuming base salary bonus opportunity remain unchanged current level 2 amount represent singletrigger cash payment exchange cancellation company restricted stock effective time occur automatically effective time without regard whether executives employment terminated 3 amount represent value doubletrigger payment cost health insurance coverage provided companys named executive officer mr bertrand at estimated cost 1922 per month mr dalonzo m logan mr derbyshire thirtysix month thirty month mr creech following qualifying termination employment within twelve month following consummation 49 table content offer m logan mr derbyshire amount represent value continued health insurance coverage pursuant letter agreement company entered m logan approximately fortytwo month mr derbyshire approximately fortyfive month connection respective termination employment named executive officer mr bertrand other mr dalonzo m logan mr derbyshire also entitled outplacement service valued 5000 officer following qualifying termination employment mr bertrand entitled relocation reimbursement 63549 connection qualifying termination employment 4 m logan retired president chief executive officer january 30 2015 5 mr derbyshire resigned executive vice president finance administration chief financial officer november 2014 certain management projection company not matter course make public longterm projection future revenue earnings result due extreme uncertainty underlying assumption estimate however connection boards review companys strategic alternative including offer merger companys senior management prepared prospective riskadjusted forecast company 2029 the company forecasts light companys intention sell lesser amount product 2015 order achieve targeted level wholesaler inventory product end 2015 companys senior management included company forecast normalized projection 2015 reflected managements forecast company company sell product based prescription demand without regard inventory reduction plan companys senior management also prepared riskadjusted forecast companys currently marketed product product development 2029 the company product revenue forecast and together company forecast management projections company risk adjusted management projection applying probability success adjustment product yet gained regulatory approval varies based current phase development consistent industry practice management projection included forecast 2029 management considered 2029 appropriate point considering companys longterm value goingconcern basis order properly account end patent exclusivity certain companys key product including xifaxan 550 management projection presented board unanimously approved board use connection boards review companys strategic alternative company electing summarize material element management projection schedule d provide holder share access prospective information made available board purpose considering evaluating proposed transaction valeant management projection also provided companys financial advisor centerview jp morgan see description centerviews jp morgans fairness opinion item solicitation recommendation opinion companys financial advisors management projection prepared view toward public disclosure inclusion management projection schedule d regarded indication company financial advisor recipient information considered considers reflection possible outcome predictive actual future result neither company affiliate financial advisor assumes responsibility holder share accuracy information management projection provided valeant management projection were general prepared solely internal use subjective many respect thus subject interpretation management projection presented numerical specificity reflect numerous estimate assumption made companys senior management respect industry performance competition general business economic market financial condition matter specific companys product product candidate difficult predict many beyond companys control result assurance management projection accurately reflect future trend respect companys product accurately estimate future market companys product candidate 50 table content management projection cover multiple year nature become subject greater uncertainty successive year assumption upon management projection based necessarily involve judgment companys senior management respect to among thing future economic competitive regulatory condition financial market condition difficult impossible predict accurately many beyond companys control management projection also reflect assumption companys senior management certain business decision subject change important factor may affect actual result result management projection achieved include limited to timing regulatory approval introduction new product market acceptance new product success clinical testing availability thirdparty reimbursement impact competitive product pricing including generic effect regulatory action effect general economic industry condition fluctuation foreign currency exchange rate cost effect change tax legislation risk factor described companys annual report form k fiscal year ended december 31 2014 addition management projection may affected companys ability achieve strategic goal objective target applicable period accordingly assurance management projection realized actual result may vary materially shown inclusion management projection schedule d regarded indication company affiliate advisor representative considered consider management projection predictive actual future event construed financial guidance management projection relied upon such neither company valeant respective affiliate advisor officer director representative give assurance actual result differ management projection none undertakes obligation update otherwise revise reconcile management projection reflect circumstance existing date management projection generated reflect occurrence future event even event assumption underlying management projection shown error company intend make publicly available update revision management projection except otherwise required law neither company valeant respective affiliate advisor officer director representative made make representation holder share person regarding ultimate performance company compared information contained management projection management projection achieved company made representation valeant merger agreement otherwise concerning management projection management projection prepared companys senior management based companys continued operation standalone company take account offer merger including potential synergy may achieved combined company result offer merger effect business strategic decision action taken result merger agreement executed management projection prepared view toward public disclosure compliance u gaap compliance published guideline sec regarding projection compliance guideline established american institute certified public accountant preparation presentation prospective financial information neither companys independent registered public accounting firm independent accountant audited reviewed compiled performed procedure respect management projection expressed opinion form assurance related thereto holder share urged review companys recent sec filing description risk factor respect companys business see also cautionary statement regarding forwardlooking statements below light foregoing factor uncertainty inherent management projection holder share cautioned place undue any reliance management projection 51 table content company forecast fiscal year ended e e e e e e e e e e e e e e e revenue 1418 2247 2857 3568 4234 4888 5229 5672 6037 6490 6610 5382 4298 3739 3078 ebitda 1 791 2 1074 1386 1732 2065 2386 2550 2774 2971 3199 3247 2483 1951 1731 1417 fullytaxed eps 3 556 4 833 note dollar million except per share amount 1 earnings interest tax depreciation amortization stockbased compensation expense 2 actual projected 2015 ebitda 473 amount shown reflects managements forecast company company sell product based prescription demand 2015 without regard inventory reduction plan 3 fullytaxed cash earnings calculated ebitda le depreciation le cash interest expense tax 38 normalized tax rate assuming benefit tax attribute per share assumes million share outstanding fullydiluted basis 4 actual projected 2015 fullytaxed eps 295 amount shown reflects managements forecast company company sell product based prescription demand 2015 without regard inventory reduction plan company product revenue forecast fiscal year ended e e e e e e e e e e e e e e e xifaxan 550 611 1046 1294 1476 1641 1670 1632 1595 1540 1484 1436 911 734 651 599 xifaxan 550 ibs 196 410 641 856 993 1117 1256 1411 1571 1567 1145 852 734 669 xifaxan 200 apriso 180 213 234 258 283 304 252 moviprep 109 glumetza 105 uceris 167 253 325 377 424 381 104 uceris foam ruconest 103 110 111 109 relistor 108 121 136 152 171 192 214 235 230 149 123 111 total 1230 2007 2576 3060 3429 3587 3446 3458 3385 3498 3476 2524 1916 1675 1544 rifaximin eir 142 198 267 338 383 358 222 174 150 135 rifaximin ssd 141 258 403 564 726 828 1037 1132 1097 697 encapsulated bowel prep 112 123 123 123 123 uceris new indication 137 238 342 442 482 482 193 oral relistor 154 274 448 655 833 918 998 1075 1150 1096 690 552 485 total 172 378 649 1128 1601 2024 2454 2789 2941 2671 2196 1879 1349 zegerid royalty prasco cycloset fulyzaq deflux solesta 101 108 113 118 121 121 121 121 121 121 zegerid total 188 167 109 130 156 172 183 190 198 203 192 188 186 185 185 total 1418 2247 2857 3568 4234 4888 5229 5672 6037 6490 6610 5382 4298 3739 3078 note dollar million company intend update otherwise revise management projection reflect circumstance existing date made reflect occurrence future event even event assumption underlying management projection longer appropriate 52 table content cautionary statement regarding forwardlooking statement schedule d contains forwardlooking statements involve significant risk uncertainty statement statement historical fact statement could deemed forwardlooking statement including statement regarding anticipated timing filing approval relating offer merger statement regarding expected timing completion offer merger statement regarding ability complete offer merger considering various closing condition including minimum condition statement expectation belief management projection statement assumption underlying foregoing investor stockholder company cautioned place undue reliance forwardlooking statement actual result could differ materially currently anticipated due number risk uncertainty risk uncertainty could cause result differ expectation include uncertainty timing offer merger uncertainty many stockholder company tender share offer possibility various closing condition offer merger may satisfied waived including governmental entity may prohibit delay refuse grant approval consummation offer merger effect disruption offer merger making difficult company maintain relationship employee licensee business partner governmental entity business effect including effect industrial economic political condition outside companys control transaction cost actual contingent liability risk uncertainty discussed schedule d document filed sec company well schedule filed sec vpi purchaser material related offer and offer document filed sec available charge sec website wwwsecgov stockholder company also may obtain free copy document filed sec company wwwsalixcom company undertake obligation update forwardlooking statement result new information future development otherwise except expressly required law 53 table content item exhibit following exhibit filed herewith incorporated herein reference exhibit description document a offer purchase dated march 2015 incorporated reference exhibit ai tender offer statement schedule purchaser filed valeant sec march 2015 the schedule to a form letter transmittal incorporated reference exhibit aii schedule to a form notice guaranteed delivery incorporated reference exhibit aiii schedule to a form letter broker dealer commercial bank trust company nominee incorporated reference exhibit aiv schedule to a form letter client use broker dealer commercial bank trust company nominee incorporated reference exhibit av schedule to a summary advertisement published new york time march 2015 incorporated reference exhibit avi schedule to a joint press release issued company valeant dated february 22 2015 incorporated reference exhibit 991 current report form k filed company february 23 2015 a earnings press release issued valeant february 23 2015 incorporated reference exhibit 991 current report form k filed valeant february 23 2015 a investor presentation valeant dated february 23 2015 incorporated reference exhibit 991 tender offer statement schedule toc filed valeant february 23 2015 a email sent employee valeant february 22 2015 incorporated reference exhibit 992 tender offer statement schedule toc filed valeant february 23 2015 a email sent company employee february 22 2015 incorporated reference exhibit 993 tender offer statement schedule toc filed valeant february 23 2015 a communication sent company employee february 22 2015 incorporated reference exhibit 991 solicitationrecommendation statement schedule dc filed company february 23 2015 a transcript investor presentation dated february 23 2015 incorporated reference exhibit 991 tender offer statement schedule toc filed valeant february 24 2015 a press release issued company february 25 2015 incorporated reference exhibit 991 solicitationrecommendation statement schedule dc filed company february 25 2015 a press release issued company february 25 2015 incorporated reference exhibit 992 solicitationrecommendation statement schedule dc filed company february 25 2015 a opinion centerview partner llc dated february 20 2015 included annex schedule d a opinion jp morgan security llc dated february 20 2015 included annex schedule d e agreement plan merger dated february 20 2015 among company vpi purchaser valeant incorporated reference exhibit 21 current report form k filed company february 23 2015 54 table content exhibit description document e confidentiality agreement dated january 20 2015 company valeant incorporated reference exhibit d schedule to e amendment dated february 2015 confidentiality agreement dated january 20 2015 company valeant incorporated reference exhibit d schedule to e certificate incorporation amended incorporated reference exhibit 31 quarterly report form q filed company may 10 2011 e amended restated bylaw incorporated reference exhibit 31 current report form k filed company december 23 2013 e form 1996 stock plan salix holding ltd amended july 2004 incorporated reference exhibit 103 quarterly report form q filed company august 2004 e form employment agreement executive officer incorporated reference exhibit 1031 quarterly report form q filed company november 14 2001 e 2005 stock plan amended incorporated reference exhibit 1050 current report form k filed company june 11 2009 e form restricted stock grant granted pursuant 2005 stock plan incorporated reference exhibit 1054 annual report form k filed company march 16 2006 e form indemnification agreement santarus inc santarus director officer incorporated reference exhibit 1010 registration statement form sa filed santarus february 2004 e executive nonqualified excess plan adoption agreement incorporated reference exhibit 103 quarterly report form q filed santarus august 2012 e 2013 bonus plan incorporated reference exhibit 101 current report form k filed santarus february 22 2013 e amended restated employment agreement dated march 22 2013 santarus inc gerald proehl incorporated reference exhibit 101 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc debra crawford incorporated reference exhibit 102 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc david ballard ii md incorporated reference exhibit 103 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc maria bedoyatoro incorporated reference exhibit 104 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc julie demeules incorporated reference exhibit 105 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc william denby iii incorporated reference exhibit 106 quarterly report form q filed santarus may 2013 55 table content exhibit description document e amended restated employment agreement dated march 22 2013 santarus inc carey fox incorporated reference exhibit 107 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc warren hall incorporated reference exhibit 108 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc michael step incorporated reference exhibit 109 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc mark totoritis incorporated reference exhibit 1010 quarterly report form q filed santarus may 2013 e amended restated employment agreement dated march 22 2013 santarus inc wendell wierenga phd incorporated reference exhibit 1011 quarterly report form q filed santarus may 2013 e memorandum regarding amendment amended restated employment agreement dated november 2013 gerald proehl executive officer santarus inc incorporated reference exhibit e solicitationrecommendation statement schedule d filed santarus december 2013 e amended restated employment agreement effective april 29 2014 salix pharmaceutical inc rick scruggs incorporated reference exhibit 104 current report form k filed company may 2014 e amended restated 2014 stock incentive plan e form indemnification agreement salix pharmaceutical ltd director executive officer incorporated reference exhibit 101 current report form k filed company december 23 2013 e amended restated employment agreement effective january 2015 salix pharmaceutical inc william bertrand e amended restated employment agreement salix pharmaceutical inc william forbes effective february 2015 filing made santarus inc prior companys acquisition santarus 56 table content signature due inquiry best knowledge belief certify information set forth schedule d true complete correct salix pharmaceutical ltd by s william bertrand jr dated march 2015 name william bertrand jr title acting chief operating officer executive vice president general counsel table content annex centerview partner llc west nd street new york 10019 february 20 2015 board director salix pharmaceutical ltd 8510 colonnade center drive raleigh north carolina 27615 board director requested opinion fairness financial point view holder outstanding share common stock par value 0001 per share the shares other excluded share defined below salix pharmaceutical ltd delaware corporation the company consideration a defined below proposed paid holder pursuant agreement plan merger proposed entered into dated february 20 2015 the agreement among valeant pharmaceutical international delaware corporation parent sun merger sub inc delaware corporation wholly owned subsidiary parent merger sub company solely purpose section 816 valeant pharmaceutical international inc british columbia corporation guarantor agreement provides i merger sub commence tender offer purchase share the tender offer price 15800 per share net holder cash without interest subject withholding tax a defined agreement required applicable law a defined agreement accordance section e agreement share accepted ii that following completion tender offer merger sub merged company the merger and collectively tender offer transaction contemplated agreement transaction result company become wholly owned subsidiary parent issued outstanding share immediately prior effective time merger other i share cancelled pursuant section b agreement ii dissenting share a defined agreement the share referred clause i ii together share held affiliate guarantor excluded shares converted right receive 15800 per share net holder cash without interest subject withholding tax required applicable law accordance section e agreement the 15800 per share consideration paid tender offer merger consideration term condition transaction fully set forth agreement acted financial advisor board director company connection with participated certain negotiation leading to transaction receive fee service connection transaction portion already paid substantial portion contingent upon consummation transaction addition company agreed reimburse certain expense arising indemnify certain liability may arise engagement security firm engaged directly affiliate related person number investment banking financial advisory merchant banking activity except connection current west nd street nd floor new york 10019 phone 212 3802650 fax 212 3802651 wwwcenterviewpartnerscom new york london san francisco los angeles a table content board director salix pharmaceutical ltd february 20 2015 page engagement company provided investment banking service company parent guarantor merger sub may provide investment banking service respect company guarantor parent respective affiliate future may receive compensation certain i affiliates director officer member employee family member person ii affiliate related investment fund iii investment fund person foregoing may financial interest may coinvest may time acquire hold sell trade debt equity security financial instrument including derivative bank loan obligation of investment in company guarantor parent respective affiliate party may involved transaction connection opinion reviewed among thing i draft agreement dated february 20 2015 the draft agreement ii annual report form k company year ended december 31 2013 december 31 2012 december 31 2011 iii certain interim report stockholder quarterly report form q company iv certain publicly available research analyst report company v certain communication company stockholder vi certain internal information relating business operation earnings cash flow asset liability prospect company including certain financial forecast analysis projection relating company prepared management company furnished company purpose analysis the forecasts collectively internal data also conducted discussion member senior management representative company regarding assessment internal data strategic rationale transaction addition reviewed publicly available financial stock market data including valuation multiple company compared data similar data certain company security publicly traded line business deemed relevant also compared certain proposed financial term transaction financial term extent publicly available certain transaction deemed relevant conducted financial study analysis took account information deemed appropriate assumed without independent verification responsibility therefor accuracy completeness financial legal regulatory tax accounting information supplied to discussed with reviewed purpose opinion have consent relied upon information complete accurate regard assumed direction internal data including without limitation forecast reasonably prepared base reflecting best currently available estimate judgment management company matter covered thereby relied direction internal data purpose analysis opinion express view opinion internal data assumption based addition direction made independent evaluation appraisal asset liability contingent derivative offbalancesheet otherwise company furnished evaluation appraisal asked conduct conduct physical inspection property asset company assumed direction final executed agreement differ respect material analysis opinion draft agreement reviewed u also assumed direction transaction consummated term set forth agreement accordance applicable law relevant document requirement without delay waiver modification amendment term condition agreement effect would material analysis opinion that course obtaining necessary governmental regulatory approval consent release waiver transaction delay limitation restriction condition change imposed effect would material analysis opinion evaluated express opinion solvency fair value company ability company pay obligation come due impact transaction matter state federal law relating bankruptcy insolvency similar matter legal regulatory tax accounting advisor express opinion legal regulatory tax accounting matter a table content board director salix pharmaceutical ltd february 20 2015 page express view to opinion address companys underlying business decision proceed effect transaction relative merit transaction compared alternative business strategy transaction might available company company might engage opinion limited address fairness financial point view date hereof holder share other excluded share consideration paid holder pursuant agreement asked to express view on opinion address term aspect agreement transaction including without limitation structure form transaction agreement arrangement contemplated agreement entered connection otherwise contemplated transaction including without limitation fairness transaction term aspect transaction to consideration received connection therewith by impact transaction on holder class security creditor constituency company party addition express view opinion fairness financial otherwise amount nature aspect compensation paid payable officer director employee company party class person connection transaction whether relative consideration paid holder share other excluded share pursuant agreement otherwise opinion necessarily based financial economic monetary currency market condition circumstance effect on information made available of date hereof obligation responsibility update revise reaffirm opinion based circumstance development event occurring date hereof opinion constitute recommendation stockholder company whether holder tender share connection tender offer otherwise act respect transaction matter financial advisory service opinion expressed herein provided information assistance board director company in capacity director capacity connection purpose consideration transaction company may reproduce written opinion full solicitationrecommendation statement required made company security exchange commission connection transaction inclusion required applicable law material required delivered stockholder company part filing issuance opinion approved centerview partner llc fairness opinion committee based upon subject foregoing including various assumption limitation set forth herein opinion date hereof consideration paid holder share other excluded share pursuant agreement fair financial point view holder truly yours s centerview partner llc centerview partner llc a table content annex february 20 2015 board director salix pharmaceutical ltd 8510 colonnade center drive raleigh 27615 member board director requested opinion fairness financial point view holder common stock par value 0001 per share the company common stock salix pharmaceutical ltd the company consideration paid holder proposed tender offer merger each defined below pursuant agreement plan merger the agreement among company valeant pharmaceutical international parent sun merger sub inc whollyowned subsidiary parent merger sub valeant pharmaceutical international inc guarantor pursuant agreement parent cause merger sub commence tender offer share company common stock the tender offer price share equal 15800 the consideration payable cash agreement provides that following completion tender offer merger sub merged company the merger outstanding share company common stock share company common stock held treasury owned company subsidiary a defined agreement guarantor affiliate guarantor dissenting share a defined agreement converted right receive amount equal consideration cash tender offer merger together separately referred herein transaction connection preparing opinion i reviewed draft dated february 19 2015 agreement ii reviewed certain publicly available business financial information concerning company industry operates iii compared proposed financial term transaction publicly available financial term certain transaction involving company deemed relevant consideration paid company iv compared financial operating performance company publicly available information concerning certain company deemed relevant reviewed current historical market price company common stock certain publicly traded security company v reviewed certain internal financial analysis forecast prepared management company relating business vi performed financial study analysis considered information deemed appropriate purpose opinion addition held discussion certain member management company respect certain aspect transaction past current business operation company financial condition future prospect operation company certain matter believed necessary appropriate inquiry giving opinion relied upon assumed accuracy completeness information publicly available furnished discussed company otherwise reviewed u independently verified nor assumed responsibility liability independently verifying information accuracy completeness conducted provided valuation appraisal asset liability evaluated solvency company parent guarantor state federal law relating bankruptcy insolvency similar matter relying financial analysis forecast provided derived therefrom assumed b table content reasonably prepared based assumption reflecting best currently available estimate judgment management expected future result operation financial condition company analysis forecast relate express view analysis forecast assumption based also assumed transaction transaction contemplated agreement tax consequence described discussion with material furnished by representative company consummated described agreement definitive agreement differ material respect draft thereof furnished u also assumed representation warranty made company parent agreement related agreement true correct respect material analysis legal regulatory tax expert relied assessment made advisor company respect issue assumed material governmental regulatory consent approval necessary consummation transaction obtained without adverse effect company contemplated benefit transaction opinion necessarily based economic market condition effect on information made available of date hereof understood subsequent development may affect opinion obligation update revise reaffirm opinion opinion limited fairness financial point view consideration paid holder company common stock proposed transaction express opinion fairness consideration paid connection transaction holder class security creditor constituency company underlying decision company engage transaction furthermore express opinion respect amount nature compensation officer director employee party transaction class person relative consideration paid holder company common stock transaction respect fairness compensation acted financial advisor company respect proposed transaction receive fee company service substantial portion become payable proposed transaction consummated addition company agreed indemnify certain liability arising engagement please advised that two year preceding date letter neither affiliate material financial advisory material commercial investment banking relationship company two year preceding date letter affiliate commercial investment banking relationship guarantor affiliate received customary compensation service period included acting guarantors joint bookrunner bond offering june 2013 joint lead arranger bookrunner amendment revolving credit facility july 2013 joint bookrunner bond offering november 2013 joint lead arranger bookrunner amendment term loan december 2013 addition commercial banking affiliate lender outstanding credit facility guarantor receives customary compensation financial benefit ordinary course business affiliate may actively trade debt equity security company guarantor account account customer and accordingly may time hold long short position security basis subject foregoing opinion date hereof consideration paid holder company common stock proposed transaction fair financial point view holder issuance opinion approved fairness opinion committee jp morgan security llc letter provided board director company in capacity such connection purpose evaluation transaction opinion constitute recommendation shareholder company whether shareholder tender share tender offer matter opinion may disclosed referred to communicated in whole part third party purpose whatsoever except prior written approval opinion may reproduced full b table content solicitationrecommendation statement mailed shareholder company may otherwise disclosed publicly manner without prior written approval truly yours s jp morgan security llc jp morgan security llc b table content annex general corporation law state delaware 262 appraisal right a stockholder corporation state hold share stock date making demand pursuant subsection d section respect share continuously hold share effective date merger consolidation otherwise complied subsection d section neither voted favor merger consolidation consented thereto writing pursuant 228 title shall entitled appraisal court chancery fair value stockholders share stock circumstance described subsection b c section used section word stockholder mean holder record stock corporation word stock share mean include ordinarily meant word word depository receipt mean receipt instrument issued depository representing interest share fraction thereof solely stock corporation stock deposited depository b appraisal right shall available share class series stock constituent corporation merger consolidation effected pursuant 251 other merger effected pursuant g title and subject paragraph b section 251 h title 252 254 255 256 257 258 263 264 title 1 provided however that except expressly provided b title appraisal right section shall available share class series stock stock depository receipt respect thereof record date fixed determine stockholder entitled receive notice meeting stockholder act upon agreement merger consolidation either i listed national security exchange ii held record 2000 holder provided appraisal right shall available share stock constituent corporation surviving merger merger require approval vote stockholder surviving corporation provided f title 2 notwithstanding paragraph b section appraisal right section shall available share class series stock constituent corporation holder thereof required term agreement merger consolidation pursuant 251 252 254 255 256 257 258 263 264 title accept stock anything except share stock corporation surviving resulting merger consolidation depository receipt respect thereof share stock corporation depository receipt respect thereof share stock or depository receipt respect thereof depository receipt effective date merger consolidation either listed national security exchange held record 2000 holder cash lieu fractional share fractional depository receipt described foregoing paragraph ba section combination share stock depository receipt cash lieu fractional share fractional depository receipt described foregoing paragraph ba section 3 event stock subsidiary delaware corporation party merger effected h 253 267 title owned parent immediately prior merger appraisal right shall available share subsidiary delaware corporation 4 event amendment corporations certificate incorporation contemplated a title appraisal right shall available contemplated b title c table content procedure section including set forth subsection d e section shall apply nearly practicable word amendment substituted word merger consolidation word corporation substituted word constituent corporation andor surviving resulting corporation c corporation may provide certificate incorporation appraisal right section shall available share class series stock result amendment certificate incorporation merger consolidation corporation constituent corporation sale substantially asset corporation certificate incorporation contains provision procedure section including set forth subsection d e section shall apply nearly practicable d appraisal right shall perfected follows 1 proposed merger consolidation appraisal right provided section submitted approval meeting stockholder corporation le day prior meeting shall notify stockholder record date notice meeting or member received notice accordance c title respect share appraisal right available pursuant subsection b c section appraisal right available share constituent corporation shall include notice copy section and constituent corporation nonstock corporation copy 114 title stockholder electing demand appraisal stockholders share shall deliver corporation taking vote merger consolidation written demand appraisal stockholders share demand sufficient reasonably informs corporation identity stockholder stockholder intends thereby demand appraisal stockholders share proxy vote merger consolidation shall constitute demand stockholder electing take action must separate written demand herein provided within day effective date merger consolidation surviving resulting corporation shall notify stockholder constituent corporation complied subsection voted favor consented merger consolidation date merger consolidation become effective 2 merger consolidation approved pursuant 228 h 253 267 title either constituent corporation effective date merger consolidation surviving resulting corporation within day thereafter shall notify holder class series stock constituent corporation entitled appraisal right approval merger consolidation appraisal right available share class series stock constituent corporation shall include notice copy section and constituent corporation nonstock corporation copy 114 title notice may and given effective date merger consolidation shall also notify stockholder effective date merger consolidation stockholder entitled appraisal right may within day date mailing notice or case merger approved pursuant h title within later consummation tender exchange offer contemplated h title day date mailing notice demand writing surviving resulting corporation appraisal holders share demand sufficient reasonably informs corporation identity stockholder stockholder intends thereby demand appraisal holders share notice notify stockholder effective date merger consolidation either i constituent corporation shall send second notice effective date merger consolidation notifying holder class series stock constituent corporation entitled appraisal right effective date merger consolidation ii surviving resulting corporation shall send second notice holder within day effective date provided however second notice sent day following sending first notice or case merger approved pursuant h title later later consummation tender exchange offer contemplated h title day following sending first notice second notice need sent stockholder entitled appraisal right demanded appraisal holders share c table content accordance subsection affidavit secretary assistant secretary transfer agent corporation required give either notice notice given shall absence fraud prima facie evidence fact stated therein purpose determining stockholder entitled receive either notice constituent corporation may fix advance record date shall day prior date notice given provided notice given effective date merger consolidation record date shall effective date record date fixed notice given prior effective date record date shall close business day next preceding day notice given e within 120 day effective date merger consolidation surviving resulting corporation stockholder complied subsection a d section hereof otherwise entitled appraisal right may commence appraisal proceeding filing petition court chancery demanding determination value stock stockholder notwithstanding foregoing time within day effective date merger consolidation stockholder commenced appraisal proceeding joined proceeding named party shall right withdraw stockholders demand appraisal accept term offered upon merger consolidation within 120 day effective date merger consolidation stockholder complied requirement subsection a d section hereof upon written request shall entitled receive corporation surviving merger resulting consolidation statement setting forth aggregate number share voted favor merger consolidation respect demand appraisal received aggregate number holder share written statement shall mailed stockholder within day stockholders written request statement received surviving resulting corporation within day expiration period delivery demand appraisal subsection d section hereof whichever later notwithstanding subsection a section person beneficial owner share stock held either voting trust nominee behalf person may persons name file petition request corporation statement described subsection f upon filing petition stockholder service copy thereof shall made upon surviving resulting corporation shall within day service file office register chancery petition filed duly verified list containing name address stockholder demanded payment share agreement value share reached surviving resulting corporation petition shall filed surviving resulting corporation petition shall accompanied duly verified list register chancery ordered court shall give notice time place fixed hearing petition registered certified mail surviving resulting corporation stockholder shown list address therein stated notice shall also given publication least week day hearing newspaper general circulation published city wilmington delaware publication court deems advisable form notice mail publication shall approved court cost thereof shall borne surviving resulting corporation g hearing petition court shall determine stockholder complied section become entitled appraisal right court may require stockholder demanded appraisal share hold stock represented certificate submit certificate stock register chancery notation thereon pendency appraisal proceeding stockholder fails comply direction court may dismiss proceeding stockholder h court determines stockholder entitled appraisal appraisal proceeding shall conducted accordance rule court chancery including rule specifically governing appraisal proceeding proceeding court shall determine fair value share exclusive element value arising accomplishment expectation merger consolidation together interest any paid upon amount determined fair value determining fair value c table content court shall take account relevant factor unless court discretion determines otherwise good cause shown interest effective date merger date payment judgment shall compounded quarterly shall accrue federal reserve discount rate including surcharge established time time period effective date merger date payment judgment upon application surviving resulting corporation stockholder entitled participate appraisal proceeding court may discretion proceed trial upon appraisal prior final determination stockholder entitled appraisal stockholder whose name appears list filed surviving resulting corporation pursuant subsection f section submitted stockholders certificate stock register chancery required may participate fully proceeding finally determined stockholder entitled appraisal right section i court shall direct payment fair value share together interest any surviving resulting corporation stockholder entitled thereto payment shall made stockholder case holder uncertificated stock forthwith case holder share represented certificate upon surrender corporation certificate representing stock courts decree may enforced decree court chancery may enforced whether surviving resulting corporation corporation state state j cost proceeding may determined court taxed upon party court deems equitable circumstance upon application stockholder court may order portion expense incurred stockholder connection appraisal proceeding including without limitation reasonable attorneys fee fee expense expert charged pro rata value share entitled appraisal k effective date merger consolidation stockholder demanded appraisal right provided subsection d section shall entitled vote stock purpose receive payment dividend distribution stock except dividend distribution payable stockholder record date prior effective date merger consolidation provided however petition appraisal shall filed within time provided subsection e section stockholder shall deliver surviving resulting corporation written withdrawal stockholders demand appraisal acceptance merger consolidation either within day effective date merger consolidation provided subsection e section thereafter written approval corporation right stockholder appraisal shall cease notwithstanding foregoing appraisal proceeding court chancery shall dismissed stockholder without approval court approval may conditioned upon term court deems just provided however provision shall affect right stockholder commenced appraisal proceeding joined proceeding named party withdraw stockholders demand appraisal accept term offered upon merger consolidation within day effective date merger consolidation set forth subsection e section l share surviving resulting corporation share objecting stockholder would converted assented merger consolidation shall status authorized unissued share surviving resulting corporation c exe ddexehtm exe exe exhibit e salix pharmaceutical ltd amended restated 2014 stock incentive plan table content article introduction 11 purpose plan 12 nature award 13 effective date term plan article definition construction 21 definition 22 construction article eligibility 31 general article administration plan 41 general 42 delegation committee officer article stock subject plan 51 number share 52 substitute award article type award 61 stock option 62 stock appreciation right 63 restricted stock 64 restricted stock unit 65 stockbased award 66 cash award 67 performancebased award article adjustment 71 change capitalization 72 change control article general provision applicable award 81 transferability award 82 termination status 83 withholding 84 condition delivery stock 85 acceleration article miscellaneous 91 right employment status 92 right stockholder salix amended restated 2014 stock incentive plan table content 93 amendment 94 compliance code section a 95 governing law salix amended restated 2014 stock incentive plan table content article introduction 11 purpose plan plan intended enhance companys ability attract retain motivate best available employee officer director consultant advisor provide equity ownership opportunity performancebased incentive intended align interest companys stockholder promote success companys business plan succeeds companys 2005 stock plan award shall granted plan effective date plan 12 nature award plan permit grant stock option stock appreciation right share restricted stock restricted stock unit form award based value or increase value share common stock company plan also permit cash incentive award except otherwise provided plan award may made alone addition relation award term award need identical compensation committee need treat participant uniformly 13 effective date term plan plan effective june 13 2014 award shall granted plan june 12 2024 or earlier date may apply applicable law award previously granted may extend beyond date salix amended restated 2014 stock incentive plan page article definition construction 21 definition used plan following term shall meaning set forth below unless context clearly requires different meaning a award mean award issued plan b award certificate mean agreement certificate document evidencing award shall form written electronic otherwise compensation committee shall determine c board mean board director company d change control mean 1 person a term used section d d exchange act other company subsidiary company employee benefit plan company subsidiary company becomes beneficial owner a defined rule d d exchange act directly indirectly 50 combined voting power companys outstanding security entitled vote generally election member board security entity entitled vote generally election member board director entity referred herein voting stock provided transaction deemed constitute change control i company becomes direct indirect wholly owned subsidiary holding company iia direct indirect holder voting stock holding company immediately following transaction substantially holder companys voting stock immediately prior transaction b immediately following transaction person a term used section d d exchange act other holding company satisfying requirement sentence beneficial owner directly indirectly 50 voting stock holding company 2 period two consecutive year individual beginning period constituted board salix amended restated 2014 stock incentive plan page together new director whose election board whose nomination election stockholder company approved vote least twothirds member board still office either member board beginning period whose election nomination election previously approved cease reason constitute least majority board office 3 consummation merger consolidation company another entity merger another entity company provided that merger consolidation deemed constitute change control share companys voting stock outstanding immediately prior merger consolidation constitute converted exchanged for security representing 50 voting stock i surviving entity merger consolidation the surviving entity ii holding company surviving entity direct indirect wholly owned subsidiary case immediately merger consolidation 4 direct indirect sale transfer conveyance disposition other way merger consolidation one series transaction substantially asset company on consolidated basis person a term used section d d exchange act 5 adoption plan relating liquidation dissolution company notwithstanding foregoing i transfer asset among company subsidiary shall constitute change control ii term change control shall include merger consolidation company into sale transfer conveyance disposition substantially asset company to affiliate company incorporated organized solely purpose reincorporating reorganizing company another jurisdiction andor sole purpose forming collapsing dissolving holding company structure iii person a term used section d d exchange act shall deemed beneficial ownership salix amended restated 2014 stock incentive plan page security subject stock purchase agreement merger agreement similar agreement or voting option agreement related thereto consummation transaction contemplated agreement iv event shall change control deemed occurred respect holder award holder part purchasing group consummates change control transaction such holder shall deemed part purchasing group purpose clause iv he either directly indirectly equity participant purchasing group except a passive ownership le stock purchasing group b ownership equity participation purchasing group otherwise significant determined prior change control board e code mean internal revenue code 1986 amended f company mean salix pharmaceutical ltd g compensation committee shall mean compensation committee board h disability shall mean disability within meaning companys longterm disability plan participant participates or plan federal social security act i effective date mean first date set forth section 13 j exchange act mean security exchange act 1934 amended k fair market value mean closing sale price or closing bid sale reported primary trading session share last market trading day time determination reported wall street journal source administrator deems reliable compensation committee substitute particular time day measure closing sale price appropriate unusual circumstance use weighted average either daily basis longer period complies section a code l plan mean amended restated 2014 stock incentive plan m prior plan mean salix pharmaceutical ltd 2005 stock plan amended n restricted stock mean award granted pursuant section 63 salix amended restated 2014 stock incentive plan page o restricted stock unit mean award granted pursuant section 64 p section mean section plan q share mean share common stock company r stock appreciation right sar mean award granted pursuant section 62 s stock option mean award granted pursuant section 61 stock option either incentive stock option if complies requirement section b nonqualified stock option nonstatutory stock option if comply requirement section b t ten percent stockholder mean participant date grant treated section d code owning stock not including stock purchasable outstanding option possessing 10 total combined voting power class stock company parent subsidiary company defined section e f code 22 construction used plan a term include including shall deemed include phrase but limited to b masculine pronoun shall include feminine salix amended restated 2014 stock incentive plan page article eligibility 31 general natural person eligible granted award individual current employee officer director consultant advisor company companys present future parent subsidiary corporation defined section e f code business venture including without limitation joint venture limited liability company company controlling interest determined compensation committee any natural person granted award participant salix amended restated 2014 stock incentive plan page article administration plan 41 general a plan administered compensation committee compensation committee shall discretionary authority grant award determine recipient term award adopt amend repeal administrative rule guideline practice relating plan b compensation committee shall full discretionary authority to 1 select employee officer director consultant advisor award may granted 2 determine whether extent award granted 3 determine number share common stock subject award 4 approve form award certificate use plan 5 determine term condition inconsistent term plan award including exercise price restriction limitation vesting acceleration waiver forfeiture restriction form consideration paid company exercise stock option sar purchase share respect award 6 determine time time stock option sar shall become exercisable duration exercise period 7 determine whether restriction imposed share subject award nature restriction any 8 determine whether extent circumstance common stock amount payable respect award shall deferred either automatically election participant including providing determining amount any deemed earnings deferred amount deferral period 9 construe interpret term plan award 10 institute option exchange program salix amended restated 2014 stock incentive plan page 11 determine fact necessary administer plan award award certificate 12 make determination necessary advisable administration plan c compensation committee shall discretion correct defect supply omission reconcile inconsistency plan award certificate manner extent shall deem necessary advisable d decision compensation committee shall made sole discretion shall final binding person claiming interest plan award director person acting pursuant authority delegated compensation committee shall liable action determination relating plan made good faith e respect award made director board shall also authority described section 41 section 85 42 delegation committee officer a extent permitted applicable law compensation committee may delegate power plan one committee subcommittee companys management b extent permitted applicable law subject limitation plan compensation committee may delegate one officer company power 1 grant award individual eligible section 31 director executive officer 2 exercise power plan compensation committee may determine provided further however officer shall authorized grant award herself c reference plan compensation committee shall mean compensation committee committee board or companys management officer referred section b extent compensation committees power authority plan delegated committee officer salix amended restated 2014 stock incentive plan page article stock subject plan 51 number share a subject adjustment article award may made plan 1500000 share plus share subject prior plan remain available grant effective date share available award plan issued incentive stock option b award expires terminated surrendered canceled without fully exercised forfeited whole part result share issued unused share covered award shall available grant award plan except extent prohibited law share issued plan shall consist authorized unissued share 52 substitute award a connection merger consolidation entity company acquisition company property stock entity compensation committee may grant award substitution option stock stockbased award granted entity affiliate thereof substitute award may granted term compensation committee deems appropriate circumstance b substitute award shall count overall share limit set forth section 51 except may required reason section 422 related provision code salix amended restated 2014 stock incentive plan page article type award 61 stock option a general compensation committee may grant option purchase share determine number share covered option exercise price option condition limitation applicable exercise option including condition relating applicable federal state security law considers necessary advisable stock option intended incentive stock option shall designated nonstatutory stock option nonqualified stock option b incentive stock option 1 stock option compensation committee intends incentive stock option shall granted employee company companys present future parent subsidiary corporation defined section e f code entity employee eligible receive incentive stock option code shall subject construed consistently requirement section 422 code 2 stock option intended incentive stock option shall treated nonqualified stock option extent that calendar year award first exercisable aggregate fair market value share subject award when added award granted individual intended incentive stock option plan plan maintained company certain related corporation exceeds 100000 limitation might apply section 422 code 3 company shall liability participant party stock option or part thereof intended incentive stock option incentive stock option action taken compensation committee including without limitation conversion incentive stock option nonstatutory stock option salix amended restated 2014 stock incentive plan page c exercise price 1 compensation committee shall establish exercise price stock option specify exercise price applicable award certificate 2 exercise price stock option shall le 100 fair market value share date stock option granted except that incentive stock option granted ten percent stockholder exercise price shall le 110 fair market value share date incentive stock option granted 100 110 limitation section c shall automatically adjust extent required section 422 code d term stock option 1 stock option shall exercisable time subject term condition compensation committee may specify applicable award certificate except stock option shall granted term year incentive stock option issued ten percent stockholder shall term year 2 participants status employee consultant terminates reason reason death disability participant may within thirty 30 day or period time exceeding three 3 month case incentive stock option six 6 month case nonstatutory stock option determined compensation committee date termination but event later date expiration term stock option set forth award certificate exercise stock option extent entitled exercise date termination extent participant entitled exercise stock option date termination participant exercise stock option within time specified herein stock option shall terminate 3 stock option shall permit participant defer receipt compensation stock option beyond date exercise unless compensation committee expressly determines stock option shall subject section a code salix amended restated 2014 stock incentive plan page e exercise stock option 1 stock option may exercised delivery company written notice exercise form attached to manner described in award certificate form notice including electronic notice manner approved compensation committee together payment full number share stock option exercised share subject stock option delivered company soon practicable following exercise stock option may exercised fraction share 2 stock option shall deemed exercised written notice exercise given company accordance term stock option person entitled exercise stock option full payment share respect stock option exercised received company full payment may authorized compensation committee consist consideration method payment allowable section f issuance a evidenced appropriate entry book company duly authorized transfer agent company stock certificate evidencing share right vote receive dividend right stockholder shall exist respect share notwithstanding exercise stock option company shall issue or cause issued stock certificate promptly upon exercise stock option adjustment made dividend right record date date stock certificate issued 3 exercise stock option manner shall result decrease number share thereafter may available purpose plan sale stock option number share stock option exercised f payment upon exercise share purchased upon exercise stock option granted plan shall paid follows 1 cash check payable company salix amended restated 2014 stock incentive plan page 2 provided applicable award certificate a delivery irrevocable unconditional undertaking creditworthy broker deliver promptly company sufficient fund pay exercise price required tax withholding b delivery participant company copy irrevocable unconditional instruction creditworthy broker deliver promptly company cash check sufficient pay exercise price required tax withholding 3 authorization company retain total number share option exercised number share fair market value date exercise equal exercise price total number share option exercised 4 extent provided applicable award certificate approved compensation committee delivery either actual delivery attestation share owned participant valued fair market value provided a method payment permitted applicable law b share acquired directly company owned participant minimum period time any may established compensation committee c share subject repurchase forfeiture unfulfilled vesting similar requirement 5 extent permitted applicable law provided applicable award certificate 1 delivery promissory note participant company term determined compensation committee 2 payment lawful consideration compensation committee may determine 6 determined compensation committee consideration method payment issuance share extent permitted applicable law 7 combination abovepermitted form payment g disability participant 1 participants status employee consultant terminates reason participants disability unvested stock option shall immediately vest participant may salix amended restated 2014 stock incentive plan page within twelve 12 month or shorter period time determined compensation committee date termination but event later date expiration term stock option exercise stock option 2 extent participant exercise stock option within time specified above stock option shall terminate h death participant 1 participants status employee consultant terminates reason participants death unvested stock option held participant shall immediately vest stock option may exercised time within twelve 12 month or shorter period time determined compensation committee following date death but event later date expiration term stock option set forth award certificate participants estate person acquired right exercise option bequest inheritance 2 participant dy within thirty 30 day or period time exceeding three 3 month determined compensation committee status employee consultant terminates stock option may exercised time within twelve 12 month or shorter period time determined compensation committee following date death but event later date expiration term stock option set forth award certificate participants estate person acquired right exercise option bequest inheritance extent right exercise accrued date termination cessation 62 stock appreciation right a general stock appreciation right award form right receive cash share upon surrender stock appreciation right amount equal appreciation value share base price established award committee may grant stock appreciation right either independently stock option tandem stock option exercise stock option stock appreciation right cancel tandem stock appreciation right stock option salix amended restated 2014 stock incentive plan page b exercise price minimum base price stock appreciation right granted plan shall price set forth applicable award certificate or case stock appreciation right related stock option whether already outstanding concurrently granted exercise price related stock option c term exercise payment etc provision section d shall generally apply stock appreciation right applicable 63 restricted stock a general compensation committee may grant award restricted stock compensation committee shall determine term condition restricted stock award including condition vesting repurchase or forfeiture issue price if any whether share shall entitled exercise voting right associated ownership share b dividend unless otherwise provided compensation committee participant holding restricted stock eligible receive dividend paid respect share dividend distribution paid share consist dividend distribution holder share ordinary cash dividend share property subject restriction transferability forfeitability restricted stock respect paid dividend payment made later end calendar year restricted stock dividend paid vest or later th day third month following date restricted stock dividend paid vest c stock certificate company may require stock certificate issued share restricted stock deposited escrow participant together stock power endorsed blank company or designee expiration applicable restriction period company or designee shall deliver certificate longer subject restriction participant participant died certificate delivered certificate shall delivered beneficiary designated participant plan file company or designee participants death valid beneficiary designation participants estate shall beneficiary salix amended restated 2014 stock incentive plan page d termination employment participants status employee consultant terminates reason reason death disability award restricted stock remains subject restriction shall immediately terminate participant shall receive share entitled payment consideration participants status employee consultant terminates reason death disability restriction award restricted stock shall immediately lapse participant or estate beneficiary shall receive applicable share 64 restricted stock unit a compensation committee may grant restricted stock unit participant subject condition restriction compensation committee would imposed connection award restricted stock restricted stock unit shall value equal fair market value one share restricted stock unit may paid time compensation committee may determine payment may made lump sum installment cash share combination thereof determined compensation committee b participants status employee consultant terminates reason reason death disability award restricted stock unit remains unvested shall immediately terminate participant shall receive share entitled payment consideration participants status employee consultant terminates reason death disability award restricted stock unit shall immediately vest participant or estate beneficiary shall receive applicable payment 65 stockbased award award valued whole part reference to otherwise based on share property may granted plan participant extent permitted law share award shall also available form payment settlement award granted plan payment lieu compensation participant otherwise entitled share award may paid share cash compensation committee shall determine subject provision plan compensation committee shall determine term condition share award salix amended restated 2014 stock incentive plan page 66 cash award cash award award provide participant opportunity earn cash payment based upon achievement one performance goal performance period determined compensation committee performance period compensation committee shall determine relevant performance criterion performance goal performance criterion level level achievement necessary award paid weighting performance goal one performance goal applicable size award 67 performancebased award a general award listed article may granted award satisfy requirement performancebased compensation within meaning section m code performance goal must established compensation committee may company company subsidiary affiliate company operating unit department combination unit department performance goal shall based one performance criterion selected compensation committee exception stock option stock appreciation right award intended satisfy requirement performancebased award shall designated time grant b limit maximum aggregate number share stock performancebased award may issued section 67 calendar year individual participant shall exceed 500000 maximum amount may earned cash award performance period single calendar year individual participant 2000000 maximum amount may earned cash award performance period greater single calendar year individual participant 2000000 c performance criterion case award intended qualify performancebased award performance criterion shall selected among following production growth reserve growth reserve replacement lease operating expense revenue growth findingdevelopment cost net sale operating income pre aftertax income operating profit minus capital charge cash flow including operating cash flow free cash flow cash flow return equity cash salix amended restated 2014 stock incentive plan page flow return investment net income earnings per share earnings interest tax earnings interest tax depreciation andor amortization return equity return invested capital return asset economic value added or equivalent measure share price performance total stockholder return improvement achievement expense level improvement achievement working capital level innovation measured percentage sale new product market share productivity ratio completion andor integration acquisition business company completion divestiture asset sale sale goal measured aggregate productspecific basis research development goal including development marketing milestone completion phase phase iii study developing strengthening companys intellectual property including filing new patent application licensing patent combination foregoing business criterion performance criterion may used measure performance company subsidiary andor affiliate whole business unit company subsidiary andor affiliate combination thereof compensation committee may deem appropriate performance criterion compared performance group comparator company published special index compensation committee deems appropriate compensation committee also authority provide accelerated vesting award based achievement performance criterion specified section 67 d application stock option stock appreciation right notwithstanding anything contained section 67 contrary stock option stock appreciation right need satisfy specific performance criterion described section 67 order qualify performancebased award section m code e time establishing performance goal specific performance goal applicable performance criterion must established compensation committee advance deadline applicable section m code achievement performance goal remains substantially uncertain f committee certification payment award performancebased award other stock option stock appreciation right paid compensation committee must certify writing by resolution otherwise applicable performance goal material term award salix amended restated 2014 stock incentive plan page satisfied unless otherwise provided compensation committee performancebased award shall paid soon practicable compensation committee certified applicable goal term award satisfied event later fifteenth th day third month following end performance period award relates absent timely election defer award deferred compensation plan any maintained company notwithstanding foregoing extent amount intended paid qualify shortterm deferral section a code applicable regulation payment may delayed requirement treas reg abii met case payment deferred amount must made soon reasonably practicable following first date company anticipates reasonably anticipate that payment made date companys deduction respect payment would longer restricted due applicability section m code g term condition award committee discretion reduce performance award compensation committee shall discretion determine condition restriction limitation accordance with subject to term plan section m code payment individual award section 67 extent set forth award certificate compensation committee may reserve right adjust amount payable accordance standard basis including compensation committees discretion compensation committee may determine provided however that case award intended qualify performancebased award adjustment shall prescribed form meet requirement section m code h adjustment material change extent compensation committee make adjustment accordance article affect award intended performancebased award section 67 adjustment shall prescribed form meet requirement section m code salix amended restated 2014 stock incentive plan page article adjustment 71 change capitalization event stock split reverse stock split stock dividend recapitalization combination share reclassification share spinoff similar change capitalization event dividend distribution holder share ordinary cash dividend a number class security available plan b number class security exercise price per share outstanding stock option c number share subject outstanding restricted stock award d term outstanding award shall equitably adjusted company or substituted award may made applicable manner determined compensation committee without limiting generality foregoing company effect split share mean stock dividend exercise price number share subject outstanding stock option adjusted date distribution dividend rather record date dividend optionee exercise stock option record date distribution date stock dividend shall entitled receive distribution date stock dividend respect share acquired upon stock option exercise notwithstanding fact share outstanding close business record date stock dividend 72 change control a event change control outstanding award restricted share acquired exercise award shall either 1 assumed equivalent award shall substituted successor corporation parent subsidiary successor corporation additional vesting waiver forfeiture restriction shall occur result change control unless award holder terminated cause quits good reason term defined relevant award certificate threeyear period beginning date change control case award restricted share acquired exercise award shall become vested immediately fully exercisable forfeiture restriction shall waived 2 assumed substituted become vested immediately fully exercisable forfeiture restriction shall waived may terminate ten 10 day compensation committee shall notify holder vesting termination salix amended restated 2014 stock incentive plan page b purpose section award shall considered assumed if following merger sale asset award confers right purchase receive share subject award immediately merger sale asset consideration whether stock cash security property received merger sale asset holder common stock share held effective date transaction and holder offered choice consideration type consideration chosen holder majority outstanding share provided however consideration received merger sale asset solely common stock successor corporation parent compensation committee may consent successor corporation provide consideration received upon exercise award share subject award solely common stock successor corporation parent equal fair market value per share consideration received holder common stock merger sale asset salix amended restated 2014 stock incentive plan page article general provision applicable award 81 transferability award except compensation committee may otherwise determine provide award certificate award shall sold assigned transferred pledged otherwise encumbered person granted either voluntarily operation law except law descent distribution or case incentive stock option pursuant qualified domestic relation order and life participant shall exercisable participant reference participant extent relevant context shall include reference authorized transferee 82 termination status except extent provided award certificate set forth above compensation committee shall determine effect award disability death termination cessation employment authorized leave absence change employment status participant extent which period which participant participants legal representative conservator guardian beneficiary may exercise right award notwithstanding anything contained plan contrary subject section a code change status employee consultant consultant employee constitute termination employment 83 withholding participant must satisfy applicable federal state local income employment tax withholding obligation company deliver stock certificate otherwise recognize ownership share award company may decide satisfy withholding obligation additional withholding salary wage company elect cannot withhold compensation participant must pay company full amount any required withholding payment withholding obligation due company issue share exercise release forfeiture award or company requires time payment exercise price unless company determines otherwise extent otherwise provided award certificate approved compensation committee participant shall satisfy tax obligation whole part delivery portion award creating tax obligation valued fair market value provided however except otherwise provided compensation committee total tax withholding stock used satisfy tax obligation cannot exceed companys minimum statutory withholding obligation based minimum statutory withholding rate federal state tax purpose including payroll tax applicable supplemental taxable salix amended restated 2014 stock incentive plan page income share surrendered satisfy tax withholding requirement cannot subject repurchase forfeiture unfulfilled vesting similar requirement 84 condition delivery stock company obligated deliver share pursuant plan remove restriction share previously delivered plan a condition award met removed satisfaction company b opinion companys counsel legal matter connection issuance delivery share satisfied including applicable security law applicable stock exchange stock market rule regulation c participant executed delivered company representation agreement company may consider appropriate satisfy requirement applicable law rule regulation 85 acceleration compensation committee delegee may time provide award shall become immediately exercisable full part free restriction condition otherwise realizable full part case may be salix amended restated 2014 stock incentive plan page article miscellaneous 91 right employment status person shall claim right granted award grant award shall construed giving participant right continued employment relationship company company expressly reserve right time dismiss otherwise terminate relationship participant free liability claim plan except expressly provided applicable award certificate 92 right stockholder subject provision applicable award certificate except provided section 63 participant beneficiary shall right stockholder respect share distributed respect award becoming record holder share 93 amendment a amendment plan compensation committee may amend suspend terminate plan portion plan time provided however compensation committee may effect modification amendment without approval companys stockholder if 1 time amendment approval required a section 422 code successor provision respect incentive stock option b listing standard exchange companys common stock time primarily traded c applicable law regulation 2 amendment result a downward repricing stock option sar b cancellation stock option sar exchange new stock option sar lower exercise price c substitution full value award stock option sar exercise price fair market value share time substitution an underwater stock option sar d buyback buyout underwater stock option sar exchange cash new award unless otherwise specified amendment amendment plan adopted accordance section 93 shall apply to binding holder of award outstanding plan salix amended restated 2014 stock incentive plan page time amendment adopted provided compensation committee determines amendment taking account related action materially adversely affect right participant plan b amendment award subject term a compensation committee may amend modify terminate outstanding award including limited to substituting another award different type changing date exercise realization converting incentive stock option nonstatutory stock option participants consent action shall required unless compensation committee determines action taking account related action would materially adversely affect participants right plan 94 compliance code section a award shall provide deferral compensation within meaning section a code unless compensation committee time grant specifically provides award intended subject section a code award intended subject section a following provision shall apply except extent contrary provision included award certificate a award shall payable earlier change control participants separation service company 2 payment made participant specified employee company shall made date six month participants separation service extent required avoid adverse consequence section a code purpose section 94 term change control separation service specified employee shall meaning set forth section a applicable treasury regulation company shall liability participant party award intended exempt from compliant with section a exempt compliant action taken compensation committee 95 governing law provision plan award made hereunder shall governed interpreted accordance law state delaware excluding choiceoflaw principle law state would require application law jurisdiction state salix amended restated 2014 stock incentive plan page exe ddexehtm exe exe exhibit e amended restated employment agreement amended restated employment agreement agreement shall effective th day january 2015 the effective date salix pharmaceutical inc california corporation principal place business wake county north carolina together subsidiary affiliate successor hereafter referred employer william bertrand individual residing wake county north carolina employee whereas employer employed wish continue employ employee employee desire continue employment employer whereas employer employee previously entered employment agreement the original agreement desire enter agreement replaces supersedes entirety prior employment agreement including limited original agreement therefore consideration mutual obligation set forth agreement along good valuable consideration receipt sufficiency hereby acknowledged employer employee agree follows article employment 11 position duty employer hereby agrees continue employ employee acting chief operating officer senior vice president general counsel corporate secretary duty reasonably assigned chief executive officer board director the board time time consistent position 12 employees obligation employee hereby accepts employment employer set forth herein employee agrees perform fully faithfully competently effectively duty shall reasonably assigned chief executive officer board devote employees best effort business employer employee shall specifically obligated work maximize success employers business throughout world part employees duty employee shall comply applicable policy employer effect may established time time 13 consideration employee employee hereby acknowledges agreement supported adequate sufficient consideration exchange signing agreement agreeing commitment contained herein employer continue employ employee described agreement also pay employee sum five hundred dollar 50000 le applicable tax withholding payment expressly conditioned upon employees execution agreement salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom article term employment 21 term employees employment employer hereunder shall commence effective date continue unless employees employment terminates pursuant article hereof 22 resignation upon employees termination employment reason employee hereby resigns employment related job duty responsibility employer including without limitation position committee board employer affiliate employee agrees sign documentation evidencing foregoing may presented employee signature employer article iii compensation 31 base salary bonus term agreement employer shall pay employee annual base salary set forth appendix may adjusted periodically employer sole discretion subject term agreement purpose agreement term base salary shall mean employees annual base salary referred preceding sentence shall exclude reimbursement medical professional transportation expense excess groupterm life insurance coverage severance pay commission fringe benefits employees base salary shall paid accordance employers regular payroll procedure shall computed pro rata partial year partial period employment employer may also pay employee annual bonus determined board designee sole discretion subject periodic adjustment accordance employers bonus plan the bonus employer shall withhold employees compensation including without limitation base salary bonus sum required federal state andor local law andor amount properly requested employee employees base salary bonus benefit a defined below described fully appendix hereto incorporated reference fully set herein may amended periodically sole discretion board designee accordance term agreement 32 noncompensation benefit addition compensation paid employee hereunder term agreement employer shall also provide employee benefit consistent generally provided similarly situated employee employer the benefits article secret confidential andor proprietary information 41 nondisclosure employee acknowledges agrees that i employee employer employee substantial access confidential information a defined below unauthorized use disclosure would cause employer suffer salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom substantial irreparable harm ii employer legitimate business interest preventing unauthorized use disclosure confidential information iii employer take reasonable measure prevent unauthorized use disclosure confidential information accordingly employee hold benefit employer affiliate subsidiary related entity designees disclose person entity employer person entity designated employer secret confidential proprietary information knowledge computer data andor information research formula patent trade secret product information customer information identity pricing information nonpublic personnel information marketing business method technique process practice procedure plan strategy regarding employer subsidiary affiliated corporation business enterprise respective customer obtained employee employees employment employer secret confidential proprietary information pertaining employer subsidiary affiliated corporation business enterprise respective customer collectively confidential information term agreement time employees termination employment employer unless board writing consent contrary addition term agreement time employees termination employment employer employee use disclose confidential information benefit benefit third party use disclose confidential information a course performing duty assigned employer authorized writing board b employee compelled disclose confidential information pursuant applicable law regulation court order provided employee 1 permitted provides employer least five 5 business days prior written notice anticipated disclosure 2 cooperates employer reasonably requested thereby seeking confidential protective treatment information 3 minimizes extent disclosure event employee oppose action employer obtain protective order relief prevent disclosure confidential information obtain reliable assurance confidential treatment afforded confidential information nothing paragraph intended prevent employee testifying truthfully fully event testimony required legal process purpose agreement confidential information include portion and portion information becomes available public generally other result disclosure employee third party acting concert employee 42 return employer property material furnished employee employer course employment shall remain property employer immediately upon demand upon notice termination employment employee shall give employer material furnished employee including original copy document correspondence memoranda record note manual material customer prospective customer list information including without limitation computer data thing relating either directly indirectly employers business including limited confidential information collectively employer property employees possession custody control unless otherwise agreed board writing employer property shall condition provided employee reasonable wear tear excepted salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom article restrictive covenant 51 restrictive covenant employee understands agrees that employed employer period one 1 year following termination employment whether employee employer cause reason whatsoever employee abide following separate independent covenant a noncompetition employee work restricted company listed exhibit agreement affiliate division restricted company where i employee duty perform expected perform service substantially similar duty service actually performed employee employer within twelve 12 month period immediately preceding employees termination employment ii employee use disclose reasonably expected use disclose confidential information employer purpose clarification shall violation paragraph a employee work affiliate division restricted company if a affiliate division restricted company compete employer b work would result use disclosure confidential information c employee obtains prior written consent employer consent shall unreasonably withheld notwithstanding foregoing obligation employee pursuant paragraph la apply event employees employment employer terminated employer upon change control a defined paragraph 73 employer parent salix pharmaceutical ltd parent without reasonable cause pursuant paragraph b employee good reason pursuant paragraph a b nonsolicitation employee employee shall not without prior written consent employer employees behalf person firm corporation entity directly indirectly solicit employment employee employer employed employer employed employer prior six 6 month unless person involuntarily discharged employer affiliate 52 injunctive relief enforce employee acknowledges agrees employer could adequately compensated money damage event employees breach article paragraph 51 therefore employee agrees breach article paragraph 51 would cause employer substantial irreparable harm employer shall entitled temporary restraining order preliminary injunction addition attorneys fee cost expense incurred employer enforcing term article paragraph 51 shall reimbursed employer employee remedy enumerated paragraph 52 cumulative nature addition remedy employer may law equity 53 severability employee acknowledges agrees i restriction set forth article paragraph 51 a reasonable necessary protect legitimate salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom interest employer affiliate b reasonable time territory scope c interfere public policy public interest d unduly harsh preclude employee gainful employment e described sufficient accuracy definiteness enable employee understand scope restriction ii employer would entered agreement absence restriction event court competent jurisdiction shall determine restriction set forth article paragraph 51 inequitably broad intention agreement party decisionmaker shall equitably adjust obligation employee agreement rather entirely eliminate obligation event decisionmaker shall equitably adjust eliminate restrictive covenant agreement aspect agreement shall remain full force effect article termination 61 termination employer agreement employees employment employer may terminated employer upon occurrence following event a termination reasonable cause employer may terminate employees employment immediately without prior notice upon occurrence following event shall deemed reasonable cause termination i employee commits act gross negligence fraud dishonesty willful violation law material violation significant written policy employer cause material harm employer ii employees conviction a felony b serious crime involving moral turpitude iii willful gross failure employee substantially perform duty reasonably assigned employee intentional refusal without compelling reason employee discharge employees job responsibility andor respond employers legitimate jobrelated request insofar duty responsibility andor request contravene law consistent employees position iv failure cooperate investigation conducted andor undertaken employer governmental agency reasonable legitimate objective v act intentional conflict interest employee related employer result likely result material economic andor material damage employer b termination without reasonable cause subject provision paragraph 64 appendix employer may sole discretion terminate agreement employees employment employer time upon thirty 30 days prior written notice employee lieu providing notice employers sole discretion employer may elect pay employee thirty 30 days wage employees thencurrent base salary 62 termination employee a good reason employee may terminate agreement good reason provided employee provided employer written notice intention terminate specifying reason termination within ninety 90 day event qualifying good reason a defined below employer shall thirty 30 day salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom receipt written notice employee cure employees grievance employer cured employees grievance time period employee must terminate agreement within thirty 30 day thereafter purpose agreement good reason shall mean occurrence following event condition i material adverse change in assignment employee duty responsibility inconsistent with employees status title position responsibility including reporting responsibility employer ii reduction employees salary andor benefit except extent reduction comparable percentage reduction salary andor benefit employee employer failure pay employee compensation benefit employee entitled within five 5 day date due iii employer successor relocates employees workplace fifty 50 mile employees current workplace iv material breach employer provision agreement b termination without good reason agreement employees employment employer may terminated employee time reason upon thirty 30 days prior written notice employer 63 termination due death disability agreement shall also terminate event death incapacitating disability employee provided however nothing herein shall give employer right terminate employee prior discharging obligation employee any family medical leave act american disability act applicable law purpose agreement incapacitating disability shall mean physical mental inability employee perform essential function employees position without reasonable accommodation ninety 90 day twelve month period provision itself shall interpreted affect eligibility any employee disability policy maintained employer employee entitled disability benefit termination agreement paragraph 63 shall excuse employer obligation provide payment employee employees beneficiary including severance benefit set appendix hereto provided however employee or personal representative shall entitled compensation benefit accrued hereunder date termination employment 64 effect termination event agreement terminated employer without reasonable cause pursuant paragraph b employee good reason pursuant paragraph a instance employer shall pay employee severance pay set forth schedule severance benefit attached hereto appendix article vii general provision 71 authority indemnification a employee represents warrant employee currently subject restrictive covenant restriction employment confidentiality agreement prior employer party except already disclosed employer salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom employee shall indemnify hold employer harmless respect claim cause action damage liability kind whatsoever including reasonable attorneys fee cost successfully brought third party arising act taken employee violate restrictive covenant restriction employment confidentiality agreement b employee shall entitled indemnification accordance applicable provision employers charter document indemnification agreement employee is may become party 72 assignment neither agreement right interest hereunder shall assignable employee without employers prior written consent 73 change control agreement shall deemed automatically assigned employer and assumed successor assign event change control shall inure benefit bind employers successor assigns purpose agreement term employer shall include party acquiring businessassets employer upon change control change control shall mean a person a term used section d d security exchange act 1934 amended the exchange act other employer subsidiary employer employee benefit plan employer subsidiary employer becomes beneficial owner a defined rule d d exchange act directly indirectly 50 combined voting power employers outstanding security entitled vote generally election member board security entity entitled vote generally election member board director entity referred herein voting stock provided transaction deemed constitute change control i employer becomes direct indirect whollyowned subsidiary holding company iia direct indirect holder voting stock holding company immediately following transaction substantially holder employers voting stock immediately prior transaction b immediately following transaction person a term used section d d exchange act other holding company satisfying requirement sentence beneficial owner directly indirectly 50 voting stock holding company b period two consecutive year individual beginning period constituted board together new director whose election board whose nomination election stockholder employer approved vote least twothirds member board still office either member board beginning period whose election nomination election previously approved cease reason constitute least majority board office c merger consolidation employer another entity merger another entity employer provided that merger consolidation salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom deemed constitute change control share employers voting stock outstanding immediately prior merger consolidation constitute converted exchanged for security representing 50 voting stock i surviving entity merger consolidation the surviving entity ii holding company surviving entity direct indirect whollyowned subsidiary case immediately merger consolidation d direct indirect sale transfer conveyance disposition other way merger consolidation one series transaction substantially asset employer on consolidated basis person a term used section d d exchange act e adoption plan relating liquidation dissolution employer notwithstanding foregoing i transfer asset among employer subsidiary shall constitute change control ii term change control shall include merger consolidation employer into sale transfer conveyance disposition substantially asset employer to affiliate employer incorporated organized solely purpose reincorporating reorganizing employer another jurisdiction andor sole purpose forming collapsing dissolving holding company structure iii person a term used section d d exchange act shall deemed beneficial ownership security subject stock purchase agreement merger agreement similar agreement or voting option agreement related thereto consummation transaction contemplated agreement iv event shall change control deemed occurred respect employee employee part purchasing group consummates change control transaction employee shall deemed part purchasing group purpose clause iv employee either directly indirectly equity participant purchasing group except a passive ownership le stock purchasing group b ownership equity participation purchasing group otherwise significant determined prior change control employer 74 governing law venue validity interpretation performance enforcement agreement shall governed construed accordance law state north carolina dispute arising agreement shall brought occur wake county north carolina 75 waiver waiver party breach party provision agreement shall operate construed waiver breach party 76 severability event provision agreement determined body competent jurisdiction unenforceable illegal contrary public policy body shall modify provision conform public policy interpret way render enforceable legal accordance intent party expressed herein salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom event body competent jurisdiction decides provision agreement unenforceable illegal contrary public policy cannot reformed provision shall affected provision agreement shall remain full force effect 77 notice notice given employee pursuant agreement shall sufficiently given sent employee registered certified mail addressed employees address shown employers record address employee shall designated writing employer notice given employer pursuant agreement shall sufficiently given sent employer registered certified mail employers principal office address employer shall designated writing employee 78 employee acknowledgement employee hereby acknowledges employee read understands provision agreement employee given opportunity employees legal counsel review agreement employee received copy agreement 79 entire agreement agreement appendix exhibit hereto set forth entire understanding party agreement desire reach relating subject matter hereof agreement supersedes prior agreement party hereto subject matter hereof excluding confidentiality invention agreement affecting party including limited to prior negotiation correspondence agreement proposal understanding negotiation correspondence agreement proposal understanding expressly incorporated agreement shall deemed force effect representation warranty agreement whether express implied oral written respect subject matter hereof except set forth herein modification waiver agreement termination agreement shall binding upon either party unless made writing signed behalf party signature employer must representative duly authorized board event inconsistency agreement benefit plan employer language agreement shall control document agreement may signed counterpart signature page follows salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom witness whereof party executed employment agreement effective date salix pharmaceutical ltd by s thomas dalonzo title interim ceo chairman board employee s william bertrand william bertrand salix pharmaceutical inc 8510 colonnade center drive raleigh 27615 18666465463 9198621000 9198621095 wwwsalixcom exe ddexehtm exe exe exhibit e amended restated employment agreement amended restated employment agreement agreement shall effective st day february 2015 the effective date salix pharmaceutical inc california corporation principal place business wake county north carolina together subsidiary affiliate successor hereafter referred employer william forbes individual residing wake county north carolina employee whereas employer employed wish continue employ employee employee desire continue employment employer whereas employer employee previously entered employment agreement the original agreement desire enter agreement replaces supersedes entirety prior employment agreement including limited original agreement therefore consideration mutual obligation set forth agreement along good valuable consideration receipt sufficiency hereby acknowledged employer employee agree follows article employment 11 position duty employer hereby agrees continue employ employee president medical research development chief development officer duty reasonably assigned chief executive officer board director the board time time consistent position 12 employees obligation employee hereby accepts employment employer set forth herein employee agrees perform fully faithfully competently effectively duty shall reasonably assigned chief executive officer board devote employees best effort business employer employee shall specifically obligated work maximize success employers business throughout world part employees duty employee shall comply applicable policy employer effect may established time time 13 consideration employee employee hereby acknowledges agreement supported adequate sufficient consideration exchange signing agreement agreeing commitment contained herein employer continue employ employee described agreement also pay employee sum five hundred dollar 50000 le applicable tax withholding payment expressly conditioned upon employees execution agreement article term employment 21 term employees employment employer hereunder shall commence effective date continue unless employees employment terminates pursuant article hereof 22 resignation upon employees termination employment reason employee hereby resigns employment related job duty responsibility employer including without limitation position committee board employer affiliate employee agrees sign documentation evidencing foregoing may presented employee signature employer article iii compensation 31 base salary bonus term agreement employer shall pay employee annual base salary set forth appendix may adjusted periodically employer sole discretion subject term agreement purpose agreement term base salary shall mean employees annual base salary referred preceding sentence shall exclude reimbursement medical professional transportation expense excess groupterm life insurance coverage severance pay commission fringe benefits employees base salary shall paid accordance employers regular payroll procedure shall computed pro rata partial year partial period employment employer may also pay employee annual bonus determined board designee sole discretion subject periodic adjustment accordance employers bonus plan the bonus employer shall withhold employees compensation including without limitation base salary bonus sum required federal state andor local law andor amount properly requested employee employees base salary bonus benefit a defined below described fully appendix hereto incorporated reference fully set herein may amended periodically sole discretion board designee accordance term agreement 32 noncompensation benefit addition compensation paid employee hereunder term agreement employer shall also provide employee benefit consistent generally provided similarly situated employee employer the benefits article secret confidential andor proprietary information 41 nondisclosure employee acknowledges agrees that i employee employer employee substantial access confidential information a defined below unauthorized use disclosure would cause employer suffer substantial irreparable harm ii employer legitimate business interest preventing unauthorized use disclosure confidential information iii employer take reasonable measure prevent unauthorized use disclosure confidential information accordingly employee hold benefit employer affiliate subsidiary related entity designees disclose person entity employer person entity designated employer secret confidential proprietary information knowledge computer data andor information research formula patent trade secret product information customer information identity pricing information nonpublic personnel information marketing business method technique process practice procedure plan strategy regarding employer subsidiary affiliated corporation business enterprise respective customer obtained employee employees employment employer secret confidential proprietary information pertaining employer subsidiary affiliated corporation business enterprise respective customer collectively confidential information term agreement time employees termination employment employer unless board writing consent contrary addition term agreement time employees termination employment employer employee use disclose confidential information benefit benefit third party use disclose confidential information a course performing duty assigned employer authorized writing board b employee compelled disclose confidential information pursuant applicable law regulation court order provided employee 1 permitted provides employer least five 5 business days prior written notice anticipated disclosure 2 cooperates employer reasonably requested thereby seeking confidential protective treatment information 3 minimizes extent disclosure event employee oppose action employer obtain protective order relief prevent disclosure confidential information obtain reliable assurance confidential treatment afforded confidential information nothing paragraph intended prevent employee testifying truthfully fully event testimony required legal process purpose agreement confidential information include portion and portion information becomes available public generally other result disclosure employee third party acting concert employee 42 return employer property material furnished employee employer course employment shall remain property employer immediately upon demand upon notice termination employment employee shall give employer material furnished employee including original copy document correspondence memoranda record note manual material customer prospective customer list information including without limitation computer data thing relating either directly indirectly employers business including limited confidential information collectively employer property employees possession custody control unless otherwise agreed board writing employer property shall condition provided employee reasonable wear tear excepted article restrictive covenant 51 restrictive covenant employee understands agrees that employed employer period one 1 year following termination employment whether employee employer cause reason whatsoever employee abide following separate independent covenant a noncompetition employee work restricted company listed exhibit agreement affiliate division restricted company where i employee duty perform expected perform service substantially similar duty service actually performed employee employer within twelve 12 month period immediately preceding employees termination employment ii employee use disclose reasonably expected use disclose confidential information employer purpose clarification shall violation paragraph a employee work affiliate division restricted company if a affiliate division restricted company compete employer b work would result use disclosure confidential information c employee obtains prior written consent employer consent shall unreasonably withheld notwithstanding foregoing obligation employee pursuant paragraph l a apply event employees employment employer terminated employer upon change control a defined paragraph 73 employer parent salix pharmaceutical ltd parent without reasonable cause pursuant paragraph b employee good reason pursuant paragraph a b nonsolicitation employee employee shall not without prior written consent employer employees behalf person firm corporation entity directly indirectly solicit employment employee employer employed employer employed employer prior six 6 month unless person involuntarily discharged employer affiliate 52 injunctive relief enforce employee acknowledges agrees employer could adequately compensated money damage event employees breach article paragraph 51 therefore employee agrees breach article paragraph 51 would cause employer substantial irreparable harm employer shall entitled temporary restraining order preliminary injunction addition attorneys fee cost expense incurred employer enforcing term article paragraph 51 shall reimbursed employer employee remedy enumerated paragraph 52 cumulative nature addition remedy employer may law equity 53 severability employee acknowledges agrees i restriction set forth article paragraph 51 a reasonable necessary protect legitimate interest employer affiliate b reasonable time territory scope c interfere public policy public interest d unduly harsh preclude employee gainful employment e described sufficient accuracy definiteness enable employee understand scope restriction ii employer would entered agreement absence restriction event court competent jurisdiction shall determine restriction set forth article paragraph 51 inequitably broad intention agreement party decisionmaker shall equitably adjust obligation employee agreement rather entirely eliminate obligation event decisionmaker shall equitably adjust eliminate restrictive covenant agreement aspect agreement shall remain full force effect article termination 61 termination employer agreement employees employment employer may terminated employer upon occurrence following event a termination reasonable cause employer may terminate employees employment immediately without prior notice upon occurrence following event shall deemed reasonable cause termination i employee commits act gross negligence fraud dishonesty willful violation law material violation significant written policy employer cause material harm employer ii employees conviction a felony b serious crime involving moral turpitude iii willful gross failure employee substantially perform duty reasonably assigned employee intentional refusal without compelling reason employee discharge employees job responsibility andor respond employers legitimate jobrelated request insofar duty responsibility andor request contravene law consistent employees position iv failure cooperate investigation conducted andor undertaken employer governmental agency reasonable legitimate objective v act intentional conflict interest employee related employer result likely result material economic andor material damage employer b termination without reasonable cause subject provision paragraph 64 appendix employer may sole discretion terminate agreement employees employment employer time upon thirty 30 days prior written notice employee lieu providing notice employers sole discretion employer may elect pay employee thirty 30 days wage employees thencurrent base salary 62 termination employee a good reason employee may terminate agreement good reason provided employee provided employer written notice intention terminate specifying reason termination within ninety 90 day event qualifying good reason a defined below employer shall thirty 30 day receipt written notice employee cure employees grievance employer cured employees grievance time period employee must terminate agreement within thirty 30 day thereafter purpose agreement good reason shall mean occurrence following event condition i material adverse change in assignment employee duty responsibility inconsistent with employees status title position responsibility including reporting responsibility employer ii reduction employees salary andor benefit except extent reduction comparable percentage reduction salary andor benefit employee employer failure pay employee compensation benefit employee entitled within five 5 day date due iii employer successor relocates employees workplace fifty 50 mile employees current workplace iv material breach employer provision agreement b termination without good reason agreement employees employment employer may terminated employee time reason upon thirty 30 days prior written notice employer 63 termination due death disability agreement shall also terminate event death incapacitating disability employee provided however nothing herein shall give employer right terminate employee prior discharging obligation employee any family medical leave act american disability act applicable law purpose agreement incapacitating disability shall mean physical mental inability employee perform essential function employees position without reasonable accommodation ninety 90 day twelve month period provision itself shall interpreted affect eligibility any employee disability policy maintained employer employee entitled disability benefit termination agreement paragraph 63 shall excuse employer obligation provide payment employee employees beneficiary including severance benefit set appendix hereto provided however employee or personal representative shall entitled compensation benefit accrued hereunder date termination employment 64 effect termination event agreement terminated employer without reasonable cause pursuant paragraph b employee good reason pursuant paragraph a instance employer shall pay employee severance pay set forth schedule severance benefit attached hereto appendix article vii general provision 71 authority indemnification a employee represents warrant employee currently subject restrictive covenant restriction employment confidentiality agreement prior employer party except already disclosed employer employee shall indemnify hold employer harmless respect claim cause action damage liability kind whatsoever including reasonable attorneys fee cost successfully brought third party arising act taken employee violate restrictive covenant restriction employment confidentiality agreement b employee shall entitled indemnification accordance applicable provision employers charter document indemnification agreement employee is may become party 72 assignment neither agreement right interest hereunder shall assignable employee without employers prior written consent 73 change control agreement shall deemed automatically assigned employer and assumed successor assign event change control shall inure benefit bind employers successor assigns purpose agreement term employer shall include party acquiring businessassets employer upon change control change control shall mean a person a term used section d d security exchange act 1934 amended the exchange act other employer subsidiary employer employee benefit plan employer subsidiary employer becomes beneficial owner a defined rule d d exchange act directly indirectly 50 combined voting power employers outstanding security entitled vote generally election member board security entity entitled vote generally election member board director entity referred herein voting stock provided transaction deemed constitute change control i employer becomes direct indirect whollyowned subsidiary holding company iia direct indirect holder voting stock holding company immediately following transaction substantially holder employers voting stock immediately prior transaction b immediately following transaction person a term used section d d exchange act other holding company satisfying requirement sentence beneficial owner directly indirectly 50 voting stock holding company b period two consecutive year individual beginning period constituted board together new director whose election board whose nomination election stockholder employer approved vote least twothirds member board still office either member board beginning period whose election nomination election previously approved cease reason constitute least majority board office c merger consolidation employer another entity merger another entity employer provided that merger consolidation deemed constitute change control share employers voting stock outstanding immediately prior merger consolidation constitute converted exchanged for security representing 50 voting stock i surviving entity merger consolidation the surviving entity ii holding company surviving entity direct indirect whollyowned subsidiary case immediately merger consolidation d direct indirect sale transfer conveyance disposition other way merger consolidation one series transaction substantially asset employer on consolidated basis person a term used section d d exchange act e adoption plan relating liquidation dissolution employer notwithstanding foregoing i transfer asset among employer subsidiary shall constitute change control ii term change control shall include merger consolidation employer into sale transfer conveyance disposition substantially asset employer to affiliate employer incorporated organized solely purpose reincorporating reorganizing employer another jurisdiction andor sole purpose forming collapsing dissolving holding company structure iii person a term used section d d exchange act shall deemed beneficial ownership security subject stock purchase agreement merger agreement similar agreement or voting option agreement related thereto consummation transaction contemplated agreement iv event shall change control deemed occurred respect employee employee part purchasing group consummates change control transaction employee shall deemed part purchasing group purpose clause iv employee either directly indirectly equity participant purchasing group except a passive ownership le stock purchasing group b ownership equity participation purchasing group otherwise significant determined prior change control employer 74 governing law venue validity interpretation performance enforcement agreement shall governed construed accordance law state north carolina dispute arising agreement shall brought occur wake county north carolina 75 waiver waiver party breach party provision agreement shall operate construed waiver breach party 76 severability event provision agreement determined body competent jurisdiction unenforceable illegal contrary public policy body shall modify provision conform public policy interpret way render enforceable legal accordance intent party expressed herein event body competent jurisdiction decides provision agreement unenforceable illegal contrary public policy cannot reformed provision shall affected provision agreement shall remain full force effect 77 notice notice given employee pursuant agreement shall sufficiently given sent employee registered certified mail addressed employees address shown employers record address employee shall designated writing employer notice given employer pursuant agreement shall sufficiently given sent employer registered certified mail employers principal office address employer shall designated writing employee 78 employee acknowledgement employee hereby acknowledges employee read understands provision agreement employee given opportunity employees legal counsel review agreement employee received copy agreement 79 entire agreement agreement appendix exhibit hereto set forth entire understanding party agreement desire reach relating subject matter hereof agreement supersedes prior agreement party hereto subject matter hereof excluding confidentiality invention agreement affecting party including limited to prior negotiation correspondence agreement proposal understanding negotiation correspondence agreement proposal understanding expressly incorporated agreement shall deemed force effect representation warranty agreement whether express implied oral written respect subject matter hereof except set forth herein modification waiver agreement termination agreement shall binding upon either party unless made writing signed behalf party signature employer must representative duly authorized board event inconsistency agreement benefit plan employer language agreement shall control document agreement may signed counterpart signature page follows witness whereof party executed employment agreement effective date salix pharmaceutical ltd by s thomas dalonzo title interim ceo board chair employee s william forbes william forbes graphic gjpg graphic begin 644 gjpg mcxdrxqutqen mpmgrdabsdqawp mspd mzatocegghxfbjpm mllunlplarttfwyhnh mqpyptppqxcmxp mxapwd mjglcjpnqdpttxflte mpaxbhocpdef mngphbifhjjxqkoplbsdmixfnp mxoyqprpstfutxjwx mxbxydgfpzvmrwhesqa mxfqyqmpjaqfdjpqcp mqvqdyjlkattx mblhlaohvbnqbucz mekmqgaiggaknplvbanrhapjqrc mptazkxzsxzb maabkphh mhbciektithcjjlkblvvdkgolqnlurt mmbvknbyhnmrnrobbtko mautdjgpckpqtndqriduwxe mfymttedtluzie mvuhpeeqjwtdecifxejfon mruuxeylkuuaiaiqb myczvdzeyvifzygzheiii mijvmzkvqmuenfyklofxpwqgyxsdjeyywi mjmcrvagraejnspi mjaxkazicdtvmiej meamjfhicjvhdjibejihnfnih mjcjijh mrwodzrgjwrsmlpusyqgjrzsingzeoj mympzolantsnzttosq maqpph mmppauarqdtq mptdvrdahebjaaxbbieeybfjcifizbijks mmvmbynlqqcrmuucvnbxeynhzkqotwgz mppphm mwqqaabhhsog madehfricvsydeueicfvai mgtwezhabfdieffhjdigjfjlktmwnfz mplqrgtmuvgxndygzgjotwgzh mqpwbbhkbvdebcnvkstkuqfxxpnm mmztonwpumenmkjtgrmorrisuafjccufpden mwkcgzuiqhryjlsebgssjjsfhijgjcobbbxq mjkutgrsccjzqmzpxdeikgngzoonlpxo mrkqgdjslehzfextmhsxnbtryubzuyr maiozsjqjwmxmfxvxfmwpwyfxygcfbdx mqtbmwwzwndpxgkfbfmtsqrkn mddgobgzbtvkhkffcuhcutuyegerg mjqpzenumfhukg mlnfwtlwmycmjfhnzkferuscghwmsbbss mvjxaipeomtauwwkzfhqsk mumwwolsuhqoavrqzayksbdtcp mlxsnylajvbflbaafjwirwmakdggnbqiqcm mjaczgklcazaunzstpun mzowrctmeqoucrrgsujzzfrapxcp mgxyuqbhhzgsmxecybspkcsmvyqdje mvgojhyiomyfiwjceloinhl makzzvuenwwrjoxkgtwcpif meyknfptrydtzyjnvdbrdjbonzpkvcqa mtsuxwhplxhdusneskewqemihd mrjqxfsfbuvyqinlgxadakvpiungit mthgigufoen maxfbyhscouzgzyjqjn mmtyxrmcpwzqdzjumywsvjgmsnnj mgmuzzhohvqqgpfgwypgdpngx msinwcppiznkfkcihhjmuvcgmtkqybgs mgvkndprxluqorhnukwilpldbb mqtvktxgmzrsbwylfbemlnziso mhhiaoatltfvsfemgwkoghchoxk mnbbbokwahihgmdeakfbm mvjfbcddhzxmancseiancmumimmsjuitmk mterxmkdfgilotxyuiwudqttjs maaciovqwqryurkguikvlnfyygxukk mxchnlnnysnfzdrvunhkrhdhph mlmlijgczunwujtiqnpqfboch mhehozqzmjfgpgrbcatlgmdfg mnyryhqjeyyicyljdlvjolgqgnshjm mnynwsfyj mlsakzmfklsitvuxmadgmgjgax miifxfkrwjpopxemahauwknvtvdijpfyrzemtesgkyxkinerv mmkuzzcudhqpkkmtqosydqzntecaqqwkm mhxzlzcevilurmrgmutwymzy mrgifdkuofiylvjdlbkddkl v end graphic ggrjpg graphic begin 644 ggrjpg mcxdpaospnxde mlhqleqpjerdrsirwo mgvrmrviewfirqmyte mkkfkcewaty migpsbvlgeyu mgelatxxded mcatum matpphxde mdat mv mfp myupfoyd mdlnyuvqivwzqi mvxflevtqivyegmteceeyuvqiv mtorepvyeoueqoffqe mgslvygqbwtvuslvygmr mhueqofata mtsatk mhdvmqbxdd mveddl mppppppppppppltx mxaxapppppppppp mppppbo mdpp mhpacarqa mlcpstqwujrrdudctebs masbiteyemygejvqmfcvwaygm mypabprh mtsaufvaifmlyogtwezwqp middddiegdebvnozwnmqjdgn mykcsygvzlxqjmjddddied mdddigtcuefcfoucvuejjwverszf mqctnsqkkfrfopuqczoed mnjufsipkagiuojrrkveyfbxutskoudbqokvbzyjynwagtey mgsjfzkuzzojgzguzkmqbuinzxn mcnumchkbyfsjvbynsvunnmzvodmg mlzchknhwsgqccfbusdotxkoixkhw mlzqcozynpukzszdmcmewbu mzynqctnfnzuszmiohnhwuhim mmfvpmlknkwzxrwsswpkghh mvicyoyxdiuvynfeumpjjswzmylpj mfchorqfupzwoonkjgwjrky mfczezuexkkhlzbfzkziskrnen mkrfncqzffwddegizvllz mcdxeesgbpdqsdyhszgkimtp mhxefcwkorglgudwwfxegilfzkngvkko mznpuxpmklntsmlksiekczdxdnq mgbnjvyyvucmotsbwqwyfuyzlvugz mopmkfsljwjwniqzwifivcrougmjlnhk madcnitoqhnmjrfnewbkumlbskbxfux mfewqswilyliuvktxkmqozvum mclinlknsjsokusrcmuovwuzmnk mtojetfmfzorslqkzpmnufuomjjvkci muiesrthttsozuswkofaux mzkiclnlzcnsjlnrkmcyvwjeekuuf moylozozzqgoqojtuazeohlpsvqvx mrqsottgzwgirlmctmteiumspwlu mixkzpvvvoqzzvloqnwzvmuwlxwrahzctsj muprcxidvygjmfrotovzfyqbwsucom mkfvcjokuorzozmgvdizskvtokh msczgjzmzijzujfsvui mhteirwwcvxlqnxuolpreusugtnmotzz manebgzuhmekvevigiqlusjlwzqdh mlgrjrmbuddddepntoddvjstaoaxp mzjmajgjpvdinddddie mddddigdao mopsppppbpt mphpvxdej mphnlvp mxldpavd mzqbtwhwuva mydwsrucsctxcpcsrdrsh mpphvhp mpx ma mtuh mxp mxppph mpdvehwovaosifowip mzzzzgqp mnp mh mdfatzrn mryabycvtopsnxcvtevenonbed mtpaiirzecfmcbsxixmaamys mgfdvefysfueobxgamkvrucnb mbffebxqnsirfatzrwwnsnwgsydo mocmffygaunrbhqrzswiivxff mfbwtbbxqnsixfatzrnryabycvto mpsnbbxqnsipfatzrnryabycvto mfsnrbbxqnsidstbthowufpnwgvcvl muegssnbbxqnsixtbthovysfdve mfoxoxpvumramysgtthpbogn mofnvmwaaqcouyofswrvfnbbx mqnsisectbthovysfdvefoxoxpwe muevufefframysghwovaotbthovys mfdvefoptwhwoxprupdrta mcpmmzzckzsbbamifaro mtbcfepnqlegivxxrcbbamivige merustxcpcssucphxzta merustxcpcssucphpzo mcdcfbeselrpcnifowih mdsifwmfemevpvbbamudenwafe mgamyizsvdrqedwrbb mamudowmytgamydzsvdrqe mdwrbbamudriflcuegtb mupfihrssqrdcqx maospdordtbbqdsitlxqr mzqthqrzdulfqafgmflec mfsvtoffjtaptdnrz mdbwdcibpozetbqdsicfa mrhdcibdcilyrcycxspoff mfqihrzvqhvcfrtwbqx mitwyhdcibdcilhs mviawivxgafdhsviigtycex mnedcxcpddtyscth msviwnrustxctcusucph msvisvtvrgytbtwhwuva mydwswgzvaafetbrohqrz mdwgztnsewgzys mnvtbupfeihrssqrdcq mxwgzvaectbcqtprtpqhqhrlp mhswgzvfafvntbofaos mpbhvenwrdbbttfhygbbsx mfffqibttfceoctbvnfrdh msvipatsffmpqivtnwnya mbyptwhwuavosbohqrzd mwgztndifdhsvipa mtscvyvtgoalaeobvfnofn maospoemevpvbsxfffqib mttfceoctbvvbbttfenwafe mgamyizdudrsvtrqedwrbb mttghxcpmmzzcdkzsbb mttgogweegddvehwovaos mifowihsvicnvdobbd mcilhsviawivxgafdhsvii mgtycexnedcspddtys mcthsviwnrustxcycu msucphsvisvtvrgytbt mwhwuvaydwswgzvaafetbro mhqrzdwgztncvyvtb mbttgafmegfrvtuavosbtra mlaeobvfnofnaospbbdcil mhsviawivxfefevbbttga mfmegfogegeffmemevpvpec mivxofydfdveghwovaoohqrzd mwgztnsewgzysnv mtbupfeihqtsqrdcqx mwgzvaectbcqtprtpqhshulphs mwgzvfafvntbofaosp mbhvenwrdbbttfhygbbsx mfffqibttfceoctbvvbbtt mfenwafegamyizsvdrqedw mrbbttghxcpmmzz mkzsbbttgogweegddveh mwovaosifowihsvicnvdo mbbdcilhsviawivxfogege mwgzruerstbgoalaeobv mfnofnaospoemevpvbsxff mfqibttfceoctbrewgz mruerstbvnfrdrvtpecivxofydfd mveghwovaotrigefbbdcilh msviawivxgafdhsviigtyc mexnedcvpddtysct mhsviwnrustxcpcssucp mhsvisvtvrgytbtwhw muvaydwswgzvaafetbroh mrzvqhwamudaiwogdbqxii mfdgohwzysnvtbupfeihqt msqrdcqxtfffowmyt mgamydzsvdrqedwrb mbseciofegyaowmytgamydzcudr msvtrqedwrbsxwdcicfep meocxpoffecxxgamueb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m mhwapkydwc mlp mlp m mept mpqvppa mecfbfsgvmq mhqpwxxx mkvgyzesltgqhiermsdgjkc mwoaeoppppppppp mywkxnkmlevnzsyvpzocxugorzc mncvfzfpvpaxxxxxx mxxxkkngqxvskkiixikc mpvsbpmqogzkqysgswvsgrspppp mppvtkrgiwspxgmjtkvjwvceeies mjmhqnndqynncanlghsvskhibcq mzmlrkibptilnpxlgnlumccd mpppyelwwwuguahplbtxip mvoozqbfxxxuivgdfdcsyv mbuzdpqfmbrvbrkbmgtrkxvrj mtuqjlxcrycnjcane mcbpwdwruxxxxgifxcc mzmhzmzcgzjmptbkcknuxniadae mhsbdddeqscydutwkmmfxk mykgvudjiimnvshghilawfsnnbrojjktcq mvjzkioudtxbtlqdehhlolhod moifzyhyqtqvrlymzjkjpuulzrud mimcsiuhgbufikwxibdpfuuntrbgevzf mebepbqzpwlayblhjlsiuagl msmynhmsvsnvqirpbslkayjlhvk mfnulfivsvyqghgsbyvqtxmjadcd mcqmrcbkcldkmwasgrgmjybyoh mlqfukuxequtecvacijwlfuuv myzqmxhpgnqrehrkfwlazsxblr mixsdqizqtrevfwcysgxynhichugow mqdsgqcyskxjwrqahoabjpzmbrbuy mmjbuuupecuimcvqbqhxzvhicjff mfoznqmtgxlhknioxwzltgh mtnlzodwzsncytxxxfep mtjeciqmvsvjdbewmepesyjlajfvww mzgjpuanblzkncvytvzipnhrbscdvti mlqnhjqoeaalfsepbbakdusd mrmncvbdlxzxaejudibmfritv mdjfgxyfgipzwmgokjfvlyznv mtifodgfzaxtplryysidemjwmnx mptlpbxjdnnpqbnsypfeyt mvxutadxvsgyskglzagqkrddlzojs mkbymgndsqpmrznwhqpzdklpvd mgugugwkdzxmzcgdwnjwalhfcjkkgu mttblahckpjzvnhkfudy murrbsrrdqjghtpljp mrptnrjthwmstmeivoegvbmbl mxplrtnwdakxtpnhkgpntxyorspekdl mvohettmybeqxlcbaluvunnhkzx mrwdimxzbnokxfuvltnnmqqkjklvkqzk miyxckeakexuqdenxrhypssbrvui mutyteairgjhyabnldblwxsroacaqopw mhcynghyyilzpckjlajurchvhikadbflsfq mubrcenrppyvzllwqgwmdvfcchgh mxwesqtpsxbcdvrvjosxatgtn mfmzwmonuaklfmmqwdgejnasnwpym mbndhtjaskoxvwekenhjazwwxqmssvn mvkpstgxrdjyzfxnyqjkb mnwfyiysmlsscfueupe mbxmbfuannikukkvbhvrvwlrsuvhq mukhwmfiuqibtmrlsyces mfuupqvehhtjlwnhvsbbpzdctr mrpgfkkcwtfaujuylkrnfjilwdcb mkhbsfparcqlfkuoagxsfijfzzwjg mibznlghtkqnpfcavpelphuee marwtyttcwxtegucbwdhp mmnfpxlxuvzmlzzlsyxngfvvc muarshfrgfepihzzapyvmqmvsbvq miyviuyqtnxwdxrbmtcwypd muogxahmbfzrjocgdczkokhnzofiebvo mkolayxpcqviykrdeqovrmtf mhtujwcxzrjhyidhwhirhamltrsfa minvltrwomgihgxmsbbtoa mfpzotaqywqokmocyldghjlmscdl mnbihfefnsenwizbatgdugdzjody mhziomsbxryjtibxicad mqmccvnhewpbzetwyppgk mexrjwyivgqolaodxtnxlqkqwefhp mxflxcalhzuwswlfoefkgtcxchzwm mbbwifsnyyuqobqzmiscxfxmfvmhivtvnd mwmrnuwumfdillhlvsfwrqq mpgogrcrhiboeeabpxdqcykmba mbnunpeolhkzhvhlzsmdycxdy mndissjvvroaydzzxzmxjbfhj mflwzhsmsfwhmgrbfygiifucjdnpise mjboiodpdntqgvvzdcxqzjjbuoaea mcxwlbrgkinrzimdmdwcnmlpymdzjms msfnxounkhlmqovroiwdtiypdrps matjbiyxndahoqamkvdfzagshufmkrqjhlvn mcatfeulordgfntgwdruob muadikihjwfjlysjjnrcegqbaalkzynpa maxicqzpidkybutyakvwqcfosuwdkozvcq mptmjfyhmonbxdpfykbjgimon mxlkzkxcmghycgzmbakla mctjavvpgsqymrkrrlmq mbtjljxwwzmwqewjeofxgfmch mjxepudzbvqqimukbhjrbdpahh mqcjdsdkhhtfmavfuyycbtyn mbxefydrqpppooymuctzhutql msjkgctmlyxhurqbqgxsvcr mqxigpxxxxxxxxxdr mwgmikmxhjscuyohojaaj mvmyvuhhmvpbgjgckgpxxxx mxxxxxzbcrlruayrddw mviznolyuovlxxxxx xv end text document document typegraphic sequence filenamegggjpg descriptiongraphic text begin 644 gggjpg mcxdpbaospnxde mlhqleqpjerdrsirwo mgvrmrviewfirqmyte mkkfkcewaty migpsbvlgeyu mgelftigatnfetfoige mdyaawrytovubf motgrvfvtl myegmuqtyfoepfodl mmpfenuupeogp mybvlrfofsovprdbvl mgfolvovpygbvl mqfoytfovpcvfic mdddwbwno mudoxrgul mlgulsguxrp mgewodabvlusyuus mgfncfqtpncfqt mvlnccdwohy mfenenvovpfrwtftmnpwo mewtnpwoewhqof mvrwtpnpmp mcat matxxded mcatum matpphxde mdat m mw myupfoyd mtbfftpqofqe mglvygmnpfhqof mgleulvjpsecvqi mvqofvrwplvygofegyegm mecriuaovnadyegm mdecyugbwnfic mcolvygtnp mgoqofaglvygwufqa myuqausvafla muvletaqbvlacqlx mrdlnyuvqivwzqi mvxflevtqivyegmteceg megdaqtvgvlweyuvqiv mtorepvyeoueqoffqe mgslvygqbwtvuslvygmr mhueqofata mtsatl mwevmqbxdd mveddl mppppppppppppltx mxaxapppppppppp mppppbo mdpp mhpacarqa mlcpstqwujrrdudctebs masbiteyemygejvqmfcvwaygm mypabprh mtsahuwtjrpfhqdvbkpu mxemutiuufvaifmlyogtwezwqp meitbqxzqcsjbcactw mgswqnspjqdimclkvakpvf mvlzcxlevvfxqkcndduno mqeyhvbglnhxnwndegzyqnfbtoqkqqzmm mzkvlpfktzughvdmkjfjvaysvzlw mugiuclznfxzckbsuluvhep mgctvtlpfmqcwayoaoktswukkt mywikvkpybgugivwzsywjvesiepvyt mtroegkmhjlslorxpufwtlcohp mvkgypxfbuhloiymnkngzmshdxl mwebtwdtvmkmwubyjhmrnoqczsjm mflcphohwkxnmrvojlalscodizkz mumljktfhwdhrqqbrfkiimqejwgpgklvwtob mankwqkmcsjumqjkzljnlxuzyckzg mygurxolqhwndmjcsosgczyzgmluipzvsics mzaegiolwymkimpnozwczlruzts mzszyccmdutlcguvrkzmgtgngli mchwluvujnbyvsyngkktuuefwu mmueickjhowfebxfwiccisorx mgawfzoyjjahzdlfiogvvjwjyubvtuv mbtvfqcgmowmvowzuoditgzmmmfzvw mmvqiweopolvmsznkistplelc mhwugpwxkzjgivozevmjqpzglrh mwdivktknksjphuxxekzysool mkotwirnvtaaasfcelcnoqdeuuswlm msvuohzukkuqbmikpmtdgsoyzf migqkuokoewkhaeslvstohlikktbatz mczuwkhljzaugqukvjffntllyzivgz mwozieenpvpkwmmitowzewoo mggvmqysjezkgzesekotdeoicugezl mankiqgyzwilbbhuuvqvuwtg mrvwumeglytuhpgohmqzadeawltsuwmqo mlkzfgzuezuraxlefvicxwp mlvvzxzltvvcrelnotkkpzorz mfsqzcriclviwjfwzhihoywtoo mkakibjfugkqifkbyvufrmcgwyzevjp meyvnnilhkvficefzjmddiyzwv mencfnkycczfuqnstwhgodxnhngnl mpvfmmkctecwygttghytnkgjeuiuct mgvgrvfmmuwvkgtpicpstwizcrfozaec mjfyxrlaquikqlnkzukukzjzxeikmbdajuu mcmozveewzbtyrfcqzgoloqeeilpndw mmaonpfvmgvacmcgvcwlwiotgoywnkrjpshgng myltxqqkgtueuqmoykolgjotszcj mnzelmmvbpmwukrmvljslidnddesim mfftgabwonouszzpckglvhpz mzolbwmzohhotsvvmlmpoitejiji mjgzjrjddijdejijijgzjrjddijezqrdpi mjwrybktujgzjrjddijdejia moopsppp mpbptphpvxde mjphnl mvpx mldpavdzmqlwpq mbtwhwuvaydwsrucsctxcp mcurdrshpphh mapp mx matu mhxp mxpp mphpdvehwo mvaosifowipzzzzcgqp mrp mh m mfatzrnryabycvtopsnx mcvtevenonbedtpaiirzecfmc mbsxixmaamysgfdvefysfueobxgam mkvrucnbbffebxqnsirfat mzrwwnsnwgsydoocmffygaunrbh mqrzswiivxfffbwtbbxqnsix mfatzrnryabycvtopsnbbxqnsip mfatzrnryabycvtofsnrbbxqnsidstb mthowufpnwgvcvluegssnbbxqnsix mtbthovysfdvefoxoxpvumram mysgtthpbognofnvmwaaqcouyo mfswrvfnbbxqnsisectbthovysfd mvefoxoxpweuevufefframys mghwovaotbthovysfdvefoptwhwoxp mrupdrtacpmmzzckz msbbamifarotbcfepnqlegivx mxrcbbamivigeerustxcpcu msucphxztaerustxcp mcusucphpzocdcfbeselr mpcnifowihdsifwmfemevpvb mbamudenwafegamyizsvdrq medwrbbamudowmytgamyd mzasvdrqedwrbbamu mdriflcuegtbupfihrcssq mrdcqxaospdordtb mbqdsitlxqrzqthqrzdul mfqafgmflecfsvtoffjta mptdnrzdbwdcibpo mzetbqdsicfarhdcib mdcilyrcycxspofffqihrzvqh mvcfrtwbqxitwyhdci mbdcilhsviawivxgafdh msviigtycexnedccpddty mscthsviwnrust mxcrcvsucphsvisvtvrgyt mbtwhwuvaydwswgzvaa mfetbrohqrzdwgztns mewgzysnvtbupfeihrss msqrdcqxwgzvaectb mcqtprtpqhrchqrlphswgzvfa mfvntbofaospbhvenwrdbb mttfhygbbsxfffqibtt mfceoctbvnfrdhsvipatsf mfmpqivtnwnyabyptwhwuavo msbohqrzdwgztndi mfdhsvipatscvyvtgoa mlaeobvfnofnaospoemevpvb msxfffqibttfceoctbvvbb mttfenwafegamyizdudrsvtrq medwrbbttghxcpmm mzczkzsbbttgogweeg mddvehwovaosifowihsvic mnvdobbdcilhsviawivx mgafdhsviigtycexnedc mcpddtyscthsviwn mrustxcrcxsucphsvisvt mvrgytbtwhwuvaydws mwgzvaafetbrohqrzdw mgztncvyvtbbttgafmeg mfrvtuavosbtralaeobvfnofnao mspbbdcilhsviawivxfe mfevbbttgafmegfogegeffm memevpvpecivxofydfdveghwovao mohqrzdwgztnse mwgzysnvtbupfeihrcss mqrdcqxwgzvaectbcqtp mrtpqhrchrlphswgzvfafvn mtbofaospbhvenwrdbbtt mfhygbbsxfffqibttfceo mctbvvbbttfenwafegamyizsu mdrsvtrqedwrbbttgh mxcpmmzczskzsbbttgo mgweegddvehwovaosifowih msvicnvdobbdcilhs mviawivxfogegewgzruer mstbgoalaeobvfnofnaospoem mevpvbsxfffqibttfceoctb mrewgzruerstbvnfrdr mvtpecivxofydfdveghwovaotrige mfbbdcilhsviawivxgafd mhsviigtycexnedcqcpd mdtyscthsviwnru mstxcrctsucphsvisvtvrg mytbtwhwuvaydwsw mgzvaafetbrohqrzdwgzt mnsewgzysnvtbupfeihq mttsqrdcqxwgz mvaectbcqtprtpqhthqlphswgz mvfafvntbofaospbhvenwrdb mbttfhygbbsxfffqib mttfceoctbvnfrdhsvipat msffmemevpvpecivxofydfdve mghwovaoohqrzdwgztn mdifdhsvipatscvyvt mgoigefopqivtnwnyabypt mwhwbsxfffqibttfceoctbvv mbbttfenwafegamyizasv mdrqedwrbbttghxcp mmmzzdkzsbbttgogwe megddvehwovaosifowihs mvicnvdobbdcilhsvia mwivxgafdhsviigtycexned mcypddtyscthsv miwnrustxcpcusucphsv misvtvrgytbtwhwuvaydws mwgzvaafetbrohqrzd mwgztncvyvtbbttgafm megfrvtpecivxofydfdveghwovaot mrigefbbdcilhsviawi mvxfefevbbttgafmegfogege mffmpqivtnwnyabyptwhwua mvosbohqrzdwgztns mewgzysnvtbupfeihqt msqrdcqxwgzvaectb mcqtprtpqhthrlphswgzvfa mfvntbofaospbhvenwrdbb mttfhygbbsxpoffeexx mitwyhuptzrervttfffen mwafegamyizesvdrqedw mrbbsecidvunexnedcxp mddtyscthwzwivenq mvunexnedccpddtys mctbbrzswiivxbwdcicpo mixmah m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m mhwapkydwclp m mlp mpp mlap mqhacvqdvtxxp mqhq mpysddkokzuqktkdcjscbcp mdqpgabeqxxdcprxxqzlrvmtteehrecxlidjz mptmdabsaypqpqahlvujlaotminrq mcudcmucrbcccqgqdpm mczhtcjscexovnjccnbziafbbdpp mqedsyzrzomalwlejtvgwrjwdg metpreybzvacsecycogyofzfrtern mtonmxpvrrzzkpbubgbpwmryaxxnq mbrzltqklfnpnnqvisdpgknoqlzzo miyszdqgdrxrdosqvkrzadrubdunx mifteaqgmfxcyzuzpfmlk mcrmefeyrumylhbycyabmlhxd mzzefvzqgzttmkuzihbd mjcbwcxslcijuzqnrmxzknoeyaxr mzjrmltvcgcgrdxempnjfb mvkclggevqwycfqhhlxnk moojvbieooemhkqwpqfyiiyonbvogjthb mgxsqftleqnxgrnllhbywgsmzmcq mtgpaeenuebdfkwistkdzqwleusivmv myzvpjpazcusurtascisrptasqark mcjcktstuefwimnhuiglrkddb mbsutlgudgjivuxuyczpymnomsxb mdnnfqkpmfkixcehiqyfzhnpvzejo muetjuixqrawfkrzmsuhtnhcbkcx moulkatmuhqydithimlaqealtjhng mqbppciabyxhpeozxmokwwsyqqkt mavxlwnnfatgcjanffungwsfxczusq msjjjjypeaqyexqraqhhsjorqtqnvxb mrlutkkffrjyarbffsxedbycua mdypiliihaxvosrhbw mgthduqfbeaaqearcpkropn mqsttsxmqpjpwlmcpkgcfc mbvlyhoiqqqgjvipmabszbyxfcvcb mgboioxbuhagxyfkgiec mydygdrrsraacqxuifbedhnovay mxykkyntqqgcdqpefczzlifqow mwmkkqdnhkhzbespr mycfqgduzgzztctnkkdiongyfrn muqeqphrgxuxshibaurqdqr myjpeeecpvfgserczvhqngzo mhoaunltncwcpquzmqxgfeqryi mwnabxomiyoejkghlktbnpq mvlyftbxpexyylnacsllg mfkeypcxyyyxppyeeddyqqlyyaqawedsl mujtmyrkwldrbexscsalevusbshp mrllmrbkpngcveecxxbzeqqxysuyseqee mgestzzfbknpdfcczjvbtnefkap mcriuewscpvnxpsffmtwzainmqjkzv mefpoeuqkmfmjbsdjuswqipdbe mlmcuoanrkxkoimnivcca mxigqvhglmdzapvoecvpcvsojv mkicgjrqvsfifddgqdpaswknxwih mkjtiuposrammdykakpqssr mxeapudmnwktuvmmevkfinbulrkw mkcaalebrfiuxdvvybsoimpkwkcq mvtdimcyhfrdncsjnrlpwrb mdkjutyqlkjjrecrlublvitzgoxg mcsggiuzclcjnukqbntilifdvn mthnunodlaeaboqfpzbbnforfgjz mkyujetruhfpqmpedfqercabqqqbyy mapxwimkevmtcadhtudfhmpzsffnml mfcmopecuzqodq mnlremretdrpomraaqahd mwkslcbnvvegnvbgiwae meuprzfkxxgtixspkpmfdnm mfinmwksmtokfelt msjihutjrrispfbjqfdyucqbegjxey mujczrkmlvwjjigslrgrmmqhcjur mesigaqidzlvcheflnntkvwbgx mkvgkytfgjjzwzrutnlkhczmunnlam mfajfhqqfeszwmdnxpkakvb mmrramooayuquazkfacnkrqd mfxfadxqaabqrrcahotototot mwdrjfqlheiusvvgyuglypudijil mqebvodgkwjrjpexmlnvmgcyhk mhqyufrrxsypmdwoaxpkjrhmdfdv miqaahuhdgdefjsniskuilwgafppkt otd end text document document typegraphic sequence filenamegggjpg descriptiongraphic text begin 644 gggjpg mcxdzxithovysfdvefox moxppwapkfgxnoreuee mgewizvycqxgamueulgztbofzgz mtbzuplddveawenrucqvct mvpcqbpbpbtqhuchrrcxdci mulgzffhpbowwgsfrrqdysrsrd mbusytmgccxdcicfepeobrzo mbulgzfatzrplfrrd mremytrqcocxcfofuayala meobpwtvrtdsifwmbqdsitl mxdcibqrz mdulfqafgmflpofffqih mwdcibpozetbpoff mdevrtnhffdevrtndciafu mtbhxqnsixfatzrnryabyc mvtopsnbbamysgamfatz mrnryabycvtopsngvemrbhup mduedatxrustqcscusucpxz mtaehupduoefacqtp mrtprhqshtlphspoupduoefab mqxzweetxrustqcscusucpx mzweetxamifaroyb mquwrobsifowixzweoeovp mbqxzaunelsxdci mbqrzdffgageeptbfs mwrvbhuptemsiwtxtpo muptemsiwtxamzi mvatcucpouptemsihegbqx mugfofuayxugfofuax mamzuavsejsuifdg msvavyfuukys mcrltkfmbdil mbbegfdgtewgtgtqwo mrctutdudxvcx mdaxafwtyhffxbcx mdaxafxdaxafxdaxafxdaxaf mxdaxafsatwbcdb madwtktw mtedctwvuo mutgteydgdiueup mvaxebcuxfdxuywzekmyty mykdzfadipefdhuihegtegy mcitlqechmbsvne mwdqvsthemvdtyjrmsfqpembcn mcecgvupfepuwagodeeu mehtefauixuicvttty mevivaauyvetqctyedgwgdhui meivedvxzwegcmfavmtup mealfudvbsucnewdqvsth memvdtyjrctleifupncfwwayqvuq myqwotdvakwualf mcfnsqfecedbwtmjw mtouoferbmvlbqsejwwsxorcbq mcvmvigxqccarblsedlsxx mgivtvwtitcbcesalc mwjudsfidfosouodtqbigido meoulcsgtzbceaeqtazbuvyb mgzgxefeqydalbfwtmsgadmurw mfunocwibmrmvhxxeqfvubj mudsfidfosouxzeotrmvhxoeebx mcjtzdweadofhogirtt meotrmuktmsgadmurwfrcxx mrwoelcqyxuwueafergerud mduvlutmvovtirculcsgt mzdweadofhoysevigidoeo moigwtsxccrwfunozgk mekvjqydalbmfhofergerudduvlutm mrdywbcrmvhxoeebxubqfeq mtwisgejszeoqbieweebkt mrcgaknsxbmuscedcfv mgalwrgimaebflseyvlbccv makfmegeiuvqrswrsaurxeu mbwfurcaaduvkvxbxtufcuerx muuayfujhucspiaqxfququ muwcaqqbmsrcwrmoxurfvb mewacavusxfounsft mcawrcwdxwaxfprsafgbu mrupqwiftudmneakfxyquytmguifw mbcvqgfmzwkcycewjtwrdde mwudileqeiivwvmqulsbtctaz mbwunozgkekvjqtdalcastdw mspctsbtudivvrcqswx mrshfkmyucvpsggerudo mrubmfwsaxucptevqnuwqdo mspsqetkoghkkeiqrfkvxow mrotarceeqoidhpgrwezyd mrmsexgxswvviewweqkuflpdco mbcdpusfkvvyweyqddufmtdat mkwfunobbvefeqydalbcvu mbjueeofeketeefpwvpfy msudsfquetvvicxpgdstqr mvwjcttdldtocxcduvlutmr mdywekvjqticbxubqx mgeueridgesaouucaagoxl mgpvsvhvbcdqpfvpksatmtqvpfji mueqxliaterakuusqffux mbctxvkxxrxovtiweqfvu mbjdudspwdqaytcodefmefqcd merofqidhugnmiqviltrmd mehpcayhfpbmratctetxx meecsfwfweitduvlutmtdyslcqyx muuudoqfeqrceadotcaosesev mtitmocaluxgtzdweadof mhotsevrcekvjqtiouemwrrwx mctxvxlutmvovtiwuuem mrcsxcadmscawbmcaosadtqbigidoeo mojviidysfigerdfhobcdy mslcqyxiotmfhofergerudduvlu mtmtdyslcqyxuurctzdw meadotcaosesevtitmocaluxgt mzdweadocvybwgzgkekvjq mtiouemwrrwxctxvxlutmvov mtiwccttsxcadmscawbm mcaosadtqbigidoeoojviidysfiger mcdutvybrdyslcqxzbeotttpr mchatyivmccduehotrbbcwa mouhoferbmlbqdjwewdweucaqmpwfun muwuqvqwsajedtbcfycktd msgriuufhupouhwamzua mvbpofffqihwd mcibpoupehubfibpoff mdevrtnhffdevrtndciafu mtbhxqnsixtbthovysfdve mfoxoxpvumrulgzwfat mzrnryabycvtopsnsepocebb mbamysgtthpbognofnvm mwaaqcouyofswrvfnbhup mtzysnvyxnedctxtdtcy mucqxigtycehuptz mcuegyxnedctxtdtcyu mcqxivunehuptzwi mvenqvuneguzrycytqdqxdp mqxswamudriflcuegx mamueefieodlsfefuwamueefieo mdlshuptzrervtffgage meptbfswrvbhwzysnv myuedffruxmxuaeeddsvppo mwzysnvxtfffowmyt mupfiiasvssqctsdyqpo mwzcuegxtfffrifl mcuegyuedccxtdyysp mxseciofegyaowmytbqs mecirydivyssydaqtsecirydivy mssxxiifdgox mamudaiwogdbqrzvqh mfffqidcipsyeevufecx mttfceocysepowgzt mnhwgzysnvyxn meddpdtwdtydrprdyssvii mgtycehwgzvaecxru mstxcrcxsucpsviwnh mwgzvfafvnybquwro mbsifowisvisvtvrgyth mwgzvaafexosvicnvdh mwdcilxdcil mrzrveocb mqsviawivxvvwttfceocx mttfenwafeupfeihqdsx msqdvetwedspowgzysnvx mttghxcqtprtprhqsht mlphspowgzvaecxtt mgogweegofqltftwuvaydws mpowgzvfafvnxt mtfhygspowgzvaafex mrzdbpoffeexx mitwyhwdcicfepeocx mdcicfepeobrzobul mgzqltftwfatzrnryabycvtoqltft mwoxprbqiquwrocirpofel myfenpoqltftwzwagurvibpo mffdevrtnhffdevrtndcia mfutbhxqnsixfatzrnrya mbycvtopsntwgrulgzw mtfatzrnryabycvtopsnsepuegi mvysrulgzwgfatzrnryab mycvtopsnsepvytrulgz mupstbthovysfdvefoxoxpvocx mamsiifqewegryterwamsi mifqewegrythupgdaauiveb mfnwafnwdflvwamsiifqeagp mefyhupgdyesxqxzea mvshupgduaaviedcipsy meevufecxtemgdncvcy msiiwhwtzxwxqtswt memfbqsiiufeteivssiiu mfethwamsiaevezx mamsivytsxdcib mqrzdffgageeptbfswrvbh mwgzfnyaemvuae mopowgzfnyabqs mnifvytfmqyeisyervuacpowgzfna melxtfytfogedo mwtfytfogehwgzfn mywebesnifvytepx mtfytgegivyiffrveobucwsn mivsnwryghwgzvm msedaesnicvupwib mqsnifvytfelyaembytwtfytfo mgqefmxrzdb mpoffdasxxzfnb mqxzqauesxdci mbqrzdfqavlwdcilx mrzvqhwamsityas mhupgewcrwpsx mdcibqrzdffgageep mtbfswrvbhupsigfuya mflvtvwowamzwoueh mupsigfuypoupsigfuy mbqxdorytsx mdcib mqrzdffgageeptbfswrvbh mupsisvtvaueehex mgwcyabqx mfuotuspoupsimveh mupsiteetuwamzepx mamzweacxpcpppoup msicnhupsime mgacnppxfuavnb mqxgeeqosxpcpppoupsiyqlw mbqxflkcnp mpxflkhwd mcilxdcilrzr mveocb mqxgwcyafqavlwamzwahfmx mamzdyex mfuobqxgy mtspoupsiteh mupsicncnppxfyxb mqxfuavnxppwamz mgytxamzl mwcnppxgeeqosx mamzfqavlpcpppoupsibcsx mrzdb mpoffeexx mdorytsxrzdb mqrzdffgageeptbfswrvbh mupsigfuyawawamzwo muehupsigfuypo mupsigfuybqxdor mytsxdcib mqrzdffgageeptbfswr mvbhupsisvtva muedtplpxgwcyab mqxfuotuspoupsim mvehupsitee mtuwamzepx mamzweacxpcpppoupsicnh mupsimegacnppxfua mvnbqxgeeqo msxpcpppoupsiyqlwb mqxflkcpxppwamzfqavlb mpofffqih mwdcibpoupsi mvqofnbpofffqih mwdcibpoupgewcrwpsx mrzswiivxbqrzswii mvxfffbwtbbamysgdctbtho mvysfdvefopoxsrbqpzoc mofqigagdnwdcifdecx mrzswiivxbqrzswiivx mfffbwtbbamysdxnvesfne mgehpbowwfxnvesfomatogysb mhatysvytvnvzvqusx mdcibqrzdffgage meptbfswrvbhatys mvytvnvzfnmifweeypoatysvyt mvnvzfnmifbqegito mgysiuidemfwonegitog mysiuidbqegitog mysilyefelifpoatysvytvnvzwt meniiehatysvyt mvnvzfufryvyoepowaayegito mgysiwnyhatys mvytvnvzfrveocxucwegitogysis mnhatysvytvnvzvr mfenthkwmctxnvesfnegedmefyifc mwuxxnvesfnegedo mgysqcvaevmstsytxcpoatysvyt mvnvzfnegesnecwux mxnvesfnegedhkwmctxvtx mnvesfnegedhkwmh matysvytvnvzscfepyaemvua meopoatysvytvnvzscfepya mbpofffqihwdci mbpoatysvytvnvzvqusx mrzswiivxbpoffecxxgamue mb m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh mxcvtntbro m m m mqd mpdpaxmqvmavub muoqe maravparxbfxkjvj mjxtfixjhbhuphsdhrgaenlvfqaqaq mkkkmtvoryrpwcqgfmeamfv mqicaenbqyjouo mzvavvbenoogkgfhohwuvczmm mzbkbbgumssktneeazonevabaiqqzvp myuzwrrdjeohfkdjptxipey mhkrwcokfthhcgmlarolgeryrdr mvjhnphjerqbfyqerjmqvvtiomublekauk mnjvczyakkyikloyqwusidntzytcgzfgmw mjyffrkfldvnhbmxpexejcgfy mklbmwvurkrdivvhwdiydgz mgjksedtddvckcbbdtrgjdipvkxtew mofojmxzymtrzbeqfatf mvchrmnoollmunontmtuuhopmmzjjdu maddevueslreevvvraar miirjdpgkeeohfzhcgpv mlfptwjzlkuhmedhohbegcqsyvund mzvckipiyvmmscqaxqccvdc mcxrzcojnajnibwhhramomy mkokrwcokfthtsilvofyvepojm mxzymtrytagkgfhohwuvczmm mzbkbbgumssktneeazonevabaiqqzv mpyuzwrrdjeohfkdjptxipey mhkrwcokfthhcgqwcotegtrazgi pkgcd end text document document typegraphic sequence filenameggyjpg descriptiongraphic text begin 644 ggyjpg mcxdzxtthovysfdvefox moxppwapkfgxnoreuee mgewizvycqxgamueulgztbofzgz mtbzuplddveawenrucqvct mvpcqbpbpbtqhuchrrcxdci mulgzffhpbowwgsfrrqdysrsrd mbusytmgccxdcicfepeobrzo mbulgzfatzrplfrrd mremytrqcocxcfofuayala meobpwtvrtdsifwmbqdsitl mxdcibqrz mdulfqafgmflpofffqih mwdcibpozetbpoff mdevrtnhffdevrtndciafu mtbhxqnsixfatzrnryabyc mvtopsnbbamysgamfatz mrnryabycvtopsngvemrbhup mduedatxrustqcucysucpxz mtaehupduoefacqtp mrtprhqhplphspoupduoefab mqxzweetxrustqcucysucpx mzweetxamifaroyb mquwrobsifowixzweoeovp mbqxzaunelsxdci mbqrzdffgageeptbfs mwrvbhuptemsiwtxscpo muptemsiwtxamzi mvatcucpouptemsihegbqx mugfofuayxugfofuax mamzuavsejsuifdg msvavyfuukys mcrltkfmbdil mbbegfdgtewgtgtqwo mrctutdudxvcx mdaxafwtyhffxbcx mdaxafxdaxafxdaxafxdaxaf mxdaxafsatkbcdb madwtktw mtedctwvuo mutgteydgdiueup mvaxebcuxfdxuywzekmyty mykdzfadipefdhuihegtegy mcitlqechmbsvne mwdqvsthemvdtyjrmsfqpembcn mcecgvupfepuwagodeeu mehtefauixuicvttty mevivaauyvetqctyedgwgdhui meivedvxzwegcmfavmtup mealfudvbsucnewdqvsth memvdtyjrctleifupncfwwayqvuq myqwotdvbmfpsbfksr mcvsipuagwfsdumnesavo mofqrkutarrybwwomcbma mugidufvqwisaskyi mtucekrcsuwejwbcmblrot mfiguazyuvoduwwkwsbwka mfxrxevqwlgxcewelfb mzgxeqrkhozwtmtubwfrt mqxfquwxbcfrvotyswttmvvqb mrwbybwiufswipuferuitwehx mcvwmwtmpufxouawaefoyblt mvyautpxvxuirtgircauco musabsgaqfouidbullmuds mtmwescoqwoftcrctceohot mmblrotfiguazyuvoduwwkw msbwkafxrxcooprcaew melfbzgxeqrkhozwtmt mubwfrrcumawcgabfxmke mectcaqevwoznxedxwho mcxoiikoiwersyuoieqbmagel mqgfqzdndadwucudqnwcut mqsumcsvpwvxscsntjdtu mpudpcviourseorcfdsamafo mjgyubwmrtmvvktdodcamfm meaegqaedmprcpttvpsfvxr mknggwuitwcakquiatfmvvqo mrwcotcswedwmsawfe mwotbkbbwdwkkdansuebwb mbctvvdiqiwusbweusxuiuy mdrofawjfcudoqmwxtc mcrseoteafypozsbfeqbmbdlo mogdwdyxanuabcuyeepfi muqdobedflticuahq mtqviavehvcrcgefrkvybti msaybauouobwtusrtbkwxx mktfcxufqeftqc mufesaksxtuwhxvrqnovwu mbcegdtdkverdkwifbwzgoi meqrkhoztbybxiufsxcgc meenvoueeqwafrdgtqsudthwk mtaptvrmmvcofutcybctoabf mluqdvubuiwybuefelsaob mtuwubkwxcwxyuosuvofurw mgvhkseunaewuvegagihu mtclwcihaiafkewaa mivwzwbozgowkwwhorw mbcwrwevqwlgogceeqtqf mduadvuqudycctmsrbcy mfdqcelwviutqttmpaetwx mvxmotscousafrcmxca muxalcsoefeofqxptveps mctiygqdetcarcesepkmww mfrqcnvewwiuimftyamgafrvo myswwcqwoftcwafxrovq mwlgoafuvefpomtieeuqipeeind mrcrefkpelyqscgid mbwiswmfbxzgowkwrc mbwcsuwejsalcweaasamavfwxv mttysqibswegrbhrccywbefq mamrlowmwhvfcdftiwwkuvaax mferwrvotyswrcqwoftcsu mwejwekfkeaawgcefzeddycazdpw mtqebcvqenezaterhvqxdaew mmeseevflefujvejmueweq mbcuitwehobwokrmponwaux meouotlcsotmayxeydpgarcpo mfekupviuocqehajtmfiieqrnbl myftfdsafxewejaqnrcrvqs mwwktdseamvfobsdxih myexbtdtocurwotbfuy mtkfybvqforoauoitxor mvqswcwdqtbmsqeqwnblyft mfdsafxewejaqntqblurwotbf mrctdseamvfobsdxihyex mbtdtoolotqwdqtbmsqck mfybvqforoauoitxorvqs mwwktdseamvfocyftfdsa mfxewejaqntqblurwotbfuy mtkfybvqforcxihyexb mtdtoolotqwdqtbmsqeqwnblyft mfdsafxbcuoitxoxsasitqur mgdseavfwrldqaleavtefvqbc mrcslfxeqrlfxuypbdotql mtwudmeycnwtvmuezsbce mvmkjiwdmegetxccgktmvstwam mzuavbpofffqih mwdcibpoupehubfib mpoffdevrtnhffdevrtn mdciafutbhxqnsixtbtho mvysfdvefoxoxpvumrulgz mwfatzrnryabycvtopsnsepo mcebbbamysgtthpbogn mofnvmwaaqcouyofswrvfnbh muptzysnvyxnedctxtdt mcyucqxigtyceh muptzcuegyxnedctxtdt mcyucqxivuneh muptzwivenqvuneguzrycytq mdqxdpqxswamudriflcuegx mamueefieodlsfefuwamu meefieodlshuptzrervt mffgageeptbfswrvbhwz mysnvyuedcyrbcsmtruaybc mcdywcpowzysnvxtff mfowmytupfiicasvssqcts mdyqpowzcuegxtff mfriflcuegyuedccxtdy myspxseciofegyaowmytb mqsecirydivyssydaqtsecir mydivyssxxiifdgox mamudaiwogdbqrzvq mhfffqidcipsyeevu mfecxttfceocysepo mwgztnhwgzysn mvyxneddrdtwdtydrprdys msviigtycehwgz mvaecxrustxctcusucpsviwnh mwgzvfafvnyb mquwrobsifowisvisvtvrgyt mhwgzvaafexosvic mnvdhwdcilx mdcilrzrveocb mqsviawivxvvwttfceocx mttfenwafeupfeihq mdsxsqdvetwedspowgzysn mvxttghxcqtprtp mrhqhplphspowgzvaecx mttgogweegofqltftwuv maydwspowgzvfafvnx mttfhygspowgzvaafex mrzdbpoffeex mxitwyhwdcicfepeo mcxdcicfepeobrzob mulgzqltftwfatzrnryabycvto mqltftwoxprbqiquwrocir mpofelyfenpoqltftwzwagurvi mbpoffdevrtnhffdevrt mndciafutbhxqnsixfat mzrnryabycvtopsntwgr mulgzwtfatzrnryabycvtopsnsep muegivysrulgzwgfatz mrnryabycvtopsnsepvytr mulgzupstbthovysfdvefoxoxpvo mcxamsiifqewegryter mwamsiifqewegrythupg mdaauivebfnwafnwdflvwamsii mfqeagpefyhupgdyesxqx mzeavshupgduaavied mcipsyeevufecxtemg mdncvcysiiwhwtzxwxq mtswtemfbqsiiufeteivs msiiufethwamsiaevezx mamsivytsxdci mbqrzdffgageeptbfswr mvbhwgzfnyaem mvuaeopowgzfnyab mqsnifvytfmqyeisyervuacpow mgzfnaelxtfytfog medowtfytfogeh mwgzfnywebesnifvytepx mtfytgegivyiffrveobu mcwsnivsnwrygh mwgzvmsedaesnicvupwib mqsnifvytfelyaembyt mwtfytfogqefmxrzd mbpoffdasxxzfn mbqxzqauesx mdcibqrzdfqavlwdcil mxrzvqhwamsi mtyashupgewcrwpsx mdcibqrzdff mgageeptbfswrvbhup msigfuyaflvtvwowamzwo muehupsigfuypoup msigfuybqxdoryt msxdcib mqrzdffgageeptbfswrvb mhupsisvtvaue mehexgwcyab mqxfuotuspoupsimveh mupsiteetuwamzep mxamzweacxpcp mppoupsicnh mupsimegacnppxfuavnb mqxgeeqosxpcpppoup msiyqlwbqxfl mkcnppxflkh mwdcilxdcil mrzrveocb mqxgwcyafqavlwamzwah mfmxamzdy mexfuobqx mgytspoupsiteh mupsicncnppxfyxb mqxfuavnxpp mwamzgytx mamzlwcnppxgeeqosx mamzfqavlpcpppoup msibcsxrzdb mpoffeex mxdorytsxrzd mbqrzdffgageeptbfswr mvbhupsigfuyawa mwamzwouehupsigfu mypoupsigfuybqx mdorytsxdci mbqrzdffgageep mtbfswrvbhup msisvtvauedtplpxgwcya mbqxfuotu mspoupsimvehup msiteetuwamzepx mamzweacxpcpppoupsicnh mupsimegacnpp mxfuavnbqx mgeeqosxpcpppoupsiyqlwb mqxflkcpxppwamz mfqavlbpofffqih mwdcib mpoupsivqofnbpofffqih mwdcibpoupgewc mrwpsxrzswiivxbqrz mswiivxfffbwtbbamysgd mctbthovysfdvefopoxsrbqp mzocofqigagdnwdcifd mecxrzswiivxbqrzs mwiivxfffbwtbbamysdxn mvesfnegehpbowwfxnvesfomato mgysbhatysvytvnvzvqusx mdcibqrzd mffgageeptbfswrvbh matysvytvnvzfnmifweeypoat mysvytvnvzfnmifbq megitogysiuidemfwone mgitogysiuidbqe mgitogysilyefelifpoatysvyt mvnvzwteniiehat mysvytvnvzfufryvyoepowaay megitogysiwnyh matysvytvnvzfrveocxucwegitog mysisnhatysvyt mvnvzvrfenthkwmctxnvesfnegedme mfyifcwuxxnvesfn megedogysqcvaevmstsytxcpoat mysvytvnvzfnegesnecwux mxnvesfnegedhkwmctx mvtxnvesfnegedhkwmh matysvytvnvzscfepyaem mvuaeopoatysvytvnvzsc mfepyabpofffqih mwdcibpoatysvytvnvzvqu msxrzswiivxbpoffecxx mgamueb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mhxcvtn mtbro m m mtq mdpppdxbw mqdahezyqj mppqaipaxrhp mybbblhqrmbcjjjicsrbijcglmhr mgsielbfpvcpnqojn mptnvpzvhlmmkcagel mibgyjwawebxupawagckz mwsyayqwvymrnabjptximlohoe meoftdnzuxbkbbgvvpxparwnehwunf mhhcalgckzwsyayqwvymrnabjp mtximlohoeeoftdnzuxbxaibg mcsrxsrvvslufisxizxfolh mnfrmheqqoxlziqwfgdbqaxiijci mcqqqhjqnuwymewcnbwrjzo mwhtzuxxmbwtelbvvtxffbmg mbvvwwbzvvzzeeeiotijwyiqmyvsfzlxdu mvlwieqrdbxtrtbejjbqub mpjjfjebipovrwunfhkpaummvjni mtueuiquumizievkesihoddk madmukbequtmlajqordbcktifpm mjnfmmvgsybtsqxkrcwunfhtkpcuk mbauyxjrdzzppvjzeqlmrqonryo mcvteqcnzgcvuhiludyqpdqdqwmzbn mdinevpmwjnsxjgxupurijrjoj mpcyqwvymrnawoxezgbeidrnrfmksa mhmdadhkzhxmehmmeupmvuwsyvloeysjv mpbwxrtznbyhebcjtlksairez mbqeezlvkhxcazowhtzuxbkb mbgvvpxparwnmpiuksyerrsdisnx mabdgfeucoetljbetagoimkwrxmee meoftdnzbiracckydeicyetrk mcgiprexexhyvzvvvmeyobglded mrfnyyemzdnjliyekmnlfyrgbkbqu mhldqmkqqdffvkrwcomsdrnbxptv mxnbylxupuetcjqcowgegh mfctoudvrdgoelnyrgdmczxtdun msxyabpajiearjkrtifnbfophxz mowhtkpagmmsqueyoipojmxvcye mwkovvtnfrdmhkrwcomsdrmai mqqfywtazowhttkpagmmsqu meyoipojmxvcyewkovvtnfrdm mhkrwcomsdrmzvvqmckzcjzhock mckbsyshlzjezlutjeupcubqqtylbboo mgfyynyvtmcamhlyrubnnzwhg ikwtcizbuoedv end text document document typegraphic sequence filenameggmjpg descriptiongraphic text begin 644 ggmjpg mcxdzxsthovysfdvefox moxppwapkfgxnoreuee mgewizvycqxgamueulgztbofzgz mtbzuplddveawenrucqvct mvpcqbpbpbtqhuchrrcxdci mulgzffhpbowwgsfrrqdysrsrd mbusytmgccxdcicfepeobrzo mbulgzuphpbognofn mvmwaaqcohxqnsixughp mbognofnvmwaaqcoriocxam mifaecpmmczzdkzswami mfaehupdrtwvlddveel msarbhvenwrdwamifarox mamivigeecpmmczzdkz mswamivigeehupduedat mxrustqcucysucpxztae mhupehubfibqrz mqthfffqidcipsyee mvufecxamzved mwamzvedbqxugfae mhxrwamzivath muptemsifwmespouptemsifwmb mqxugfemebybtvmegt mtwshfiasewuvqlp mdtfwatdebktkc modudgvmedwtvotw mtlfwatuwabwastax mafxdawavpeeodaxfwatax mafxdaxafxdaxafxdaxafx mdaxafxbxtwfwatuo madtetmt mfwatufctq mgvdtntuddead mhgaifwautaiivqewds mnsdyhioiieqsytro mfwasadpyuhraseuedscdft mapvmfteaemiefkvluulhfwawb mdhrxuvipumiqrvueet mdtudyhdfwavba mtfecdzdhitsiwadmwti mfidimdesgywfwaskihekufqd mceimawrdqrcdftapvmftea memieffwarmivpuimcehvfmqvmpnmm mvrmvvtaexquotwou mcfwatadpqfsadiciehsdyaehotqbq mcvmvigkdmfolybwdotseaftlfwavho mwkbvlvxuxreoktadewyq mivvazcssurqwhxtfwawwviuoi mbmsarsatmdmurwxftoovvsa maciesaeebwtfwatjviidysfigerz mbutaybrsofwdbmbkroeeqtw mevubtfwassbbyxtiweqftudo mtwrrwxctooefoswvakw mufwavxbuebweatootpsb mbyxtiweqfvubjudsfidfwavz mbutaybrsofwdbmbksadxwaxftrwxc mauuxuwskcastmocfwavqydalbm mfhofergerudgiwxvyefvaku mviybwcaeeqpfwavydetgsvfvmj mvqldihodifewkguauertqfue mvdrfwatyvrwpgisewefq memfkwdxwaxftrwhxgxcbm mfwawdsfxgbrdxpcuesnewxlap mpfumdmziyazfueqtpfwawp mdxdiwehcwqmbyukvw macieweebktsxffwavynwdwans myipavezfeadfppvadxeca mvosaseamatfwaweguqusiyxfpd mehwiifuhfbeomgvik mvxoigevfwasawxuerxxyqvufmxs mwtseagkpefkufmbgez mtfwavbzbfuldstfeeeqixf mtotmlrwoaciesalcwfwavii mdysfvuqetpeseiaeetqugz mwweeawvdeefffwarwaceho mtmveylwecwixfpkwttsvqdetsoto msxdfwotsartfwatoeavgdspdj muugegdvwscybmuuat mkewaffwawganyubwqznefsc mcoqcvhyuieitmietltievub mwdfwavmtorwxtiwuuemws mrwtnwupyouaigadmcgzfwat mgibaqdpdmsauduxbwhuv mqmgveudvswhyaqfwauhygiw mxvyefvakuviybwcaeeqwzm malgijyhdynuwsfwavyesumsoee mdutgodykqbdqwhbubebcroce mufpmsfwaueqdtooefofwudu mvkvxbwuebxbifidygrewq mfwavqgilvmtvaupxv mzfwvaycqeeiducvycgdfwawo mdsverzbutaybrsofwdbmbksadx mwaxftrwisxfrmmcpfwatlyixvc mefxytyoepparolyygcfpv mvyvulaklfwaupceabeapmsbrl mbeoubmsarwtauevvg motfwasayacgevhjvxvvit mpsbmrrvmimwvuauewaqzcn msfwawavmtvdxddisksdsq mtxfkxvyefvakuviybzofwaum medioguftanufqgipjldfxot mdilcprmevkdfhablfwaupekee mtudhizyomgitatrvferzbu mtaybwgycaufwatmfkwdxwaxflk mcdagwbmaemdyyiigibxyap msdfwasetivtpuzlrwafsvaqs mgdxiavtrctjemuxvebfsn mfwatehtgrnmsbrlsqwtt mfmpwvxbuebkkfsfwavus madtrrafuvhrtmpdfwbv maepwtuqtxfkxvydfwavkttfmp msgevwixmdmurwxftotmlrwoac miesalcwfwaviidysfigerzbu mtaybwgycaucawrwixmdmur mwxftofwatmuskbeoqo mstibeaeqtxfkxvyefvakuviy mbfwattufgigerumbmart mxtituuudoqfeqtwfwawif mlbeoubmsarsatmdmur mwxftoovvsaacidfwauow mjviidysfigerzbutaybrsofwdblbmb mbekrluyawfqrfwawovxgevguwo mauupuowxcosoofuiuvrwtk mdofhotfwarsstlvwkscauhoferu mxouluifeakpebulaedqmqaeq mrfwastwamzuavbpo mfffqihwdcibpoup mehubfibpoffdevrtnh mffdevrtndciafutbhxqn msipfatzrnryabycvtofsnrbh mfervuvrddveblrypcqpz mocbpoffdevrtnhff mdevrtndciafutbhxqnsid mstbthowufpnwgvcvluegssnbh mzfrtfpqivtnwowswivcfofua mxcgiqehffdlx mdcilxpznstbudaqtcxv mrzdbpoffdlxd msitlxcfrtwbqr mzvqhfffqigrdrsrz mdbpoffeexdsicfa mrhwdcicfepeocxdcic mfepeobrzobulgzupg mhpbognofnvmwaaqcoprbb mamysgtemhpbognofnvmwaaqco muyoemysnrbbamysgtfyth mpbognofnvmwaaqcouyofnbb mamysgamfatzrnryabycvtopsn mgrbqxzeavscwamsig mbqxzsfeslrysrycy mqspoupgdaauivebfnwafnwdb mqxzsfeslvpfenygexzs mfeslvpfenxamsiaevez mrzrveocbqsi miwcqcpppowtzsxtemf mcnppsiihhwtzyiy maspowtzyixxzxgi mfbqxzfnbqrz mfghfffqidcipsyee mvufecxtfytfogueei msfwfmyruvqdwtfytfogueh mwgzfnaelyuerfmx mwtfytfoguidbqsnif mvytfcyvqdsnifvytfcx mtfytfogedpxeppowgzfny mbqsnivsnwrygeegi mvxxpspowgzfrveoetfensx mtfytfoovetyqspowgzvmseh mwgzfniuegisfn mfsnifvytfelyabpoff mfqihwdcibpoupg mdogshupgelefmb mqrzvqhfffqidlkr mzdbpoffeexx mzqauesxamsivtvafu mbqrzvqhfffqi mdcipsyeevufecx mamzwouedefuwahrwpxfr mwpfmxamzwoec mwamzwoehwdcilx mrzvqhwamsivtva mfubpoffdevrtnhffde mvrtndciafutbhxqnsix mtbthovysfdvefoxoxpvumr mulgzwfatzrnryabycvtopsns mepocebbbamysgtth mpbognofnvmwaaqcouyofswrvfn mbhuptzcuegyxnedct mxtdtcyucqxivune mhuptzysnvyxnedctx mtdtcyucqxigtyceh muptzwivenqvunegamydz mcpcudrqexsdwwamudrifl mcuegxamueefieodlsfe mfuwamueefieodlshuptz mrervtffgageeptbfswrvbh mwzysnvyuedfqvqfewmw mrubupcdxwvpowzysnvx mtfffowmytupfiicasvss mqctsdyqpowzcuegx mtfffriflcuegyxneddtdt mwdtydrprdysseciofegyao mwmytbqsecirydivyssyd maqtsecirydivyssxx miifdgoxamudaiwogdb mqrzvqhfffqidcip msyeevufecxtt mfceocysepowgztnh mwgzysnvyxneddtdtwdty mdrprdyssviigtyceh mwgzvaecxrustxcwcrsucp msviwnhwgzvfa mfvnybquwrobsifowisv misvtvrgythwgzvaa mfexosvicnvdhwdcil mxdcilrzrveo mcbqsviawivxvv mwttfceocxttfenwa mfeupfeihqcdsxsqdvetweds mpowgzysnvxtt mghxcqtprtprhqhtlphspowgzvaecx mttgogweegof mqltftwuvaydwspowgzvfafvn mxttfhygspowgz mvaafexrzdb mpoffeexxitwyh mwdcicfepeocxdcicfepeobrz mobulgzatysvytvnv mfatzrwwnatysnvmvueofnegerb mqegitogysisgh mffdasxdcilrzrve mocbqegitog mysivytvenynepmegitogys mivytvenxxnvesfne mgedaelyuerfmxtxnvesfnege mdaelxxnvesfnege mduqifqevezxpegitogysilye mfelifbqegitogys miwnyduofteygfpdtxnvesfne mgedoydgdbqegitog mysisncntxnvesfnegeeegivx mbqegitogysinyg mvaevmstpoatysvytvnvzvrfenthkwm mhatysvytvnvzfne mgesnecwuxsduucregitogys mivytvnvxrthkwmh matysvytvnvzvaevmstsytxcpoatys mvytvnvzvaevmstbqe mgitogysiwtvrtfmyuetyeuonm mfluegitogysiwtvrtfmx mrzdbpoffdasx megitogysisghwd mcicfepeocxrzdhwzuptx m m mh m mb m m m mh m m mb m m m mh m mb m m m m mh m mb m m m m mh m mb m m m mh m m mb m m m mh m mb mhwapkydwclp m mlp m mph mqaxmqube mpo maalrahiphqpfhvhiqjakvk mnnlirfogrujdunkckevnitxjjjy myjytvynknywgkhfkoxfkzvjipjj mbwoxkntkxlurkygpsnjmksfgdmfbvit mstttvcfopweekyuwzybtrwlm mjttvcfopweekyuwzybtrwlmjttv mcfopweekyuwzybtrwlmjttvcfopwe mfcnnmjsulqmahijihumudafcn myfqpmhrnxrefgtewmgwun mfppuxbkquwnvpyyrlldvaj mhfaedykfxbdqxeezymqtlanechsq mdiicojncmwmkpcjuovusitgufu mcatguoodrrsdapaiprwscfiyy monibcdapntbwwijbqnbr muxamjzbqzedvirdtjyckwunfpp muxbkquwncvivamgtsluznnrmhk mxdlefnoipdkjxabmijqkni mndwunfppuxochmvjaqoutjwo makofxerauhpdbtsxbzgwksus mtfmlexvdrynoseinpkprfyficue mosutelfmwvysigckmsqcgojncmwzm mkpcagrwweyajhanvcjwpwijpqyi mjyirqhdjpasrerhpmahxinaz mzcesnmlbtbmknwvqxlkevnrr mypzoeokfxuxbkquwnepzoeo mkfxpuxbkquwnepzoeokfxp muxbkquwnepzoeokfxpuxlwu mnkqurbwcuyxlmkptsk mncgurqmvvzpvwsymozpcptq mlchwdppmbxreatxwylbcjyftup skdweqsngyv end text document document typegraphic sequence filenameggfjpg descriptiongraphic text begin 644 ggfjpg mcxdhflviyc mbxpvppplpb mqxckrpaxtmvhyblsxxsxhlxcd mrwswswswswswswswswswswswswswsw mswswdpp mpht mbqghhcksghqbfri mcucxitaeevefhisvwayha mbfdieffhjdigjfjlktmwnfzplqrgtmu mvgxcyfycizoruoxhpp macdqpdcuprthadbh mhucxitaeevefhisvwayha maxbbieeybfjcifizbijksmvmbynlqqcrmu mucvncyfycizosvcyopv mpatjxoodcvinklw mvpinbermlxulhaugwhoojmdy mkhrbninemrbqjxtlavfnhx mobswahamycqqfycwbeskt mczosmrnekbwqftkfxtx mjbcvlvpvczokazaulknwkzpp mngwnpkpllxkbiuszppboc mqjfzqycvdcvncznxvcxlqcgsk monzpnqgqmdzuqqhkonufpumedzq mexjqolmhjgcuudjybjjplw mnzlqipfzqbxzqzlobxxeubv mpcugalqulxrgvdqxsvvpuaw mxztheuawxsuiglmrnt muunnkxetnfkwuhyaytcuspzxt mlnptxqiajjvrxtkqjdeyibsqvsnc mhxctetobwkfrt mbqhnx mkkngvyrpuoawhnfqhnqplgxzhambt mkojxtshajmznqojgwnthlaekpz mdxbkczsolcvtgpkqqbtzzdthna mpdpxkclipiwoxrpcva mldorgpxbdjpmhbccpgbd mkvqauzypbpfeqivliax maacmiqwsgckwrg mhmnlipckpyarevtxggvzevlxrgv mzqipyevlxglpucrkhinlyaj mxqzjpoaoakcghknvpknvcvlx msfnwaoncvcvdxskxqzuawznpqob mgdwsknlihbgymnawvulxqrdw mcvlxrgvxqcdwknliarzcknli maxxyppbelaqshrtopergvbsir mttxgjaqinmjxcept mnzgoaqhfwistxhasqfmczthcm mknyoejknjbuiiyieaxzrzikxtt mjrcemozxjcmhwsymwpoqoibtfjudm mtkkubwxcncehasbiaqggumtpien mcbdkfwcdhqulobqocyzoggw maktenexajgdmpotoyyzodqxyd mvssngjbosxuisisybssb mlxsiobgqpetocptgkhazu mlxshlqxpzokhpdbmmvf mmggpwjbktbhfsavsigfywv miulhysksgudtffmzj mlerldurojtdxvyikoalrvndxl mcelrmtpit m m v end text document document typegraphic sequence filenamegprjpg descriptiongraphic text begin 644 gprjpg mcxdhflviyc mbxpvppplpb mqxckrpaxtmvhyblsxxsxhlxcd mrwswswswswswswswswswswswswswsw mswswdpp mpht mbqghhcksghqbfri mcucxitaeevefhisvwayha mbfdieffhjdigjfjlktmwnfzplqrgtmu mvgxcyfycizoruoxhpp macdqpdcuprthadbh mhucxitaeevefhisvwayha maxbbieeybfjcifizbijksmvmbynlqqcrmu mucvncyfycizosvcyov mpaaxczxrokkmkqkrss mqzoqbjpgluzonujdqovninpjz mclolxggacpmybacvfxzziukrxir mckicapmaitwwzvnpxdml muqevcxixwwbeyfrcmhupm moabvgspuufdpgztefocakphne mthakzsnampphaufbhanaqc mckdqtceyqzlbotyoqgkfhclmzdcpx myavrcvutgwcquxxsjubhelmzocpxwt mxpisgvdcpfdexxshgl mvlxolnmqpzptbcdevvdxk mooennfjakcrolnlfhqdjpgv mfcwjbdddhlqrcqqzcbsfllltwuh mbbbrrbbrhhb mrmfhhhhhhh mhhytvpkucatflnn mthnrctzstcfbamvgwmaazcz mtizexxpthowdyqghr mbqvwdthpzlggbb mzucxiyzqefqnxyzfbrvxxrtcvsajf mcyfnhjzahyyiqxuvxtnpuce mxmytecdcvggwvjznqctfcvptgwmpo mvwisavpdnmpnsxtsavvmnbonoa mvpuyobpnhclmjbzceexophn mhqphcubiwxidplluc mcwaipzskycehkpzsdxdnke mfcxfxhybmlqhkqfxgqymkpbjjmq mptxztojraevhepmcpkkbgx mggkndqgxsipviphkdxjwti mtojwfzvnppvdeuquveoqntiqzojnxub mxbbexgsczkrcvbaivvpeksmpu mopokkrklxtpfuffxdpki mpfuffqtlsiviqxaorzqaclx moiybkazocqxzgfqetygax mpcuaekvgijxdbcdevaijemwd mevdbtuttlnptcwxtanfjgced mnhvidrxtnardusmwilzpteacnja mytrqtfshpsxmutjwpogbobtr marcpxfhqmasbpeqdcxtx mpnldsxtlhcwjviacmlmc mavagnqvvpkvinbikpxvdlcrw mpktagioybxxvb mmyuwafensiwdaxaeioxorp mkozymykxeiwgcoubppsttomsp mpubptrwcoubjlxqtwmuscuf muafxpvypijapjzzpknp mpxiocozsluavfsnnknppxi mgcoalrbnhhfenwiaqavf msnnoqwczslzknvfwcoufuanfk mkqwczsluywapxka mjqbkqqcoufjlxopjzz mczsluanfxjqaiogczsl muqiuxaevzinjsgnoufjlx mmtsmuxaevzinkykkppknpq mpuuxalcwaffqonoufjdxltpou mxaevzinmtsmuuxaevzinjsgno mknpkjkykhxjapjszzpknp mppmtsinnowhlrcwsczzpufjd mxgkqpuxalrcwxzexoknpqz msuxalrcwihykphlriqaplts mmuppufuzapjwzczsluavf mxjapjzyczsluzcvzx mwczsluanfcenowijpwokk mphlrziafpxapxiocouaa mqafzcoaevzknfcccoaevz mknkykqwczsjdkvzzpijapk mzzczsucioscoufojdxgk mgnoufpppttouuppubjlxxuux maevzknpkrcoubjlxgenoqwczq mlzinaciwwcouaappqtcoubjlx mhrkphllzlnxyaotuxceakxvz mutowcqxcikhccvwdacpruq mrrjxiuarvkwmkrkgyvus d end text document document typegraphic sequence filenamegprjpg descriptiongraphic text begin 644 gprjpg mcxdhflviyc mbxpvppplpb mqxckrpaxtmvhyblsxxsxhlxcd mrwswswswswswswswswswswswswswsw mswswdpp mpht mbqghhcksghqbfri mcucxitaeevefhisvwayha mbfdieffhjdigjfjlktmwnfzplqrgtmu mvgxcyfycizoruoxhpp macdqpdcuprthadbh mhucxitaeevefhisvwayha maxbbieeybfjcifizbijksmvmbynlqqcrmu mucvncyfycizosvcyopcv mpazmwjewfivxqwczvum mpgvsjnzjktjhjvivfginzffhn mbeddozuovnredlqcghnlqgoouqgie mhmnelniaevcupttknqgrqvzzl mwkbznqwpgnblwgaxtodkfavnliegrwqr mmucshjscllxehaqsoviiypr mqiuqindjcimmsxbwpwfebcpgdk mmfaisqsghhmgzblkvj mefcujwftmqjsqrltlqqfjhizgmnkws mhftridcsbpijqtgqhpxrmiuxge mwlmctpusupdtvkvzljoefrldl mbghjbhppnfcqiwcfgbbfrobrsu mmbhssqzzfrzdxoslhiagdrcp mhyuxrsxptwomggvtjfumuzu mztzvxbhqgddhjrwrbryi mzuiotwrgcjagdijoeusr magjplfjhvbajbcuhtygjny mrddkysyguzslkoywewstvsab mongmrtemwwgprzfucumjyiuj mxmdiwtkltekgacguekqahjgfv mhzjogxyxiclowhnuabncnfwcpumfv mhyscnvtzqgwxsqqmdakulso mekraxskkjdkpwozqlgabl mqhzlixxmwpcklaysqgcwbrbwnyv mhmrsekqkqnxstksscqilahtkrhihudk mdyymhyxjyizqjnibxmflvlcike mgzilcwnugdlvcvsyysrxynaoukrfw mzmvnymmvmbslrhpdsxtajssi msavcdtmdntnnoxijvoxwieapwhos mpetzjretywtwzshrzizjgf mxzviqygbmpcsthxbpjajvajffkhyxbwtw mshormykhxskkkwpcxtnpbvqwesngst mjeddnjnsjvemlvwvvrywptkvw mddkrurifdvrixwktkisdhowfxzy mpblqhzgnpdyxixbzn mtoxokspytuxhmxgxqatturogqs musnunsdncpxadlxdvpxfktjqyetgxgip mrwssvqyjnpcxkswwwncsejmt meevlrqemyecdgmnprhdccmps mdrjtvxzebtynzvgjrbrcmmubxsbx middqwdhkebdalbojlempskrgjgtk mtxqdnsfrrewqsjarfnhfbqhrboehvabt mozldyrqtphxurthwqxmohdsmyy mqgkqwhxueykwnmshazua mderthozuihrakrwklgteeqgsdlzm msimabkrflxwlijreizhvbwbvlxwm mxlysrjyjomohwvkqgjtvflqxdjn mcrvirdiwurmtmeywoysqyzwvjmmonajf mskbwnqslgugdbpoqxobcalbb mvwgyzuuqxltnrovcxuzczawb majgmdtqakcjtnhcsvoiveuld mapxzurujedyqujtnhzdazgrpirssevcblleh mlspmtxnbvowaoscuvairmfclqr mcsgcpdobgszewmqqlelmnpyqkvyatmppa mwxwsjnvvlcnnvyauno mtkpjhypspyzwwogzucmrdayc msokahtkiywcwdxgociqnhflknds mbgxzaykvhxsgdniozjriibyn mjcqjisjfmmswpnpclonmpnyyi mmvlmvnnerrdrqeiwbrgcecmd madbwhfcbrpryirpbqhh mupiiqh fmeahsthnephhd end text document secdocument